<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006801" GROUP_ID="MUSKEL" ID="699206111300025622" MERGED_FROM="" MODIFIED="2008-05-15 06:17:20 +0200" MODIFIED_BY="Renea Johnston" REVIEW_NO="A006-R" REVMAN_SUB_VERSION="5.0.8" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.2">
<COVER_SHEET MODIFIED="2008-05-15 06:17:20 +0200" MODIFIED_BY="Renea Johnston">
<TITLE>Custom-made foot orthoses for the treatment of foot pain</TITLE>
<CONTACT MODIFIED="2008-05-15 06:17:20 +0200" MODIFIED_BY="Renea Johnston"><PERSON ID="DE5E5C0382E26AA20145240A156DED0E" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Fiona</FIRST_NAME><LAST_NAME>Hawke</LAST_NAME><SUFFIX>BApplSci (Pod) Hons</SUFFIX><POSITION>Associate Lecturer in Podiatry</POSITION><EMAIL_1>fiona.hawke@newcastle.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>School of Health Sciences</DEPARTMENT><ORGANISATION>The University of Newcastle</ORGANISATION><ADDRESS_1>Health Precinct</ADDRESS_1><ADDRESS_2>PO Box 127</ADDRESS_2><CITY>Ourimbah</CITY><ZIP>2258</ZIP><REGION>NSW</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 4349 4549</PHONE_1><FAX_1>+61 2 4349 4538</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-05-15 06:17:20 +0200" MODIFIED_BY="Renea Johnston"><PERSON ID="DE5E5C0382E26AA20145240A156DED0E" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Fiona</FIRST_NAME><LAST_NAME>Hawke</LAST_NAME><SUFFIX>BApplSci (Pod) Hons</SUFFIX><POSITION>Associate Lecturer in Podiatry</POSITION><EMAIL_1>fiona.hawke@newcastle.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>School of Health Sciences</DEPARTMENT><ORGANISATION>The University of Newcastle</ORGANISATION><ADDRESS_1>Health Precinct</ADDRESS_1><ADDRESS_2>PO Box 127</ADDRESS_2><CITY>Ourimbah</CITY><ZIP>2258</ZIP><REGION>NSW</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 4349 4549</PHONE_1><FAX_1>+61 2 4349 4538</FAX_1></ADDRESS></PERSON><PERSON ID="12783F8F82E26AA200492FF178234496" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Joshua</FIRST_NAME><LAST_NAME>Burns</LAST_NAME><POSITION>NHMRC Australian Clinical Research Fellow</POSITION><EMAIL_1>JoshuaB2@chw.edu.au</EMAIL_1><URL>http://www.inmr.com.au/ourteam_member.asp?sectionID=1&amp;id=33</URL><MOBILE_PHONE>0413 278 891</MOBILE_PHONE><ADDRESS><DEPARTMENT>Institute for Neuromuscular Research</DEPARTMENT><ORGANISATION>The Children's Hospital at Westmead Clinical School, The University of Sydney</ORGANISATION><ADDRESS_1>Locked Bag 4001</ADDRESS_1><ADDRESS_2>Westmead</ADDRESS_2><CITY>Sydney</CITY><ZIP>2145</ZIP><REGION>New South Wales</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 9845 1228</PHONE_1><FAX_1>+61 2 9845 1317</FAX_1></ADDRESS></PERSON><PERSON ID="17558" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Joel</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Radford</LAST_NAME><EMAIL_1>joel.radford@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>School of Biomedical and Health Sciences</DEPARTMENT><ORGANISATION>University of Western Sydney</ORGANISATION><ADDRESS_1>Building 24, Campbelltown Campus</ADDRESS_1><ADDRESS_2>Locked Bag 1797</ADDRESS_2><CITY>Sydney</CITY><ZIP>1797</ZIP><REGION>New South Wales</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>02 4625 9687</PHONE_1></ADDRESS></PERSON><PERSON ID="DE61ECEA82E26AA20145240AFC33F445" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Verona</FIRST_NAME><LAST_NAME>du Toit</LAST_NAME><POSITION>Senior Lecturer / Head of Program (Podiatry) </POSITION><EMAIL_1>v.dutoit@uws.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>School of Biomedical and Health Sciences</DEPARTMENT><ORGANISATION>University of Western Sydney</ORGANISATION><ADDRESS_1>Building 24, Campbelltown Campus</ADDRESS_1><ADDRESS_2>Locked Bag 1797</ADDRESS_2><CITY>Sydney</CITY><REGION>New South Wales</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 4620 3758</PHONE_1><FAX_1>+61 2 4620 3792</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-05-12 22:07:38 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="11" MONTH="5" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="11" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="14" MONTH="5" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2008-05-12 22:20:14 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-05-12 22:20:14 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>CMSG ID A006-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="16" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-04-23 14:12:30 +1000" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Podiatry program, School of Biomedical and Health Sciences, University of Western Sydney</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Health and Medical Research Council (NHMRC)</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-05-15 14:10:49 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-05-15 14:10:49 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-05-12 22:11:36 +1000" MODIFIED_BY="[Empty name]">Custom-made foot orthoses for the treatment of foot pain </TITLE>
<SUMMARY_BODY MODIFIED="2008-05-15 14:10:49 +1000" MODIFIED_BY="[Empty name]">
<P>This summary of a Cochrane review presents what we know from research about the effect of custom-made foot orthoses for the treatment of foot pain;</P>
<P>
<B>The review shows that in adults who have had painful pes cavus (high arch), for more than one month custom foot orthoses:</B>
</P>
<P>Decreases foot pain after 3 months compared with fake foot orthoses.</P>
<P>
<B>The review shows that for people at least 5 years of age and diagnosed with juvenile idiopathic arthritis (JIA), custom foot orthoses:</B>
</P>
<P>Reduce foot pain after 3 months compared with supportive shoes, but do not reduce foot pain after 3 months compared with using prefabricated neoprene shoe inserts.</P>
<P>
<B>The review shows that in adults with rheumatoid arthritis (RA), custom foot orthoses:</B>
</P>
<P>Reduce rearfoot pain after 3 months, compared with doing nothing, but do not reduce foot pain after 3 years, compared with using fake foot orthoses.</P>
<P>May not reduce pain in the metatarsophalangeal joint (where the big toe meets the foot) after 6 weeks or 3 months any more than wearing supportive shoes or using soft non-custom foot orthoses.</P>
<P>
<B>The review shows that for people diagnosed with plantar fasciitis (heel pain), custom foot orthoses:</B>
</P>
<P>May not reduce foot pain after 3 or 12 months any more than using fake foot orthoses</P>
<P>May not reduce foot pain after 6 weeks or 3 months any more than using night splints to hold your feet in a stretched position while you sleep.  However, using custom foot orthoses and night splints together may reduce foot pain.</P>
<P>May not reduce foot pain after 2-3 months or 1 year any more than non-custom foot orthoses</P>
<P>May not reduce foot pain after 6-8 weeks when used along with a program of stretching exercises or night splints.</P>
<P>May not reduce foot pain after 2 weeks any more than a combined treatment of manipulation, mobilisation and stretching.</P>
<P>
<B>This review shows that for people younger than 60 years of age with painful hallux vagus (a condition where the base of the big toe bulges out sideways, away from the foot) custom-made foot orthoses:</B>
</P>
<P>Reduce foot pain after 6 months compared to no treatment, but may not reduce foot pain after 6 or 12 months compared to surgery.</P>
<P>
<B>Safety of custom foot orthoses</B>
</P>
<P>We often do not have precise information about side effects and complications. This is particularly true for rare but serious side effects. Reported adverse effects included additional foot pain, ankle instability and skin irritation.</P>
<P>
<B>What are custom foot orthoses and what is foot pain?</B>
</P>
<P>This review focuses only on custom ('custom-made') foot orthoses, which are defined in this review as contoured, removable in-shoe devices that are moulded or milled from an impression of the foot (for example a plaster cast, three-dimensional laser scan) and fabricated according to practitioner-prescribed specifications.</P>
<P>Foot pain may be experienced following an injury; long-term overuse; infection; or systemic disease involving any tissue of the foot, including bones, joints, ligaments, muscles, tendons, nerves, skin, and nails. Foot pain can be generalised or more specifically diagnosed according to location (for example heel pain), structure (for example tendon or ligament damage) or condition (for example osteoarthritis).</P>
<P>
<B>Best estimate of what happens to people with foot pain caused by a high arch who use custom foot orthoses compared to a fake foot orthoses:</B>
</P>
<P>After 3 months, a custom-made foot orthoses improves foot pain by 11 more points on a scale of 0 to 100 (possibly as many as 19 points or as few as 3 points).</P>
<P>
<B>Best estimate of what happens to people with RA who have foot pain and who use custom foot orthoses compared to wearing supportive shoes or doing nothing:</B>
</P>
<P>After 3 months, custom-made foot orthoses improve foot pain by 14 more points on a scale of 0 to 100 (possibly as many as 23 points or as few as 5 points). </P>
<P>After 2 and a half years, custom-made foot orthoses improve foot pain. </P>
<P>
<B>Best estimate of what happens to children with JIA who have foot pain and who use custom foot orthoses compared to wearing supportive shoes:</B>
</P>
<P>After 3 months, custom-made foot orthoses improve foot pain by 19 more points on a scale of 0 to 100 (possibly as many as 36 points or as few as 3 points).</P>
<P>
<B>Best estimate of what happens to people with a painful bunion with hallux valgus who use custom foot orthoses:</B>
</P>
<P>After 6 months, custom-made foot orthoses improve foot pain by 9 more points on a scale of 0 to 100 (possibly as many as 17 points or as few as 1 point) compared to doing nothing.</P>
<P>After 6 months, surgery improved foot pain by 10 more points on a scale of 0 to 100 (possibly as many as 18 or as few as 2 points) compared to the custom foot orthoses.</P>
<P>After 12 months, surgery improved foot pain by 17 more points on a scale of 0 to 100 (possibly as many as 25 or as few as 9 points) compared to the custom foot orthoses.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-05-05 12:30:04 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Custom foot orthoses are commonly recommended for the treatment of foot pain.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effectiveness of custom foot orthoses for different types of foot pain. </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-05-05 11:42:52 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2007, Issue 2), MEDLINE (from January 1966), EMBASE (from January 1980), CINAHL (from January 1982) and the Physiotherapy Evidence Database (PEDro) (to June 2007). We also contacted authors of included trials and known researchers in the field and checked the reference lists of included trials to identify trials. No language or publication restrictions were applied.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-05-05 11:42:22 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials and controlled clinical trials evaluating custom-made foot orthoses for any type of foot pain. Outcomes included quantifiable levels of foot pain, function, disability, health-related quality of life, participant satisfaction, adverse effects and compliance.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-05-05 12:30:04 +1000" MODIFIED_BY="[Empty name]">
<P>Two authors independently selected trials, rated methodological quality and cross checked data extraction. Data were analysed separately for different diagnoses of foot pain and follow-up time points.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-05-05 11:51:09 +1000" MODIFIED_BY="[Empty name]">
<P>Eleven trials involving 1332 participants were included: five trials evaluated custom-made foot orthoses for plantar fasciitis (691 participants); three for foot pain in rheumatoid arthritis (231 participants); and one each for foot pain in pes cavus (154 participants), hallux valgus (209 participants) and juvenile idiopathic arthritis (JIA) (47 participants). Comparisons to custom-made foot orthoses included sham orthoses; no intervention; standardised interventions given to all participants; non-custom (prefabricated) foot orthoses; combined manipulation, mobilisation or stretching; night splints; and surgery. Follow up ranged from one week to three years. Custom-made foot orthoses were effective for painful pes cavus (NNTB:5), rearfoot pain in rheumatoid arthritis (NNTB:4), foot pain in JIA (NNTB:3) and painful hallux valgus (NNTB:6); however, surgery was even more effective for hallux valgus and non-custom foot orthoses appeared just as effective for JIA but the analysis may have lacked sufficient power to detect a difference in effect. It is unclear if custom-made foot orthoses were effective for plantar fasciitis or metatarsophalangeal joint pain in rheumatoid arthritis. Custom-made foot orthoses were a safe intervention in all studies.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-05-05 11:51:39 +1000" MODIFIED_BY="[Empty name]">
<P>There is limited evidence on which to base clinical decisions regarding the prescription of custom-made foot orthoses for the treatment of foot pain. Currently, there is gold level evidence for painful pes cavus and silver level evidence for foot pain in JIA, rheumatoid arthritis, plantar fasciitis and hallux valgus.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-05-13 10:02:01 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-05-05 12:26:20 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Description of the condition<BR/>
</B>Foot pain is an unpleasant sensory and emotional experience associated with perceived damage to any tissue below the ankle (<LINK REF="REF-IASP-1994" TYPE="REFERENCE">IASP 1994</LINK>). It may be experienced following direct injury; long-term musculoskeletal overload (for example overuse); infection or systemic disease involving any tissue of the foot, including bones, joints, ligaments, muscles, tendons, apophyses, retinacula, fascia, bursae, nerves, skin, nails and vascular structures. Foot pain can be generalised or more specifically diagnosed according to location (for example heel pain), structure (for example tendon or ligament damage) or condition (for example osteoarthritis).</P>
<P>While large, population-based studies of general foot pain prevalence are lacking, more narrowly focused studies have reported foot pain prevalence at 24% for women and 20% for men aged 18 to 80 years (<LINK REF="REF-Garrow-2004" TYPE="REFERENCE">Garrow 2004</LINK>), 42% for people over 65 years of age (<LINK REF="REF-Badlissi-2005" TYPE="REFERENCE">Badlissi 2005</LINK>) and 14% for adolescents (<LINK REF="REF-Spahn-2004" TYPE="REFERENCE">Spahn 2004</LINK>). Foot pain classified as disabling has been reported by 36% of people aged 70 to 95 years (<LINK REF="REF-Menz-2006" TYPE="REFERENCE">Menz 2006</LINK>) and by 10% of people aged 18 to 80 years (<LINK REF="REF-Garrow-2004" TYPE="REFERENCE">Garrow 2004</LINK>).</P>
<P>Foot pain has been linked to limitations in activities of daily living, disability and deterioration of physical and mental aspects of health-related quality of life (<LINK REF="REF-Benvenuti-1995" TYPE="REFERENCE">Benvenuti 1995</LINK>; <LINK REF="REF-Leveille-1998" TYPE="REFERENCE">Leveille 1998</LINK>; <LINK REF="REF-Menz-2001" TYPE="REFERENCE">Menz 2001</LINK>). Foot pain is more likely to be experienced by people suffering from knee, hip, back or hand and wrist pain or a chronic disease (<LINK REF="REF-Garrow-2004" TYPE="REFERENCE">Garrow 2004</LINK>; <LINK REF="REF-Leveille-1998" TYPE="REFERENCE">Leveille 1998</LINK>; <LINK REF="REF-Menz-2006" TYPE="REFERENCE">Menz 2006</LINK>). Concerning the treatment of foot pain, in a cross-sectional, community-based randomly selected sample of 3417 people, only 36% of persons with disabling foot pain reported receiving foot-related treatment from a healthcare professional (for example a podiatrist, general practitioner or physiotherapist) in the preceding six months (<LINK REF="REF-Garrow-2004" TYPE="REFERENCE">Garrow 2004</LINK>).</P>
<P>
<B>Description of the intervention<BR/>
</B>A wide variety of interventions is available for treating the different types of foot pain, including mechanical interventions, physical therapy, drug therapy and surgery. People with foot pain may be offered just one of these options or several of them in combination. In-shoe foot orthoses are one form of mechanical therapy that is widely prescribed as a conservative treatment for some types of foot pain, particularly for problems occurring during walking and running (<LINK REF="REF-Landorf-2000" TYPE="REFERENCE">Landorf 2000</LINK>). There are many types of foot orthoses available for the treatment of foot pain, ranging from generic 'off-the-shelf' heel pads and contoured prefabricated inner soles to custom-made foot orthoses of varying styles, construction materials, additions and modifications (<LINK REF="REF-Landorf-2004" TYPE="REFERENCE">Landorf 2004</LINK>). Consistent terminology is not always used for these different types, which has caused confusion (<LINK REF="REF-Landorf-2004" TYPE="REFERENCE">Landorf 2004</LINK>).</P>
<P>This review focuses only on custom (custom-made) foot orthoses, which are defined in this review as contoured, removable in-shoe devices that are moulded or milled from an impression of the foot (for example a plaster cast or three-dimensional laser scan) and fabricated according to practitioner-prescribed specifications. There is no international or interdisciplinary consensus for the definition of customised foot orthoses. Readers are advised to check carefully whether the foot orthoses they consider 'custom-made' fall within the definition used in this review.<BR/>
<B>
<BR/>How the intervention might work<BR/>
</B>It is not well understood how custom-made foot orthoses might affect foot pain. There are a number of theoretical explanations, including resisting or facilitating motion (<LINK REF="REF-Nigg-1998" TYPE="REFERENCE">Nigg 1998</LINK>; <LINK REF="REF-Novick-1990" TYPE="REFERENCE">Novick 1990</LINK>; <LINK REF="REF-Stacoff-2000" TYPE="REFERENCE">Stacoff 2000</LINK>); plantar pressure reduction and redistribution (<LINK REF="REF-Cornwall-1997" TYPE="REFERENCE">Cornwall 1997</LINK>; <LINK REF="REF-Novick-1993" TYPE="REFERENCE">Novick 1993</LINK>; <LINK REF="REF-Redmond-2000" TYPE="REFERENCE">Redmond 2000</LINK>); altered muscle activity (<LINK REF="REF-Nawoczenski-1999" TYPE="REFERENCE">Nawoczenski 1999</LINK>; <LINK REF="REF-Tomaro-1993" TYPE="REFERENCE">Tomaro 1993</LINK>) and enhanced proprioception (position sense) (<LINK REF="REF-Nawoczenski-2004" TYPE="REFERENCE">Nawoczenski 2004</LINK>). Scientific evaluation of these theories has posed many challenges for researchers (<LINK REF="REF-Landorf-2000" TYPE="REFERENCE">Landorf 2000</LINK>) and overwhelming support for one particular theoretical model is lacking (<LINK REF="REF-Razeghi-2000" TYPE="REFERENCE">Razeghi 2000</LINK>). It is likely, however, that orthoses have different mechanisms for different types of foot pain.</P>
<P>
<B>Why it is important to do this review<BR/>
</B>A broad but largely uncoordinated body of research that is relevant to the treatment of different types of foot pain with custom-made foot orthoses is accumulating. Inconsistencies in trial methodology, trial quality, orthoses-related terminology and orthosis fabrication have made understanding and assimilating the available evidence particularly challenging for interested groups, including healthcare providers, users and policy decision makers. A systematic review of the effect of custom-made foot orthoses for the treatment of different types of foot pain would assist in this assimilation process and provide a basis for an ongoing appraisal of the custom-made foot orthoses literature.</P>
<P>Custom-made foot orthoses have been evaluated in, or might be evaluated in future updates of, Cochrane systematic reviews on the relative effectiveness of various interventions for specific musculoskeletal conditions (<LINK REF="REF-Ashford-2005" TYPE="REFERENCE">Ashford 2005</LINK>; <LINK REF="REF-Brouwer-2005" TYPE="REFERENCE">Brouwer 2005</LINK>; <LINK REF="REF-Burns-2006a" TYPE="REFERENCE">Burns 2006a</LINK>; <LINK REF="REF-Crawford-2003" TYPE="REFERENCE">Crawford 2003</LINK>; <LINK REF="REF-D_x0027_hondt-2002" TYPE="REFERENCE">D'hondt 2002</LINK>; <LINK REF="REF-Egan-2001" TYPE="REFERENCE">Egan 2001</LINK>; <LINK REF="REF-Ferrari-2004" TYPE="REFERENCE">Ferrari 2004</LINK>; <LINK REF="REF-Rome-2005" TYPE="REFERENCE">Rome 2005</LINK>; <LINK REF="REF-Rome-2007" TYPE="REFERENCE">Rome 2007</LINK>; <LINK REF="REF-Sackley-2007" TYPE="REFERENCE">Sackley 2007</LINK>; <LINK REF="REF-Spencer-2000" TYPE="REFERENCE">Spencer 2000</LINK>; <LINK REF="REF-Thomson-2004" TYPE="REFERENCE">Thomson 2004</LINK>). This review provides an overall evaluation of the effectiveness of custom-made foot orthoses with a specific focus on treating different types of foot pain.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-05-05 12:26:38 +1000" MODIFIED_BY="[Empty name]">
<P>To evaluate the effectiveness of custom-made foot orthoses for the treatment of different types of foot pain.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES MODIFIED="2008-05-05 12:28:15 +1000" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials and controlled clinical trials (as defined by <LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>) of custom-made foot orthoses for the treatment of any type of foot pain.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-05-05 12:28:30 +1000" MODIFIED_BY="[Empty name]">
<P>Participants of any age who reported foot pain of any type, aetiology and duration. Analyses were conducted separately for different diagnoses of foot pain.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-05-05 12:31:59 +1000" MODIFIED_BY="[Empty name]">
<P>All trials investigated custom-made foot orthoses, which were defined in this review as contoured, in-shoe devices that were moulded or milled from an impression of the foot (for example a plaster cast or three-dimensional laser scan) and fabricated according to practitioner-prescribed specifications. All comparative interventions and non-interventions evaluated in trials investigating the effectiveness of custom-made foot orthoses for the treatment of foot pain were included.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-05-05 12:33:28 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
<BR/>The level of a quantifiable measure of foot pain, or the change in the level of pain, after intervention. Any similarly defined outcome measure used to evaluate foot pain was to be considered. Trials investigating the effectiveness of custom-made foot orthoses for the prevention of foot pain or deformity were not included.</P>
<P>
<B>Secondary outcomes</B>
<BR/>(1) Disability or functional ability, or both<BR/>(2) Health-related quality of life<BR/>(3) Participant satisfaction with the intervention<BR/>(4) Adverse events<BR/>(5) Compliance</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-05-05 12:36:59 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Electronic searches</B>
<BR/>The following databases were searched up to June 2007:</P>
<P>(1) MEDLINE (from 1966) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>);<BR/>(2) CINAHL (from 1982) (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>);<BR/>(3) EMBASE (from 1980) (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>);<BR/>(4) Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library </I>2007, Issue 2) (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>); and<BR/>(5) Physiotherapy Evidence Database (PEDro) (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>The search strategies used for each of these databases are displayed under Additional Tables 01 to 05. There were no language restrictions applied.</P>
<P>
<B>Other sources</B>
<BR/>The reference lists of all included trials were checked recursively for other potentially relevant trials. The first authors of included trials and known researchers in the field were contacted via e-mail to assist in identifying unpublished and published trials.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-05-13 10:02:01 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Study selection</B>
<BR/>Two review authors (FH and JB) independently assessed titles and abstracts (where available) of all trials identified by the search. Full-text copies of potentially relevant trials were then assessed independently for inclusion by the same two review authors (FH and JB) using predetermined inclusion criteria. Disagreements were resolved by discussion between authors or, when necessary, arbitration by a third author (JR).<BR/>
<B>
<BR/>Methodological quality assessment</B>
<BR/>The methodological quality of included trials was rated independently by two review authors (FH and JR) using the following criteria as described in the Cochrane Handbook of Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>):<BR/>(1) randomisation;<BR/>(2) concealment of allocation;<BR/>(3) blinding of intervention provider;<BR/>(4) blinding of participants;<BR/>(5) blinding of outcomes assessment;<BR/>(6) handling of withdrawals and losses (analysis by intention to treat);<BR/>(7) completeness of follow up.</P>
<P>Within this review, there were two essential criteria for intention-to-treat (ITT) analyses as defined by the Cochrane Handbook of Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>):<BR/>(1) trial participants were analysed in the groups to which they were randomised regardless of which (or how much) treatment they received; and<BR/>(2) all participants were included in analyses regardless of whether their outcomes were actually collected.</P>
<P>When only the first of the two criteria was fulfilled, this was termed available case analysis. When trials based analyses only on those participants for whom outcomes were measured and who complied with their allocated treatment, this was termed per protocol analysis (also known as treatment received analysis) (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>).</P>
<P>Each criterion, excluding allocation concealment, was assigned a yes, no or unclear classification. Allocation concealment was classified as: adequate (A), unclear (B), inadequate (C), not used (D) in accordance with definitions provided by the Cochrane Musculoskeletal Group (<LINK REF="REF-Maxwell-2006" TYPE="REFERENCE">Maxwell 2006</LINK>) (see <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>Quality criteria for individual trials were summarised using a three-category rank corresponding to overall risk of bias (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>), classified as:<BR/>(1) low, all individual quality criteria met;<BR/>(2) moderate, one or more criteria partially met;<BR/>(3) high, one or more criteria not met.<BR/>
<B>
<BR/>Data extraction<BR/>
</B>One review author (FH) extracted data from included trials using separate, standardised, pilot-tested forms. Two other authors (JR and VdT) independently cross checked extracted data. Study authors were contacted via e-mail and requested to provide missing information or clarification of unclear data, as required. Each author who replied to the initial e-mail was later sent the complete data extraction form for their paper and encouraged to elaborate on clinically relevant information that was not included in the published paper, for example description of interventions. All additions made to the data extraction forms by the authors were italicised and clear notes made that the information presented was obtained through personal communication with the study author. Any disagreement in data extraction was resolved by discussion between review authors (FH, JR and VdT).</P>
<P>
<B>Analysis<I>
<BR/>Measures of treatment effect</I>
</B>
<I>
<BR/>
</I>Where possible, continuous data were extracted and analysed using weighted mean differences (WMD) and 95% confidence intervals (CI). When different measurement scales were used within a single analysis, standardised mean differences (SMD) were estimated. Changes from baseline (mean change scores) were used as the primary outcome. Where change scores with appropriate measures of variability were not available, follow-up scores adjusted for the baseline score on the outcome of interest were to be used, if available. When neither change scores nor baseline-adjusted scores were available with appropriate measures of variability, plain follow-up (final value) scores were used. Change scores, baseline-adjusted scores and plain follow-up scores were combined in the same analysis using WMD when equivalent outcome measures were used (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>). Results for dichotomous data were reported as relative risks (RR) with 95% CI.</P>
<P>
<B>
<I>Crossover trials</I>
</B>
<I>
<BR/>
</I>Crossover trials were included, however, only data from the first phase of interventions were included in analyses (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>) as the effectiveness of wash-out periods for custom-made foot orthoses is unknown.</P>
<P>
<B>
<I>Dealing with missing data</I>
</B>
<I>
<BR/>
</I>Where available, data were extracted from intention-to-treat analyses. If the original researchers did not perform intention-to-treat analyses but sufficient raw data were available to do so, intention-to-treat analysis was to be conducted before entering data into Review Manager to limit attrition bias.</P>
<P>
<B>
<I>Assessment of heterogeneity</I>
</B>
<I>
<BR/>
</I>Three review authors (FH, JB and JR) assessed clinical heterogeneity across trials. When trials were deemed sufficiently clinically homogenous in terms of participants, interventions and outcomes they were combined in meta-analysis. Inter-trial statistical heterogeneity was quantified using I<SUP>2</SUP> (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>). Trials in the meta-analysis were considered to have low statistical heterogeneity if I<SUP>2</SUP> was equal to or less than 25% (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>), in which case a fixed-effect model was used. If I<SUP>2</SUP> was greater than 25%, and the heterogeneity could not be readily explained, a random-effects model was used to incorporate inter-trial heterogeneity (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>).</P>
<P>
<B>
<I>Data synthesis</I>
</B>
<I>
<BR/>
</I>The Cochrane statistical package, Review Manager 4.2 (<LINK REF="REF-Review-Manager-2003" TYPE="REFERENCE">Review Manager 2003</LINK>), was used for statistical analyses. Data were entered into Review Manager by one review author (FH) and checked by a second author (JR) using the double data entry facility.</P>
<P>
<B>
<I>Primary analysis</I>
</B>
<I>
<BR/>
</I>Results were analysed separately for different diagnoses of foot pain. Since the assumption of steady rates of change could not be reasonably justified, trials with differing follow-up periods were not combined (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>).</P>
<P>
<B>
<I>Subgroup analysis</I>
</B>
<I>
<BR/>
</I>Subgroup analyses according to participant age (&lt; 18 years versus &#8805; 18 years) were planned but were not performed due to lack of data.</P>
<P>
<B>
<I>Sensitivity analyses</I>
</B>
<I>
<BR/>
</I>Sensitivity analyses were performed by including only trials of high methodological quality (low to moderate risk of bias). Where all trials had a high risk of bias, sensitivity analyses were performed by excluding trials not concealing allocation or blinding the participants to the intervention group. If one or more outliers were found to contribute to heterogeneity, and a reason for the outlying result was apparent, analyses were performed both with and without outlying trials as a component of the sensitivity analyses (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>).</P>
<P>
<B>Grading the strength of evidence</B>
<BR/>The strength of evidence was graded as platinum, gold, silver or bronze using criteria described in the Cochrane Musculoskeletal Group (CMSG) module scope and in Evidence-based Rheumatology (<LINK REF="REF-Tugwell-2004" TYPE="REFERENCE">Tugwell 2004</LINK>) (see <LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK>).</P>
<P>
<B>Clinical relevance tables </B>
<BR/>Clinical relevance tables were constructed to improve the readability of the review (Additional Tables 09 to 25). These were constructed for the primary outcome (pain) and for adverse effects as per CMSG guidelines. For dichotomous data, the weighted absolute risk difference was calculated using the risk difference (RD) statistic in RevMan; RR - 1 calculated the weighted relative per cent change (<LINK REF="REF-Cates-2004" TYPE="REFERENCE">Cates 2004</LINK>). Becasue all comparisons using dichotomous data found no statistically significant differences between groups, the number needed to treat to benefit (NNTB) and the number needed to treat to harm (NNTH) could not be calculated, as planned.</P>
<P>For continuous outcomes, weighted absolute change was calculated from the WMD statistic in RevMan when outcomes within each analysis were measured on the same scale. For outcomes pooled on different scales, the weighted absolute change was calculated by multiplying the SMD by the baseline SD in the control group. Relative per cent change from baseline was calculated by dividing the absolute benefit by the baseline mean of the control group. For outcomes where a statistically significant difference had been detected, NNTB was calculated using the MID for each outcome and the Wells calculator software available at the Cochrane Musculoskeletal Group's editorial office.</P>
<P>NNTB or NNTH was calculated for each statistically significant estimate of effect for any outcome. Where possible for continuous outcomes, NNT was calculated using:<BR/>(1) the minimal important differences (MID) calculated by Landorf and Radford (<LINK REF="REF-Landorf-2007" TYPE="REFERENCE">Landorf 2007</LINK>) for the Foot Health Status Questionnaire, Foot Function Index and 100 mm visual analogue pain scale; and<BR/>(2) the Wells calculator software available at the Cochrane Musculoskeletal Group's editorial office, based on the theory of Norman et al (<LINK REF="REF-Norman-2001" TYPE="REFERENCE">Norman 2001</LINK>) for determining NNTB based on achieving a MID on a continuous outcome.</P>
<P>MID calculations by Landorf and Radford (<LINK REF="REF-Landorf-2007" TYPE="REFERENCE">Landorf 2007</LINK>) were based on data from two trials evaluating the effectiveness of foot orthoses and low-Dye taping for plantar fasciitis. These estimates are currently the most carefully prepared estimates of MID for foot-related research. MID for types of foot pain other than plantar fasciitis and for interventions other than foot orthoses and low-Dye taping might differ from those used for this review. MID for the 36-Item Short-Form Health Survey (physical functioning and vitality domains) were based on estimates by three expert panels of physicians for Chronic Obstructive Pulmonary Disease, Asthma and Heart Disease (<LINK REF="REF-Wyrwich-2005" TYPE="REFERENCE">Wyrwich 2005</LINK>).</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION MODIFIED="2008-05-07 10:19:50 +1000" MODIFIED_BY="[Empty name]">
<P>Details of individual trials are presented in the 'Characteristics of included studies' table.</P>
<P>
<B>Selection of studies</B>
<BR/>Electronic searches retrieved a total of 389 citations. Of these, 27 were identified as potentially relevant. Personal communication with authors of included trials and known researchers in the field yielded an additional eight potentially relevant trials. Recursive searching of reference lists of included trials did not retrieve any additional potentially relevant trials. In total, 35 potentially relevant trials were identified.</P>
<P>
<B>Excluded studies</B>
<BR/>Twenty-four potentially relevant trials were excluded upon reading the full-text versions. Reasons for exclusion were: eight were not randomised or controlled clinical trials (as defined by <LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>) (<LINK REF="STD-Chao-1996" TYPE="STUDY">Chao 1996</LINK>; <LINK REF="STD-Doxey-1985" TYPE="STUDY">Doxey 1985</LINK>; <LINK REF="STD-Magalhaes-2006" TYPE="STUDY">Magalhaes 2006</LINK>; <LINK REF="STD-Poon-1997" TYPE="STUDY">Poon 1997</LINK>; <LINK REF="STD-Sobel-1999" TYPE="STUDY">Sobel 1999</LINK>; <LINK REF="STD-Stell-1998" TYPE="STUDY">Stell 1998</LINK>; <LINK REF="STD-Torkki-2003" TYPE="STUDY">Torkki 2003</LINK>; <LINK REF="STD-Turlik-1999" TYPE="STUDY">Turlik 1999</LINK>); nine did not evaluate custom-made foot orthoses as defined in this review (<LINK REF="STD-Hodge-1999" TYPE="STUDY">Hodge 1999</LINK>; <LINK REF="STD-Kilmartin-1994" TYPE="STUDY">Kilmartin 1994</LINK>; <LINK REF="STD-Kusumoto-2007" TYPE="STUDY">Kusumoto 2007</LINK>; <LINK REF="STD-Larsen-2002" TYPE="STUDY">Larsen 2002</LINK>; <LINK REF="STD-Meijad-2004" TYPE="STUDY">Meijad 2004</LINK>; <LINK REF="STD-Orteza-1992" TYPE="STUDY">Orteza 1992</LINK>; <LINK REF="STD-Rome-2004" TYPE="STUDY">Rome 2004</LINK>; <LINK REF="STD-Russell-1999" TYPE="STUDY">Russell 1999</LINK>; <LINK REF="STD-Saygi-2005" TYPE="STUDY">Saygi 2005</LINK>); three did not evaluate pain specific to the foot (<LINK REF="STD-Grau-2003" TYPE="STUDY">Grau 2003</LINK>; <LINK REF="STD-Saggini-1996" TYPE="STUDY">Saggini 1996</LINK>; <LINK REF="STD-Wenger-1989" TYPE="STUDY">Wenger 1989</LINK>); three did not report current foot pain as an inclusion criteria (<LINK REF="STD-Postema-1998" TYPE="STUDY">Postema 1998</LINK>; <LINK REF="STD-Wenger-1989" TYPE="STUDY">Wenger 1989</LINK>; <LINK REF="STD-Whitford-2007" TYPE="STUDY">Whitford 2007</LINK>); and one did not evaluate custom-made foot orthoses in such a way that their effect could be isolated (<LINK REF="STD-Lynch-1998" TYPE="STUDY">Lynch 1998</LINK>). Details of individual trials are presented in the table 'Characteristics of excluded studies'.</P>
<P>
<B>Included studies</B>
<BR/>Eleven of the potentially relevant trials fulfilled all criteria for inclusion in the review (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). Electronic searching identified all of these trials. Details of individual trials are presented in the table 'Characteristics of included trials'.</P>
<P>Of the 11 trials included, 10 were parallel-designed randomised controlled trials and one was a crossover randomised controlled trial (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>). The duration of follow up ranged from two months to three years. All trials were published in the English language in peer-reviewed journals between 1996 and 2006.</P>
<P>
<B>Participants</B>
<BR/>A total of 1332 participants were included in the 11 trials. The number of participants recruited in each study ranged from 20 to 255. Of the 10 trials for which adequate details were reported, 889 (72.5%) were female and 337 (27.5%) were male. <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK> did not report gender. Of the 10 trials reporting mean age of participants, mean age within treatment groups ranged from 12.7 to 63 years. <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK> did not report mean age of participants. One trial included primarily children (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>) and seven explicitly excluded children.</P>
<P>
<B>Type of foot pain </B>
<BR/>Custom-made foot orthoses were evaluated for the treatment of foot pain in: plantar fasciitis (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); rheumatoid arthritis (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>); juvenile idiopathic arthritis (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>); pes cavus (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>); and hallux valgus (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>).</P>
<P>
<B>Comparisons</B>
<BR/>There were 12 comparisons made to custom-made foot orthoses. These included sham orthoses, no intervention or an intervention provided to all groups; manipulation, mobilisation and stretching; night splints; surgery for hallux valgus; and seven types of non-customised foot orthoses. Seven trials compared more than two intervention arms (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>). Details of individual interventions are presented in the 'Characteristics of included studies' table.</P>
<P>
<B>Setting</B>
<BR/>Of those trials reporting trial setting, three were set in hospitals (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>), three in university clinics (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) and three in other health centres or clinics (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>). Four reported using multiple centres (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>).</P>
<P>
<B>Source of participants</B>
<BR/>Of those trials reporting recruitment source, three reported recruiting only from centres associated with the research (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>), two only through referrals from other healthcare providers (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>) and two combined advertisements in local media with either recruitment from associated centres (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) or referrals from healthcare providers (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>).</P>
<P>
<B>Method of orthoses customisation</B>
<BR/>All included trials reported fabricating custom-made foot orthoses from impressions of the feet: 10 trials reported taking plaster casts and one (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>) reported scanning the plantar surface of the foot with a three-dimensional laser scanner. Seven trials reported impressions taken from a neutral foot position (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). Five of the 11 trials did not report the experience of the practitioner performing foot impression. Three trials reported that casts were taken by experienced practitioners (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>) and one trial each reported that casts were taken by a podiatrist (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>) and that practitioners reviewed an instructional video on casting technique (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>).</P>
<P>
<B>Orthoses prescription</B>
<BR/>Three trials reported the custom-made foot orthoses prescription process: one used a standardised, previously developed and pilot-tested prescription (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>); one based orthosis selection on devices most commonly prescribed by surveyed podiatrists (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) and one evaluated participants using the orthoses manufacturer's prescription form (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>).<BR/>
<B>
<I>
<BR/>
</I>Orthoses construction materials</B>
<BR/>All trials described the shell material used for custom-made foot orthoses construction. Four used polypropylene (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>); two used ethyl vinyl acetate (EVA) (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>); and one trial each used subortholen (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>), rohadur (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>), polydur (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>), metal particle-reinforced polyolefin (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>) and carbon graphite composite (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). Five of the 11 trials reported incorporating a rear foot heelpost to the shells of the orthoses (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>).</P>
<P>
<B>Orthoses manufacturing</B>
<BR/>Six trials reported using commercial laboratories to manufacture the custom-made foot orthoses (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>) and two trials reported orthoses fabrication by a practitioner involved in the research: one by a participating occupational therapist with at least two years experience in arthritis care and according to clinical protocols (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>) and one by the principal researcher from the Department of Orthopaedics, Lund University Hospital (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). Three trials did not report details of the orthoses manufacturing process (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>).</P>
<P>
<B>Additional instructions</B>
<BR/>Two trials reported providing footwear advice (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>) and one trial each reported providing: identical written instructions specified for the randomised treatment protocol (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>); instruction on caring for the orthoses (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>); and education on a progressive wearing schedule (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>). Two trials explicitly stated that routine treatment was continued throughout the duration of the trial (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>) while one other trial disallowed any other treatment for foot pain throughout the trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). One trial permitted normal daily walking aids (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>) and one trial reported encouraging participants not to change their regular footwear or activity for the duration of the trial (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>). It is unclear for the remaining trials whether these issues were unaddressed or unreported.<BR/>
<B>
<I>
<BR/>
</I>Outcomes</B>
<BR/>Foot pain was an outcome in all 11 trials. Outcome measures of pain included: the pain scale of the Foot Function Index (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>); 100 mm visual analogue scale (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>); the pain domain of the Foot Health Status Questionnaire (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>); the pain scale of the Foot &amp; Ankle Outcome Score (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); and the Numeric Pain Rating Scale 101 (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>).</P>
<P>Function was an outcome in seven trials. Outcome measures of function included: the activity limitation scale of the Foot Function Index (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>); the function domain of the Foot Health Status Questionnaire (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>); the sport and recreation subscale of the Foot and Ankle Outcome Score (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); and the walking component of the Toronto Activities of Daily Living Measure (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>).</P>
<P>Disability (functional ability) was an outcome in four trials. Outcome measures of disability included: the disability scale of the Foot Function Index (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>); the activities of daily living subscale of the Foot and Ankle Outcome Score (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); and the 100 mm 'ability to work' visual analogue scale (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>).</P>
<P>Health-related quality of life was an outcome in three trials. Outcome measures of health-related quality of life included: the four domains of the 36-Item Short-Form Health Survey (physical functioning, general health, vitality and social functioning) (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>); the quality of life subscale of Foot &amp; Ankle Outcome Score (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); and the Health-Related Quality of Life Index (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>).</P>
<P>Participant satisfaction with intervention was an outcome in one trial (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>), measured using 100 mm 'satisfaction' visual analogue scales (0 = totally unsatisfied and 100 = totally satisfied).</P>
<P>Adverse effects were reported by six trials. Three trials reported the number and nature of adverse effects per group (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>), two trials reported only the total number of all adverse effects in each group (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>) and one trial reported only the number of adverse effects in just one group (surgical group) (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>).</P>
<P>Compliance was reported by eight trials. Compliance reports were based on: log book records of use and daily wear time in two trials (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>); participant-reported retrospective use of the intervention in a specified period before the follow-up session in four trials (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>); participant-reported breaks of protocol in one trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>); and unclear methods in one trial (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>). Compliance data in Chalmers (2000) could not be isolated to the first phase of intervention so were not included in the analyses.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-05-12 22:27:34 +1000" MODIFIED_BY="[Empty name]">
<P>Details of methodological quality are reported in Additional <LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>: Methodological quality of included studies.<BR/>
<B>Randomisation</B>
<I>
<BR/>
</I>All participants in all trials were randomly allocated to treatment groups. Allocation sequence was generated using computers (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>), random number table (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>), a lottery method (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>), balanced blocks of four (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>) and undisclosed methods (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>).</P>
<P>
<B>Concealment of allocation</B>
<BR/>Concealment of allocation was adequate in three of the included trials (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). For all other trials, concealment of allocation was unclear from published reports.</P>
<P>
<B>Blinding of intervention provider</B>
<BR/>No included trial blinded the intervention provider. Intervention provider blinding is particularly difficult, if not impossible, to achieve with mechanical therapies such as custom-made foot orthoses. To the review authors' knowledge, blinding of intervention provider has never been reported in any foot orthoses research.</P>
<P>
<B>Blinding of participants</B>
<BR/>Three trials blinded the participants to the intervention(s) provided (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). In these three trials, participant blinding was achieved by comparing custom-made foot orthoses to sham foot orthoses. Sham foot orthoses are developed to have minimal physical effect yet to appear similar enough to the custom-made foot orthoses that participants are unable to determine which treatment they have been provided with.</P>
<P>
<B>Blinding of outcomes assessment</B>
<BR/>Five trials blinded the outcome assessors (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>).</P>
<P>
<B>Handling of withdrawals and losses</B>
<BR/>Three trials based analyses on principles of intention to treat (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>), seven used available case analysis (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>) and one used per protocol analysis (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>), as defined in 'Methodological quality assessment'.</P>
<P>
<B>Completeness of follow up</B>
<BR/>Nine trials obtained measures for at least one key outcome from more than 85% of the participants initially allocated to groups (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>; <LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>; <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>; <LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>; <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). Follow up was achieved for 81% in Pfeffer et al (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>) and 76% in Martin et al (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>).</P>
<P>
<B>Summary ranking of overall risk of bias</B>
<BR/>All 11 trials received a high summary ranking for overall risk of bias. In three trials (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>; <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) this ranking was only given due to the lack of intervention provider blinding. To the review authors' knowledge, this has never been achieved in any foot orthoses research. Without including intervention provider blinding in the summary ranking of overall risk of bias, Burns et al (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>) was at low risk of bias and Conrad et al (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>) and Landorf et al (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) were at moderate risk of bias. Summary ranking remained the same for all other trials.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-05-12 22:42:25 +1000" MODIFIED_BY="[Empty name]">
<P>In total, 482 participants were allocated to a group receiving custom-made foot orthoses and 850 were allocated to a group receiving another intervention or no intervention. Details of all interventions are provided in the table 'Characteristics of included studies'.</P>
<P>Eight of the 11 published trials presented summary statistics appropriate for use in meta-analysis. Of the remaining three trials: Pfeffer et al (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>) presented 95% CI from which SD were calculated (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>); Dimou et al (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>) presented group mean scores in a graph (from which the means were measured) and provided exact inter-group P values (from which SDs were calculated) (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>); and Martin et al (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>) presented only mean change scores for follow up (no SD). Martin et al (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>) did not respond to requests for SDs of mean change scores. As a result, plain follow-up mean scores were calculated from the change and baseline mean scores provided and the SD estimated by carrying forward the SD of baseline scores.</P>
<P>Authors of three trials responded to requests for additional data for use in meta-analyses: Woodburn et al (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>) provided plain scores for all primary outcomes at three months and change scores for pain outcomes at three months (requested due to baseline differences); Chalmers et al (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>) supplied data isolated to the first phase of intervention for six and 12-weeks follow up; and Roos et al (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>) supplied mean change scores and SDs for all Foot and Ankle Outcome Score subscales at six weeks (to allow pooling with other change scores using SMD analysis).</P>
<P>Where possible, analyses were performed using a 0 (worst) to 100 (best) scale. To achieve this, if outcomes were reported on 0 (best) to 100 (worst) scales, group mean scores were multiplied by -1. A second review author (JR) checked all conversions. All estimates of effect using the WMD method applied 0 to 100-point scales unless otherwise indicated.<BR/>
<B>
<BR/>
</B>Details of all custom-made foot orthoses and comparison interventions are provided in the table 'Characteristics of included studies'.</P>
<P>Comparisons are ordered by foot pain type, beginning with the strongest level of evidence (pes cavus, Comparison 01) followed by juvenile idiopathic arthritis (Comparisons 02, 03), rheumatoid arthritis (Comparisons 04, 05, 06), plantar fasciitis (Comparisons 07, 08, 09, 10) then hallux valgus (Comparisons 12, 13).</P>
<P>
<B>Comparison 01: custom-made foot orthoses versus sham orthoses for painful pes cavus<BR/>
</B>Custom-made foot orthoses were compared with sham orthoses for painful pes cavus in one trial (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>), including 154 people assessed at three months.<BR/>
<I>
<B>Foot pain </B>
</I>
<BR/>Difference in foot pain between groups was statistically significant: in favour of custom-made foot orthoses after 3 months with a WMD of 10.90 points (95% CI 3.21 to 18.59; NNT 5, 95% CI 3 to 16) (<LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>The difference in function between groups was statistically significant: in favour of custom-made foot orthoses after 3 months with a WMD of 11.00 (95% CI 3.35 to 18.65; NNT 5, 95% CI 3 to 15).<BR/>
<I>
<B>Health-related quality of life</B>
</I>
<BR/>Differences in health-related quality of life between groups was statistically significant: in favour of custom-made foot orthoses after 3 months for the Medical Outcomes Short Form-36 domains of physical functioning (WMD 9.50, 95% CI 4.07 to 14.93); NNT 4, 95% CI 3 to 9) and vitality (WMD 5.50, 95% CI 0.26 to 10.74; NNT 7, 95% CI 4 to 221); but were not statistically significant for the domains of general health (WMD 0.5, 95% CI -5.70 to 6.70) or social functioning (WMD 2.50, 95% CI -3.28 to 8.28).<BR/>
<I>
<B>Adverse effects</B>
</I>
<BR/>Any difference in total numbers of reported adverse effects between groups was not statistically significant after 3 months (9% versus 15%; RR 0.61, 95% CI 0.26 to 1.48). Reported adverse effects included additional foot pain, ankle instability and skin irritation (<LINK REF="TBL-10" TYPE="TABLE">Table 10</LINK>).<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>Differences in the proportion of participants between the custom-made and sham orthoses groups who reported not using the assigned intervention for most of their shoe wearing time were not statistically significant after 3 months (20% versus 21%; RR 0.98, 95% CI: 0.52 to 1.83).</P>
<P>
<B>Comparison 02: custom-made foot orthoses versus standardised intervention for foot pain in juvenile idiopathic arthritis<BR/>
</B>Custom-made foot orthoses were compared with a standardised intervention of supportive shoes provided to all groups in one trial (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>) including 33 children assessed at three months.<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>The difference in foot pain between groups was statistically significant after 3 months: in favour of custom-made foot orthoses (WMD 19.19, 95% CI 2.88 to 35.50; NNT 3, 95% CI: 2 to 23) (<LINK REF="TBL-11" TYPE="TABLE">Table 11</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>Difference in function between groups was statistically significant after 3 months: in favour of custom-made foot orthoses (WMD 19.38, 95% CI 3.22 to 35.54; NNT 3, 95% CI: 2 to 19).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>Difference in disability between groups was statistically significant after 3 months: in favour of custom-made foot orthoses (WMD 18.55, 95% CI 2.68 to 34.42; NNT 3, 95% CI 2 to 22).</P>
<P>
<B>Comparison 03: custom-made foot orthoses versus non-custom foot orthoses for foot pain in juvenile idiopathic arthritis<BR/>
</B>Custom-made foot orthoses were compared with non-custom foot orthoses (prefabricated neoprene shoe inserts, Spenco Medical Corporation) for juvenile idiopathic arthritis in one trial (<LINK REF="STD-Powell-2005" TYPE="STUDY">Powell 2005</LINK>) including 30 participants assessed at three months.<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>The difference in foot pain between groups was not statistically significant after 3 months (WMD 12.11, 95% CI -4.73 to 28.95) (<LINK REF="TBL-12" TYPE="TABLE">Table 12</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>The difference in function between groups was not statistically significant after 3 months (WMD 11.42, 95% CI -1.07 to 23.91).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>The difference in disability between groups was not statistically significant at 3 months (WMD 14.38, 95% CI -1.46 to 30.22).</P>
<P>
<B>Comparison 04: custom-made foot orthoses versus no intervention or standardised intervention for foot pain in rheumatoid arthritis<BR/>
</B>Custom-made foot orthoses were compared with no intervention or a standard intervention provided to all groups for foot pain in rheumatoid arthritis in two trials, at time points ranging from six weeks to 30 months: <LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK> in 16 people with metatarsophalangeal (MTP) joint pain and <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK> in 101 people with rear foot pain. Comparisons with custom-made foot orthoses included a standard intervention of supportive shoes (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>) and no intervention (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>).<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>Foot pain was assessed after six weeks by one trial (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>). The difference in foot pain between groups after 6 weeks was not statistically significant (WMD 8.40, 95% CI -19.92 to 36.72). Foot pain was assessed after three months by both trials. When data were pooled, the difference between groups was not statistically significant (SMD 0.44, 95% CI -0.10 to 0.98), expressed in units of standard deviations. Since both trials had high risk of bias and neither blinded participants to the intervention, sensitivity analysis was performed by including only the trial that concealed allocation (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). When sensitivity analysis was performed, the difference between groups was statistically significant: in favour of custom-made foot orthoses (SMD 0.59, 95% CI 0.19 to 1.00) equivalent to a WMD of 13.80 (95% CI 4.68 to 22.92; NNT 4 (95% CI 2 to 11), indicating that the result of the meta-analysis is not robust. Further research is needed to investigate the clear effect of custom-made foot orthoses on foot pain in rheumatoid arthritis after three months. <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK> also assessed foot pain as a summary of change over 30 months. The difference between groups was statistically significant: in favour of custom-made foot orthoses (WMD 307.80, 95% CI 67.37 to 548.23; no interpretable scale range) (<LINK REF="TBL-13" TYPE="TABLE">Table 13</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>Foot pain-related function was assessed after six weeks by one trial (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>). The difference between groups was not statistically significant (WMD 0.25, 95% CI -0.52 to 1.02). Function was assessed after three months by both trials. When data was pooled, the difference between groups was not statistically significant (SMD 0.08, 95% CI -0.29 to 0.45). Since both trials had a high risk of bias and neither blinded participants to the intervention, sensitivity analysis was performed by including only the trial that concealed allocation (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). When sensitivity analysis was performed, the difference between groups remained not statistically significant (SMD 0.10, 95% CI -0.30 to 0.50) indicating that the result of meta-analysis is robust. <LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK> also assessed function as a summary of change over 30 months. The difference between groups was not statistically significant (WMD 81.40, 95% CI -86.33 to 249.13; no interpretable scale range).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>Disability was assessed by one trial (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). Differences between groups were not statistically significant after 3 months (WMD 0.60, 95% CI -9.34 to 10.54) but were statistically significant for scores summarising changes over 30 months (WMD 309.10, 95% CI 61.15 to 557.05; no interpretable scale range).<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>Compliance was assessed as a summary of change over 30 months by one trial (<LINK REF="STD-Woodburn-2002" TYPE="STUDY">Woodburn 2002</LINK>). The difference between groups was not statistically significant (96% versus 94%; RR 1.02, 95% CI 0.93 to 1.12).</P>
<P>
<B>Comparison 05: custom-made foot orthoses versus sham orthoses for foot pain in rheumatoid arthritis</B>
<BR/>Custom-made foot orthoses were compared with sham orthoses for the treatment of foot pain in rheumatoid arthritis in one trial (<LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>) including 102 people assessed at 36 months. <B>
<BR/>
<I>Foot pain </I>
</B>
<BR/>The difference in foot pain between groups was not statistically significant after 36 months (WMD 0.90, 95% CI -10.97 to 12.77) (<LINK REF="TBL-14" TYPE="TABLE">Table 14</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>The difference in function between groups was not statistically significant after 36 months (WMD -1.60, 95% CI -10.40 to 7.20).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>Disability was assessed by <LINK REF="STD-Conrad-1996" TYPE="STUDY">Conrad 1996</LINK>, who reported no statistically significant difference between groups at 36 months (WMD 4.20, 95% CI -7.63 to 16.03).<BR/>
<I>
<B>Adverse effects</B>
</I>
<BR/>No participant in either group reported adverse effects of the interventions (<LINK REF="TBL-15" TYPE="TABLE">Table 15</LINK>).<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>The difference in the proportion of participants in the custom-made and sham orthoses groups who reported not wearing their orthoses during the previous 30 days was not statistically significant after 36 months (31% versus 31%; RR 1.00, 95% CI: 0.54 to 1.84).</P>
<P>
<B>Comparison 06: custom-made foot orthoses versus non-custom foot orthoses for foot pain in rheumatoid arthritis</B>
<BR/>Custom-made foot orthoses were compared with non-custom foot orthoses for rheumatoid arthritis in one trial (<LINK REF="STD-Chalmers-2000" TYPE="STUDY">Chalmers 2000</LINK>) including 16 people reporting MTP joint pain in rheumatoid arthritis, assessed at six weeks and three months. Non-custom foot orthoses were soft plastazote orthoses.<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>The difference in foot pain between groups was not statistically significant after 6 weeks (WMD 5.80, 95% CI -14.74 to 26.34) or 3 months (WMD -13.30, 95% CI -32.13 to 5.53) (<LINK REF="TBL-16" TYPE="TABLE">Table 16</LINK> and <LINK REF="TBL-17" TYPE="TABLE">Table 17</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>The difference in function between groups was not statistically significant after 6 weeks (WMD 0.63, 95% CI -0.25 to 1.51) or 3 months (WMD 0.62, 95% CI: -0.54 to 1.78).</P>
<P>
<B>Comparison 07: custom-made foot orthoses versus standardised intervention for plantar fasciitis<BR/>
</B>Custom-made foot orthoses were compared with no intervention or a standard intervention provided to all groups for plantar fasciitis in two trials at time points ranging from six weeks to three months: <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK> in 88 people and <LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK> in 31 people. Standard interventions included Achilles' tendon and plantar fascia stretching (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>) and night splints (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>).<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>Foot pain was assessed at six to eight weeks by both trials. When data were pooled, the difference in foot pain between groups was not statistically significant (SMD 0.05, 95% C: -0.35 to 0.46; expressed in units of SD). Sensitivity analysis could not be performed because: (1) both trials were at high risk of bias; (2) neither study concealed allocation; and (3) neither study blinded participants to the intervention. Therefore, the robustness of this not statistically significant result is unknown. Foot pain was assessed at three months by one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). The difference in foot pain between groups at 3 months was not statistically significant (WMD 6.00, 95% CI -6.75 to 18.75) (<LINK REF="TBL-18" TYPE="TABLE">Table 18</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>Any limitation in function associated with foot pain was assessed by one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). The difference in function between groups was not statistically significant after 6 weeks (WMD -2.24, 95% CI -24.60 to 20.12) or 3 months (WMD -4.00, 95% CI -24.09 to 16.09).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>Disability was assessed by one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). The difference in disability between groups was not statistically significant after 6 weeks (WMD -2.05, 95% CI -17.28 to 13.18) or 3 months (WMD 8.00, 95% CI -4.75 to 20.75).<BR/>
<B>Health-related quality of life</B>
<BR/>Health-related quality of life was assessed by one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). The difference in health-related quality of life between groups was not statistically significant after 6 weeks (WMD 3.69, 95% CI -13.98 to 21.36) or 3 months (WMD 8.00, 95% CI -9.76 to 25.76).<BR/>
<I>
<B>Adverse effects </B>
</I>
<BR/>Adverse effects were reported in the different groups by one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>). The difference in total numbers of participant-reported adverse effects was not statistically significant at 1 week (40% versus 60%; RR 0.67, 95% CI 0.32 to 1.40) or 3 months (36% versus 36%; RR 1.02, 95% CI 0.36 to 2.91). Adverse effects included pressure, pain and sleep disturbance (<LINK REF="TBL-19" TYPE="TABLE">Table 19</LINK>).</P>
<P>
<B>Comparison 08: custom-made foot orthoses versus sham orthoses for plantar fasciitis<BR/>
</B>Custom-made foot orthoses were compared with sham orthoses for plantar fasciitis in one trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>) including 92 people assessed at three and 12 months.<BR/>
<I>
<B>Foot pain </B>
</I>
<BR/>The difference in foot pain between groups was not statistically significant after 3 months (WMD 5.10, 95% CI -5.19 to 15.39) or 12 months (WMD -2.50, 95% CI -12.55 to 7.55) (<LINK REF="TBL-20" TYPE="TABLE">Table 20</LINK>).<BR/>
<I>
<B>Function</B>
</I>
<BR/>Differences in foot pain-related function between groups were statistically significant: after 3 months (WMD 10.40, 95% CI 2.43 to 18.37; NNT 4, 95% CI 2 to 19) and 12 months (WMD 10.40, 95% CI 0.22 to 20.58; NNT 5, 95% CI 3 to &gt; 215), both favouring custom-made foot orthoses over sham orthoses for plantar fasciitis.<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>The difference in the proportion of participants in the custom-made and sham orthoses groups who self reported breaking protocol (for example taken anti-inflammatory drugs, received a corticosteroid injection, used a night stretch splint or used alternative orthoses) was not statistically significant after 3 months (4% versus 9%; RR 0.49, 95% CI 0.09 to 2.53) or 12 months (18% versus 28%; RR 0.64, 95% CI 0.29 to 1.40). Differences remained not statistically significant when including only those participants who reported using alternative foot orthoses: at 3 months (0% versus 4.5%; RR 0.20, 95% CI: 0.01 to 3.96) and 12 months (2% versus 16%; RR 0.14, 95% CI 0.02 to 1.06).<BR/>
<B>
<BR/>Comparison 09: custom-made foot orthoses versus non-custom foot orthoses for plantar fasciitis<BR/>
</B>Custom-made foot orthoses were compared with non-custom foot orthoses for plantar fasciitis in three trials assessed at time points ranging from two to 12 months: <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK> in 90 people; <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK> in 170 people; and <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK> in 190 people. Non-custom foot orthoses included: prefabricated off-the-shelf orthoses (Formthotics, Foot Science International, Christchurch, New Zealand) (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>); over-the-counter arch supports (Foot Soldiers, Professional Footcare International, Valencia, California) (<LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>); felt inserts (Hapad, Bethel Park, PA) (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>); rubber heel cups (Tuli International Comfort Products, San Marcos, CA) (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>); and silicone heel pads (Bauerfeind, Kennesaw, GA) (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>).<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>Foot pain was assessed at two to three months in three trials (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>, <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK> and <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>). Due to the combination of change and plain scores for different measurement scales, data from all three trials could not be pooled in the same meta-analysis. Meta-analysis could be conducted by dropping <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK> from the analysis or by estimating the SD of pain scores for <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>. Since the SD for <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK> are imprecise estimations, <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK> was dropped from the analysis. SMD was, therefore, used to pool results from two trials (<LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK>; <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK> compared custom-made foot orthoses to three different types of non-custom foot orthoses. Since only one group could be combined in this pooled estimate, the non-custom foot orthoses most similar to those used by <LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK> was selected for pooling (the felt insert). When groups were pooled, the difference between the custom-made foot orthoses and the other orthoses groups was not statistically significant (SMD -0.11, 95% CI -0.42 to 0.19). Since all trials were at high risk of bias, sensitivity analysis was performed by only including trials that concealed allocation or blinded participants to the intervention group (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). When sensitivity analysis was performed, the difference between groups remained not statistically significant (SMD -0.21, 95% CI -0.63 to 0.20); equivalent to the WMD of -5.90 (95% CI -17.25 to 5.45), indicating that the result of the meta-analysis is robust. For the other types of non-custom foot orthoses evaluated by <LINK REF="STD-Pfeffer-1999" TYPE="STUDY">Pfeffer 1999</LINK> and <LINK REF="STD-Martin-2001" TYPE="STUDY">Martin 2001</LINK>, the difference in foot pain between groups was not statistically significant at 2 months for rubber heel cups (WMD -8.70, 95% CI: - 22.32 to 4.92) or silicone heel pads (WMD -3.90 points, 95% CI: -15.94 to 8.14), or at 3 months for over-the-counter arch supports (WMD 3.00 points, 95% CI -4.66 to 10.66). Foot pain was assessed at 12 months in one trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). The difference in foot pain between groups was not statistically significant (WMD -7.00 points, 95% CI -17.20 to 3.20).<BR/>
<I>
<B>Function</B>
</I>
<BR/>Function was assessed by one trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). The difference in function between groups was not statistically significant after 3 months (WMD -3.80 points, 95% CI -13.42 to 5.82) or 12 months (WMD -3.40 points, (95% CI -13.44 to 6.64).<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>Compliance was assessed in one trial (<LINK REF="STD-Landorf-2006" TYPE="STUDY">Landorf 2006</LINK>). The difference in the proportion of participants in the custom-made and sham orthoses groups who self reported breaking protocol (for example taken anti-inflammatory drugs, received a corticosteroid injection, used a night stretch splint or used alternative orthoses) was not statistically significant after 3 months (4% versus 9%; RR 0.65, 95% CI 0.11 to 3.71) or 12 months (18% versus 26%; RR 0.69, 95% CI 0.31 to 1.56). Differences remained not statistically significant when including only those participants who reported not using alternative foot orthoses: after 3 months (0% versus 0%; RR not estimable) and 12 months (2% versus 4.7%; RR 0.48, 95% CI 0.04 to 5.08).</P>
<P>
<B>Comparison 10: custom-made foot orthoses versus manipulation, mobilisation and stretching for plantar fasciitis<BR/>
</B>Custom-made foot orthoses were compared with a combined treatment of manipulation, mobilisation and stretching for plantar fasciitis in one trial (<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK>) including 20 people assessed at two weeks, one month and two months.<B>
<BR/>
<I>Foot pain</I>
<BR/>
</B>The difference in foot pain between groups was statistically significant: in favour of manipulation, mobilisation and stretching after 2 weeks (WMD -23.30, 95% CI: -42.67 to -3.93; NNT 2, 95% CI 2 to 30) but was not statistically significant after 1 month (WMD -11.10, 95% CI -28.81 to 6.61) or 2 months (WMD -6.10, 95% CI -21.35 to 9.15) (<LINK REF="TBL-21" TYPE="TABLE">Table 21</LINK>). <B>
<BR/>
<I>Adverse effects</I>
<BR/>
</B>No participant in either group reported any adverse effect.<BR/>
<I>
<B>Compliance</B>
</I>
<B>
<BR/>
</B>
<LINK REF="STD-Dimou-2004" TYPE="STUDY">Dimou 2004</LINK> reported that compliance was "very good". The method used to measure compliance to produce this result was unclear.</P>
<P>
<B>Comparison 11: custom-made foot orthoses versus night splint for plantar fasciitis<BR/>
</B>Custom-made foot orthoses were compared with night splints for plantar fasciitis in one trial (<LINK REF="STD-Roos-2006" TYPE="STUDY">Roos 2006</LINK>) including 29 participants assessed at six weeks and three months. Details of the interventions are provided in the table 'Characteristics of included studies'.<B>
<BR/>
<I>Foot pain</I>
<BR/>
</B>The difference in foot pain between groups was not statistically significant after 6 weeks (WMD -0.89, 95% CI -14.51 to 12.73) or 3 months (WMD 6.00, 95% CI -12.72 to 24.72) (<LINK REF="TBL-22" TYPE="TABLE">Table 22</LINK>).<B>
<BR/>
<I>Function</I>
<BR/>
</B>The difference in function between groups was not statistically significant after 6 weeks (WMD -15.01, 95% CI -34.78 to 4.76) or 3 months (WMD -1.00, 95% CI -24.38 to 22.38).<B>
<BR/>
<I>Disability</I>
<BR/>
</B>The difference in disability between groups was not statistically significant after 6 weeks (WMD 1.05, 95% CI -14.64 to 16.74) or 3 months (WMD 1.00, 95% CI -16.54 to 18.54).<B>
<BR/>
<I>Health-related quality of life</I>
<BR/>
</B>The difference in health-related quality of life between groups was not statistically significant at 6 weeks (WMD -5.99, 95% CI -23.69 to 11.71) or 3 months (WMD 9.00, 95% CI -11.35 to 29.35).<B>
<BR/>
<I>Adverse effects</I>
<BR/>
</B>The difference in participant-reported adverse effects between the orthoses and night splint groups was not statistically significant at 6 weeks (23% versus 60%; RR 0.38, 95% CI 0.13 to 1.13) or 3 months (11% versus 36%; RR 0.31, 95% CI 0.04 to 2.25). Adverse effects included pressure-related pain and tiredness of the foot in the orthoses group and pressure, pain and sleep disturbance in the night splint group (<LINK REF="TBL-23" TYPE="TABLE">Table 23</LINK>). <B>
<BR/>
<I>Compliance</I>
<BR/>
</B>The difference in compliance between orthoses and night splint groups was not statistically significant at 3 months (RR 1.17, 95% CI 0.76 to 1.79).</P>
<P>
<B>Comparison 12: custom-made foot orthoses versus no intervention for painful bunion with hallux valgus<BR/>
</B>Custom-made foot orthoses were compared with no intervention for painful hallux valgus in one trial (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>) including 138 people assessed at six and 12 months.<BR/>
<I>
<B>Foot pain</B>
</I>
<BR/>Differences in foot pain between groups were statistically significant after 6 months (WMD 9.00, 95% CI 1.16 to 16.84; NNT 6, 95% CI 3 to 52) but not after 12 months (WMD 0.00, 95% CI -8.19 to 8.19) (<LINK REF="TBL-24" TYPE="TABLE">Table 24</LINK>).<BR/>
<I>
<B>Disability</B>
</I>
<BR/>Differences in foot pain between groups were not statistically significant after 6 months (WMD 4.00, 95% CI -4.86 to 12.86) or 12 months (WMD -2.00, 95% CI -10.51 to 6.51).<BR/>
<I>
<B>Health-related quality of life</B>
</I>
<BR/>Differences in health-related quality of life between groups were not statistically significant after 6 months (WMD 1.50, 95% CI -0.97 to 3.97) or 12 months (WMD 0.50, 95% CI -1.90 to 2.90).<BR/>
<I>
<B>Participant satisfaction with intervention</B>
</I>
<BR/>Differences in foot pain between groups were statistically significant after 6 months (WMD 25.00, 95% CI 14.52 to 35.48; NNT not calculable due to unknown MID) but not after 12 months (WMD 9.00, 95% CI -1.67 to 19.67).<BR/>
<I>
<B>Compliance</B>
</I>
<BR/>The difference in compliance between groups was not statistically significant after 12 months (97% versus 94%; RR 1.03, 95% CI 0.96 to 1.11).</P>
<P>
<B>Comparison 13: custom-made foot orthoses versus surgery for painful bunion with hallux valgus<BR/>
</B>Custom-made foot orthoses were compared with surgery for painful bunion with hallux valgus in one trial (<LINK REF="STD-Torkki-2001" TYPE="STUDY">Torkki 2001</LINK>) including 140 people assessed at six and 12 months.<B>
<BR/>
<I>Foot pain</I>
<BR/>
</B>The difference in foot pain between groups was statistically significant: in favour of surgery at 6 months (WMD -10.00, 95% CI -17.79 to -2.21; NNT 5, 95% CI 3 to 33) and 12 months (WMD -17.00, 95% CI -24.62 to -9.38; NNT 3, 95% CI 2 to 5) (<LINK REF="TBL-25" TYPE="TABLE">Table 25</LINK>).<B>
<BR/>
<I>Disability</I>
<BR/>
</B>The difference in disability between groups was not statistically significant at 6 months (WMD -1.00, 95% CI -9.12 to 7.12) but was statistically significant in favour of surgery at 12 months (WMD -8.00, 95% CI -15.56 to -0.44; NNT not calculable due to unknown MID).<B>
<BR/>
<I>Health-related quality of life</I>
<BR/>
</B>The difference in health-related quality of life between groups was not statistically significant at 6 months (WMD 0.00, 95% CI -2.29 to 2.29) or 12 months (WMD -0.20 points, 95% CI -2.39 to 1.99).<B>
<BR/>
<I>Participant satisfaction with intervention</I>
<BR/>
</B>Differences in participant satisfaction with the intervention was not statistically significant between groups at 6 months (WMD -8.00, 95% CI -17.65 to 1.65) but was statistically significant in favour of surgery at 12 months (WMD -10.00, 95% CI -18.95 to -1.05; NNT not calculable due to unknown MID).<B>
<BR/>
<I>Adverse effects</I>
<BR/>
</B>Differences in adverse effects between groups could not be calculated as adverse effects were only reported for the surgery group. <B>
<BR/>
<I>Compliance</I>
<BR/>
</B>The difference in the proportion of participants in the custom-made foot orthoses group who reported retrospective use of orthoses at least six days per week to the proportion of participants in the surgery group who received surgery was not statistically significant at 6 months (96% versus 93%; RR 1.01, 95% CI 0.93 to 1.11) or 12 months (97% versus 93%; RR 1.04, 95% CI 0.97 to 1.13).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-05-07 13:21:24 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Strength of evidence</B>
<BR/>Since the different types of foot pain were analysed separately, an overall conclusion regarding the effectiveness of custom-made foot orthoses for the treatment of foot pain cannot be drawn and all results cannot be classified into a single 'level of evidence'. The levels of evidence for the primary outcome (pain) and the most commonly reported secondary outcome (function) are presented below, beginning with the strongest evidence (summarised further in <LINK REF="TBL-26" TYPE="TABLE">Table 26</LINK>).</P>
<P>
<B>
<I>Painful pes cavus</I>
</B>
<BR/>There is gold level evidence that custom-made foot orthoses are more effective than sham orthoses for reducing foot pain and improving function after three months in people aged 18 years or older with bilateral pes cavus and musculoskeletal foot pain of more than one month duration.</P>
<P>
<B>
<I>Juvenile idiopathic arthritis<BR/>
</I>
</B>There is silver level evidence that for people at least five years of age and diagnosed with juvenile idiopathic arthritis, custom-made foot orthoses are:<BR/>
</P>
<UL>
<LI>more effective than a standardised intervention of supportive shoes for reducing foot pain and improving function, after three months;</LI>
<LI>not more effective than prefabricated neoprene shoe inserts for reducing foot pain or improving function, after three months.</LI>
</UL>
<P>
<B>
<I>Rheumatoid arthritis<BR/>
</I>
</B>There is silver level evidence that for people diagnosed with rheumatoid arthritis, custom-made foot orthoses are:<BR/>
</P>
<UL>
<LI>more effective than no intervention for reducing rearfoot pain but not for improving function, after three months and as a summary of change over 30 months;</LI>
<LI>not more effective than sham orthoses for reducing foot pain or improving function, after 36 months;</LI>
<LI>not more effective than a standard intervention of supportive shoes for reducing metatarsophalangeal (MTP) joint pain or improving function, after six weeks or three months;</LI>
<LI>not more effective than soft plastazote non-custom foot orthoses for reducing MTP joint pain or improving function, after six weeks or three months.</LI>
</UL>
<P>
<B>
<I>Plantar fasciitis</I>
</B>
<BR/>There is silver level evidence that for people diagnosed with plantar fasciitis, custom-made foot orthoses:<BR/>
</P>
<UL>
<LI>are more effective than sham orthoses for improving function, but not for reducing foot pain, after three and 12 months;</LI>
<LI>are not more effective than night splints but do increase the effectiveness of a standard intervention of night splints for reducing foot pain or improving function, after six weeks or three months;</LI>
<LI>are not more effective than non-custom foot orthoses for reducing foot pain or improving function, after two to three months or 12 months;</LI>
<LI>do not increase the effectiveness of a standard intervention of Achilles' tendon and plantar fascia stretching or night splints for reducing foot pain, after six to eight weeks;</LI>
<LI>are less effective than a combined treatment of manipulation/mobilisation/stretching for reducing foot pain after two weeks, but not after one or two months.</LI>
</UL>
<P>
<B>
<I>Painful hallux valgus </I>
</B>
<BR/>There is silver level evidence that for people aged less than 60 years with a painful bunion, mild to moderate hallux valgus and no limitation of the first MTP joint range of motion, custom-made foot orthoses are less effective than surgery for reducing foot pain after six or 12 months of wear but are more effective than no intervention for reducing foot pain after six months but not after 12 months of wear.</P>
<P>
<B>Effect of custom-made foot orthoses over time</B>
<BR/>From the available evidence, it does not appear that there is a linear time-effect relationship between the use of custom-made foot orthoses and pain reduction; that is, custom-made foot orthoses do not seem to reduce foot pain incrementally over time. In contrast, the difference between groups tended to decrease over time. This could be due to the natural history of pain resolving over time or a relative reduction in effectiveness of custom-made foot orthoses over time, from: (1) reduced mechanical or a psychophysiological effect of the custom-made foot orthoses, or both; or (2) a continued increasing effect of comparison interventions.</P>
<P>
<B>Clinical applicability</B>
<BR/>The findings of research can only be safely applied to clinical practice when there is reasonable similarity between clinical practice and the research protocol; in this case between the types of foot pain, participants and custom foot orthoses evaluated within included trials. Due to the marked variation among included trials, all analyses within this review contain data from only one, two or three trials. The vast majority of analyses contain data from only one trial. The applicability of results from these analyses is the same as those of the primary trials. For analyses where data from two or three trials were pooled, the applicability extends across the characteristics of all trials pooled. Information to guide applicability of these comparisons is available in the table 'Characteristics of included studies'.<BR/>
<BR/>
<B>Limitations of included trials</B>
<BR/>All included trials have methodological limitations that, according to the grading system used in this review, expose trial findings to a high risk of bias. The only criterion unmet by all trials was intervention provider blinding, which is inherently difficult in orthotic therapy as: (1) it is standard clinical practice for the practitioner to check the fit of the orthoses to the feet; and (2) practitioners are typically able to differentiate between custom-made and sham orthoses. As a result, there exists the risk in all trials that intervention providers may have intentionally or unintentionally influenced participants with their preconceived expectations of intervention effectiveness. Unless a feasible method is devised to achieve intervention provider blinding while maintaining high standards of clinical care, this risk will remain as a potential source of bias in all future randomised trials evaluating custom-made foot orthoses.</P>
<P>Trials with more participants tended to detect statistically significant differences in favour of custom-made foot orthoses over no intervention, standardised intervention or sham orthoses for reducing pain, while trials with fewer participants did not. This might be due to type II errors within the statistical analyses of data from small samples; that is, failure to detect true differences in effects between interventions (<LINK REF="REF-Keech-2007" TYPE="REFERENCE">Keech 2007</LINK>). For all future research, minimum sample size should be calculated a priori to ensure analyses are adequately powered to detect a clinically important difference in effectiveness between the interventions evaluated.</P>
<P>
<B>Limitations of available evidence</B>
<BR/>The evidence base of custom-made foot orthoses for the treatment of foot pain is incomplete. Many clinically important aspects of custom-made foot orthotic therapy have not been evaluated in randomised or controlled clinical trials. The following list identifies just some of the evidence gaps in the current body of literature.</P>
<UL>
<LI>Effectiveness of custom-made foot orthoses for the treatment of foot pain other than in plantar fasciitis, rheumatoid and juvenile idiopathic arthritis, painful pes cavus and painful hallux valgus. For example, in osteoarthritis, diabetes, tendinopathies (particularly tibialis posterior dysfunction), stress fractures, compression neuropathies (e.g. interdigital neuroma), sesamoiditis, metatarsalgia or painful plantar callosities (hyperkeratosis).</LI>
<LI>Effectiveness of custom-made foot orthoses for the treatment of foot pain in children other than for juvenile idiopathic arthritis.</LI>
<LI>Effectiveness of custom-made foot orthoses for the treatment of foot pain experienced during moderate to heavy physical activity, e.g. within sporting or military populations.</LI>
<LI>The difference in effectiveness between the many styles, modifications, construction materials or prescription rationales of custom-made foot orthoses for the treatment of foot pain.</LI>
<LI>Whether improvements can be maintained or additional clinical benefits achieved by using custom-made foot orthoses for a period longer than 36 months.</LI>
</UL>
<P>
<B>Limitations of the review</B>
</P>
<P>
<B>
<I>Defining custom foot orthoses </I>
</B>
<BR/>There is no international or interdisciplinary consensus for defining custom-made foot orthoses. As a result, the definition used in this review might be different to that used by some other healthcare providers. Where this is the case, readers are advised to refer to the table 'Characteristics of excluded studies' to determine if they consider the foot orthoses excluded from this review as being custom made.<BR/>
<B>
<BR/>
<I>Scope of the review</I>
</B>
<BR/>This review does not evaluate the effectiveness of custom-made foot orthoses for the treatment of any pain other than foot pain, nor does it evaluate the effectiveness of custom-made foot orthoses for the prevention of foot pain. This review also does not evaluate the cost effectiveness of custom-made foot orthoses for the treatment of foot pain, however, as this review has a broad international perspective, international differences in healthcare practices and economic conditions limit the usefulness of financial comparisons (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). Readers are, therefore, encouraged to seek information regarding the local costs of the interventions evaluated in this review and to use this information in making decisions about the use of custom-made foot orthoses for the treatment of foot pain.</P>
<P>Readers are also reminded that some of the evidence presented in this review may overlap with other Cochrane systematic reviews evaluating the relative effectiveness of various interventions for specific musculoskeletal conditions (<LINK REF="REF-Ashford-2005" TYPE="REFERENCE">Ashford 2005</LINK>; <LINK REF="REF-Brouwer-2005" TYPE="REFERENCE">Brouwer 2005</LINK>; <LINK REF="REF-Burns-2006a" TYPE="REFERENCE">Burns 2006a</LINK>; <LINK REF="REF-Crawford-2003" TYPE="REFERENCE">Crawford 2003</LINK>; <LINK REF="REF-D_x0027_hondt-2002" TYPE="REFERENCE">D'hondt 2002</LINK>; <LINK REF="REF-Egan-2001" TYPE="REFERENCE">Egan 2001</LINK>; <LINK REF="REF-Ferrari-2004" TYPE="REFERENCE">Ferrari 2004</LINK>; <LINK REF="REF-Rome-2005" TYPE="REFERENCE">Rome 2005</LINK>; <LINK REF="REF-Rome-2007" TYPE="REFERENCE">Rome 2007</LINK>; <LINK REF="REF-Sackley-2007" TYPE="REFERENCE">Sackley 2007</LINK>; <LINK REF="REF-Spencer-2000" TYPE="REFERENCE">Spencer 2000</LINK>; <LINK REF="REF-Thomson-2004" TYPE="REFERENCE">Thomson 2004</LINK>).</P>
<P>
<B>
<I>Locating relevant trials</I>
</B>
<BR/>All trials in this review have been published in English-language journals and were initially identified through electronic searching. While efforts were made to identify unpublished trials and trials published in non-English language journals, none were eligible for inclusion. Given that only about 60% of randomised or controlled clinical trials presented as summaries or abstracts at professional gatherings are subsequently published in peer-reviewed journals (<LINK REF="REF-Scherer-2003" TYPE="REFERENCE">Scherer 2003</LINK>), there is a risk that trials eligible for inclusion were not identified, which threatens the internal validity of this review. However, we are reasonably confident that all relevant trials were identified because:<BR/>(1) randomised or controlled trials evaluating custom-made foot orthoses are rare and are, therefore, typically well publicised and subsequently published;<BR/>(2) some non-English language and unpublished papers were identified for potential inclusion but were excluded due to failing to meet all inclusion criteria; and<BR/>(3) no first author of included trials or known researchers in the field were able to identify additional relevant trials.</P>
<P>
<B>
<I>Exclusion bias</I>
</B>
<BR/>Authors of included trials were not contacted to obtain information on excluded participants. Analyses within this review are, therefore, only based on principles of intention to treat where primary study researchers had done so. Therefore, there is a risk of exclusion bias influencing the available case analyses presented in this review (see <LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>: Methodological quality of included studies).</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE MODIFIED="2008-05-07 13:19:16 +1000" MODIFIED_BY="[Empty name]">
<P>Considering the range of diagnoses for which custom-made foot orthoses are prescribed and the many types of custom-made foot orthoses available, very few have been adequately evaluated in randomised or controlled clinical trials. As such, there is limited evidence on which to base clinical decisions for the use of custom-made foot orthoses for the treatment of foot pain. Nonetheless, evidence for clinical practice is accumulating (summary in Additional table 26). Currently, there is gold level evidence for painful pes cavus and silver level evidence for foot pain in juvenile idiopathic arthritis (JIA), rheumatoid arthritis, plantar fasciitis and hallux valgus. Custom-made foot orthoses were effective for painful pes cavus (NNTB: 5), rear foot pain in rheumatoid arthritis (NNTB: 4), foot pain in JIA (NNTB: 3) and painful hallux valgus (NNTB: 6); however, surgery was even more effective for hallux valgus and non-custom foot orthoses appeared just as effective for JIA but the analysis may have lacked sufficient power to detect a difference in effect. It is unclear if custom-made foot orthoses were effective for plantar fasciitis or metatarsophalangeal joint pain in rheumatoid arthritis. Overall, custom-made foot orthoses were a safe intervention for foot pain. Clinical applicability of all these results will depend on the healthcare context, including: timely access to interventions; monetary cost of interventions; time commitment required for therapy; and strength of evidence for (and safety of) alternative interventions.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>To develop a strong evidence base for the treatment of foot pain, the effectiveness of custom foot orthoses requires further evaluation in well designed and clearly reported randomised controlled trials. Recommendations to improve the quantity and quality of evaluating custom foot orthoses for the treatment of foot pain include: investigating other types of foot pain; recruiting more children; assessing efficacy in athletes; experimenting with different orthotic styles, adjunctive therapy and standardised footwear (as in the military and industrial setting); developing an effective and safe protocol for intervention blinding; and measuring long term outcomes. For all future research, minimum sample size should be calculated <I>a priori </I>to ensure analyses are adequately powered to detect clinically important differences in effects between interventions evaluated. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-05-07 13:23:13 +1000" MODIFIED_BY="[Empty name]">
<P>The reviewers would like to thank the editorial team of the Cochrane Musculoskeletal Group, particularly Ms Miranda Cumpston (Australia), Dr Renea Johnston (Australia) and Professor Rachelle Buchbinder (Australia) for their assistance in preparing this review and co-ordination of the peer review process; and Ms Louise Falzon (USA) for assisting in developing the search strategy and conducting searching of electronic databases. Thanks are also extended to the authors of included trials who responded to requests for additional information/data: Dr Elly Budiman-Mak (USA), Dr James Brantingham (USA), Dr Karl Landorf (Australia), Dr Barbara Porter (Canada), Dr Ewa Roos (Denmark), and Professor James Woodburn (United Kingdom). Finally, the review authors would like to thank Associate Professor Hylton Menz (Australia) and Mr Craig Payne (Australia) for helping to identify potentially relevant trials for inclusion.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-05-12 22:43:28 +1000" MODIFIED_BY="[Empty name]">
<P>J Burns (JB) was principal investigator of an included trial (<LINK REF="STD-Burns-2006" TYPE="STUDY">Burns 2006</LINK>).</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>FH was responsible for selecting trials; assessing trial quality; extracting, converting, entering and analysing data; interpreting results; and writing the review. JB was responsible for conceiving the review; selecting trials; and providing comments on the draft review. JR was responsible for assessing trial quality; checking data extraction; checking the conversion of data; performing double data entry; and providing comments on the draft review. VdT was responsible for checking data extraction and providing comments on the draft review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-05-07 13:39:40 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-05-07 13:39:40 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-05-07 13:39:40 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-2006" NAME="Burns 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burns J, Crosbie J, Ouvrier R, Hunt A</AU>
<TI>Effective orthotic therapy for the painful cavus foot</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2006</YR>
<VL>96</VL>
<NO>3</NO>
<PG>205-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chalmers-2000" NAME="Chalmers 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers AC, Busby C, Goyert J, Porter B, Schulzer, M</AU>
<TI>Metatarsalgia and rheumatoid arthritis- a randomised, single blind, sequential trial comparing 2 types of foot orthoses and supportive shoes</TI>
<SO>The Journal of Rheumatology</SO>
<YR>2000</YR>
<VL>27</VL>
<PG>1643-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Conrad-1996" NAME="Conrad 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Conrad K J, Budiman-Mak E, Roach KE, Hedeker D, Caraballada R, Burks, D et al.</AU>
<TI>Impacts of foot orthoses on pain and disability in rheumatoid arthritis. Journal of Clinical Epidemiology</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1996</YR>
<VL>49</VL>
<NO>1</NO>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dimou-2004" NAME="Dimou 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dimou ES, Brantingham, JW, Wood T</AU>
<TI>A randomised, controlled trial (with blinded observer) of chiropractic manipulation and achilles stretching vs. orthotics for the treatment of plantar fasciitis</TI>
<SO>Journal of the American Chiropractic Association</SO>
<YR>2004</YR>
<VL>41</VL>
<NO>9</NO>
<PG>32-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Landorf-2006" NAME="Landorf 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Landorf KB, Keenan A, Herbert RD</AU>
<TI>Effectiveness of foot orthoses to treat plantar fasciitis: a randomized trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2006</YR>
<VL>166</VL>
<PG>1305-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-2001" NAME="Martin 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin JE, Hosch JC, Goforth WP, Murff RT, Lynch DM, Odom, RD</AU>
<TI>Mechanical treatment of plantar fasciitis. A prospective study</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2001</YR>
<VL>91</VL>
<NO>2</NO>
<PG>55-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pfeffer-1999" NAME="Pfeffer 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pfeffer G, Bachetti P, Deland J, Lewis A, Anderson R, Davis W, et al</AU>
<TI>Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis</TI>
<SO>Foot &amp; Ankle International</SO>
<YR>1999</YR>
<VL>20</VL>
<NO>4</NO>
<PG>214-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powell-2005" NAME="Powell 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powell M, Seid M, Szer IS</AU>
<TI>Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomised trial</TI>
<SO>Journal of Rheumatology</SO>
<YR>2005</YR>
<VL>32</VL>
<PG>943-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roos-2006" NAME="Roos 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roos E, Engstrom M, Soderberg B</AU>
<TI>Foot orthoses for the treatment of plantar fasciitis</TI>
<SO>Foot &amp; Ankle International</SO>
<YR>2006</YR>
<VL>27</VL>
<NO>8</NO>
<PG>606-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torkki-2001" MODIFIED="2008-05-07 13:39:40 +1000" MODIFIED_BY="[Empty name]" NAME="Torkki 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-05-07 13:39:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torkki M, Malmivaara A, Seitsalo S, Hoikka V, Laippala P, Pekka P</AU>
<TI>Surgery vs orthosis vs watchful waiting for hallux valgus: a randomised controlled trial</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>285</VL>
<NO>19</NO>
<PG>2474-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woodburn-2002" NAME="Woodburn 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woodburn J, Barker S, Helliwell PS</AU>
<TI>A randomised controlled trial of foot orthoses in rheumatoid arthritis</TI>
<SO>Journal of Rheumatology</SO>
<YR>2002</YR>
<VL>29</VL>
<PG>1377-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Budiman_x002d_Mak-1995" NAME="Budiman-Mak 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Budiman-Mak E, Conrad KJ, Roach KE, Moore JW, Lertratanakul Y, Koch AE, et al</AU>
<TI>Can foot orthoses prevent hallux valgus deformity in rheumatoid arthritis? A randomized clinical trial</TI>
<SO>Journal of Clinical Rheumatology</SO>
<YR>1995</YR>
<VL>1</VL>
<NO>6</NO>
<PG>313-321</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chao-1996" NAME="Chao 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chao W, Wapner K, Lee T, Adams J, Hecht P</AU>
<TI>Nonoperative management of posterior tibial tendon dysfunction</TI>
<SO>Foot &amp; Ankle International</SO>
<YR>1996</YR>
<VL>17</VL>
<NO>12</NO>
<PG>736-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doxey-1985" NAME="Doxey 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doxey G E</AU>
<TI>Management of metatarsalgia with foot orthotics</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1985</YR>
<VL>6</VL>
<NO>6</NO>
<PG>324-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grau-2003" NAME="Grau 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Grau S, Valiant G, Horstmann T</AU>
<TI>Efficiency of different therapeutic treatments of chronic achilles tendinitis in runners</TI>
<SO>Paper presented at the International Society of Biomechanics technical group on footwear biomechanics conference. Queenstown, New Zealand</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hodge-1999" NAME="Hodge 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hodge MC, Bach TM et al</AU>
<TI>Orthotic management of plantar pressure and pain in rheumatoid arthritis</TI>
<SO>Clinical Biomechanics</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>8</NO>
<PG>567-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilmartin-1994" NAME="Kilmartin 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kilmartin TE, Wallace WA</AU>
<TI>Effect of pronation and supination orthosis on Morton's neuroma and lower extremity function</TI>
<SO>Foot &amp; Ankle International</SO>
<YR>1994</YR>
<VL>15</VL>
<NO>5</NO>
<PG>256-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kusumoto-2007" NAME="Kusumoto 2007" YEAR="2007">
<REFERENCE NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kusumoto A, Suzuki T, Yoshida H, Kwon J</AU>
<TI>Intervention study to improve quality of life and health problems of community-living elderly women in Japan by shoe fitting and custom-made insoles</TI>
<SO>Gerontology</SO>
<YR>2007</YR>
<VL>53</VL>
<NO>6</NO>
<PG>110-118</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larsen-2002" NAME="Larsen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen K F, Weidich, et al</AU>
<TI>Can custom-made biomechanic shoe orthoses prevent problems in the back and lower extremities? A randomized, controlled intervention trial of 146 military conscripts</TI>
<SO>Journal of Manipulative and Physiological Therapeutics</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>5</NO>
<PG>326-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lynch-1998" NAME="Lynch 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lynch DM, Goforth WP, Martin JE, Odom RD, Preece CK, Kotter MW</AU>
<TI>Conservative treatment of plantar fasciitis</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>1998</YR>
<VL>88</VL>
<NO>8</NO>
<PG>375-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magalhaes-2006" NAME="Magalhaes 2006" YEAR="2006">
<REFERENCE NOTES="&lt;p&gt;Magalhaes EP., Davitt M., Filho, D.J.,  Battistella, L.R., &amp;amp; Bertolo, M.B&lt;br&gt;The effect of foot orthoses in rheumatoid arthritis&lt;br&gt;Rheumatology&lt;br&gt;2006&lt;br&gt;45&lt;br&gt;449-53&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magalhaes EP, Davitt M, Filho, DJ, Battistella, LR, Bertolo, MB</AU>
<TI>The effect of foot orthoses in rheumatoid arthritis</TI>
<SO>Rheumatology</SO>
<YR>2006</YR>
<VL>45</VL>
<PG>449-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meijad-2004" NAME="Meijad 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mejjad O, Vittecoq O, et al</AU>
<TI>Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients</TI>
<SO>Joint, Bone, Spine: Revue du Rhumatisme</SO>
<YR>2004</YR>
<VL>71</VL>
<NO>6</NO>
<PG>542-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Orteza-1992" NAME="Orteza 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Orteza LC, Vogelbach WD, et al</AU>
<TI>The effect of molded and unmolded orthotics on balance and pain while jogging following inversion ankle sprain</TI>
<SO>Journal of Athletic Training</SO>
<YR>1992</YR>
<VL>27</VL>
<NO>1</NO>
<PG>80-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poon-1997" NAME="Poon 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poon C, Love B</AU>
<TI>Efficacy of foot orthotics for metatarsalgia</TI>
<SO>Foot</SO>
<YR>1997</YR>
<VL>7</VL>
<NO>4</NO>
<PG>202-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Postema-1998" NAME="Postema 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Postema K, Burm PE, et al</AU>
<TI>Primary metatarsalgia: the influence of a custom moulded insole and a rockerbar on plantar pressure</TI>
<SO>Prosthetics &amp; Orthotics International</SO>
<YR>1998</YR>
<VL>22</VL>
<NO>1</NO>
<PG>35-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rome-2004" NAME="Rome 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rome KJ, Gray, et al</AU>
<TI>Evaluating the clinical effectiveness and cost-effectiveness of foot orthoses in the treatment of plantar heel pain: a feasibility study</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2004</YR>
<VL>94</VL>
<NO>3</NO>
<PG>229-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Russell-1999" NAME="Russell 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Russell BE</AU>
<TI>Comparison of the plantar fasciitis splint versus the night resting splint in the treatment of plantar fasciitis</TI>
<SO>Texas Woman's University, Ph.D Thesis</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saggini-1996" NAME="Saggini 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saggini R, Giamberardino MA, et al</AU>
<TI>Myofascial pain syndrome of the peroneus longus: biomechanical approach</TI>
<SO>Clinical Journal of Pain</SO>
<YR>1996</YR>
<VL>12</VL>
<NO>1</NO>
<PG>30-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saygi-2005" NAME="Saygi 2005" YEAR="2005">
<REFERENCE NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saygi B, Yildirim Y, Saygi E, Hasan K, Esemeni T</AU>
<TI>Morton neuroma: Comparative results of two conservative methods</TI>
<SO>Foot &amp; Ankle International</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>7</NO>
<PG>556-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sobel-1999" NAME="Sobel 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sobel E, Levitz SJ, et al</AU>
<TI>Orthoses in the treatment of rearfoot problems</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>1999</YR>
<VL>89</VL>
<NO>5</NO>
<PG>220-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stell-1998" NAME="Stell 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stell JF, Buckley JG</AU>
<TI>Controlling excessive pronation: a comparison of casted and non-casted orthoses</TI>
<SO>The Foot</SO>
<YR>1998</YR>
<VL>8</VL>
<PG>210-214</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torkki-2003" NAME="Torkki 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torkki M, Malmivaara A, Seitsalo S, Hoikka V, Laippala P, Pekka P</AU>
<TI>Hallux valgus: immediate operation versus 1 year of waiting with or without orthoses</TI>
<SO>Acta orthopaedica Scandinavica</SO>
<YR>2003</YR>
<VL>74</VL>
<NO>2</NO>
<PG>209-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turlik-1999" NAME="Turlik 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Turlik MA, Donatelli TJ, Veremis MG</AU>
<TI>A comparison of shoe inserts in relieving mechanical heel pain</TI>
<SO>The Foot</SO>
<YR>1999</YR>
<VL>9</VL>
<PG>84-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wenger-1989" NAME="Wenger 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenger DR, Mauldin D, et al</AU>
<TI>Corrective shoes and inserts as treatment for flexible flatfoot in infants and children</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1989</YR>
<VL>American Volume 71</VL>
<NO>6</NO>
<PG>800-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitford-2007" NAME="Whitford 2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitford D, Esterman A</AU>
<TI>A randomized controlled trial of two types of in-shoe orthoses in children with flexible excess pronation of the feet</TI>
<SO>Foot and Ankle International</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>6</NO>
<PG>715-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Burns-_x0028_n.d._x0029_" NAME="Burns (n.d.)" YEAR="n.d.">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Burns J, Wegener C, Begg L, Vicaretti M, Fletcher J</AU>
<TI>Effect of custom foot orthoses on foot pain and plantar pressure in people with diabetes and peripheral arterial disease: A randomised controlled trial</TI>
<SO>ANZCTR No.: 12607000300471</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Ashford-2005" NAME="Ashford 2005" TYPE="COCHRANE_REVIEW">
<AU>Ashford R, Kippen C, Rome K</AU>
<TI>Interventions for pes planus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>1</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD005120"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Badlissi-2005" NAME="Badlissi 2005" TYPE="JOURNAL_ARTICLE">
<AU>Badlissi F, Dunn J, Link C, Keysor J, McKinlay J, Felson D</AU>
<TI>Foot musculoskeletal disorders, pain, and foot-related functional limitation in older persons</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2005</YR>
<VL>53</VL>
<PG>1029-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Benvenuti-1995" NAME="Benvenuti 1995" TYPE="JOURNAL_ARTICLE">
<AU>Benvenuti F, Ferrucci L, Guralnik JM, Gangemi S, Baroni A</AU>
<TI>Foot pain and disability in older persons: an epidemiologic survey</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>1995</YR>
<VL>43</VL>
<NO>5</NO>
<PG>479-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brouwer-2005" NAME="Brouwer 2005" TYPE="COCHRANE_REVIEW">
<AU>Brouwer RW, Jakma TSC, Verhagen AP, Verhaar JAN, Bierma-Zeinstra SMA</AU>
<TI>Braces and orthoses for treating osteoarthritis of the knee</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>1</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD004020.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Burns-2006a" NAME="Burns 2006a" TYPE="COCHRANE_REVIEW">
<AU>Burns J, Landorf KB, Ryan MM, Crosbie J, Ouvrier RA</AU>
<TI>Interventions for the prevention and treatment of pes cavus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD006154"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cates-2004" NAME="Cates 2004" NOTES="&lt;p&gt;Cates C. EBM website. http://www.nntonline.net/ 2003&lt;/p&gt;" TYPE="OTHER">
<AU>Cates C</AU>
<TI>EBM website</TI>
<SO>http://www.nntonline.net/</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cornwall-1997" NAME="Cornwall 1997" NOTES="&lt;p&gt;Cornwall MW and McPoil TG. Effect of foot orthotic on the initiation of plantar surface loading. The Foot. 1997;7 148-52.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Cornwall MW, McPoil TG</AU>
<TI>Effect of foot orthotic on the initiation of plantar surface loading</TI>
<SO>The Foot</SO>
<YR>1997</YR>
<VL>7</VL>
<PG>148-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crawford-2003" NAME="Crawford 2003" TYPE="COCHRANE_REVIEW">
<AU>Crawford F, Thomson C</AU>
<TI>Interventions for treating plantar heel pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD000416"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-D_x0027_hondt-2002" NAME="D'hondt 2002" TYPE="COCHRANE_REVIEW">
<AU>D'hondt NE, Struijs PAA, Kerkhoffs GMMJ, Verheul C, Lysens R, Aufdemkampe G et al</AU>
<TI>Orthotic devices for treating patellofemoral pain syndrome</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD002267"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egan-2001" NAME="Egan 2001" TYPE="COCHRANE_REVIEW">
<AU>Egan M, Brosseau L, Farmer M, Ouimet M, Rees S, Tugwell P et al</AU>
<TI>Splints and orthosis for treating rheumatoid arthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD004018"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ferrari-2004" NAME="Ferrari 2004" TYPE="COCHRANE_REVIEW">
<AU>Ferrari J, Higgins JPT, Prior TD</AU>
<TI>Interventions for treating hallux valgus (abductovalgus) and bunions</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD000964.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Garrow-2004" NAME="Garrow 2004" NOTES="&lt;p&gt;Garrow AP, Silman AJ and Macfarlane GJ. The Chesire foot pain and disability survey: a population survey assessing prevalence and associations. Pain. 2004;110 378-384.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Garrow AP, Silman AJ, Macfarlane GJ</AU>
<TI>The Cheshire foot pain and disability survey: a population survey assessing prevalence and associations</TI>
<SO>Pain</SO>
<YR>2004</YR>
<VL>110</VL>
<PG>378-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" NAME="Higgins 2002" NOTES="&lt;p&gt;Higgins JPT and Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21 1539-1558.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" NOTES="&lt;p&gt;Higgins JPT, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analysis. British Medical Journal. 2003;327 557-560.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2006" NAME="Higgins 2006" TYPE="BOOK">
<AU>Higgins JPT and Green S</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006].</TI>
<SO>The Cochrane Library</SO>
<YR>Issue 4, 2006</YR>
<PB>Chichester, UK: John Wiley &amp; Sons. Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-IASP-1994" NAME="IASP 1994" NOTES="&lt;p&gt;IASP Task Force on Taxonomy. Classification of Chronic Pain, Second Edition. Seattle: IASP Press, 1994.&lt;/p&gt;" TYPE="OTHER">
<AU>IASP Task Force on Taxonomy</AU>
<TI>International Association for the Study of Pain: classification of chronic pain, second edition</TI>
<SO>Seattle</SO>
<PG>IASP Press, 1994</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keech-2007" NAME="Keech 2007" TYPE="BOOK">
<AU>Keech A, Gebski V, Pike R</AU>
<SO>Interpreting and Reporting Clinical Trials. A guide to the consort statement and the principles of randomised controlled trials</SO>
<YR>2007</YR>
<PB>Australasian Medical Publishing</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landorf-2000" NAME="Landorf 2000" NOTES="&lt;p&gt;Landorf KB and Keenan A. Efficacy of foot orthoses. What does the literature tell us? Journal of the American Podiatric Medical Association. 2000;90 (3):149-158.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Landorf KB, Keenan A</AU>
<TI>Efficacy of foot orthoses. What does the literature tell us?</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2000</YR>
<VL>90</VL>
<NO>3</NO>
<PG>149-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landorf-2004" NAME="Landorf 2004" NOTES="&lt;p&gt;Landorf KB, Keenan A and Herbert RD. Effectiveness of different types of foot orthoses for the treatment of plantar fasciitis. Journal of the American Podiatric Medical Association. 2004;94 (6):542-549.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Landorf KB, Keenan A, Herbert RD</AU>
<TI>Effectiveness of different types of foot orthoses for the treatment of plantar fasciitis</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2004</YR>
<VL>94</VL>
<NO>6</NO>
<PG>542-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landorf-2007" NAME="Landorf 2007" TYPE="JOURNAL_ARTICLE">
<AU>Landorf KB, Radford JA</AU>
<TI>Minimal important difference: Values for the foot health status questionnaire, foot function index and visual analogue scale</TI>
<SO>Foot</SO>
<YR>2007</YR>
<VL>doi:10.1016/j.foot.2007.06.006</VL>
<PG>[in press]</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leveille-1998" NAME="Leveille 1998" NOTES="&lt;p&gt;Leveille SG, Guralnik JM, Ferrucci L, Hirsch R, Simonsick EM and Hochberg MC. Foot pain and disability in older women. American Journal of Epidemiology. 1998;148 (7):657-665.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Leveille SG, Guralnik JM, Ferrucci L, Hirsch R, Simonsick EM, Hochberg MC</AU>
<TI>Foot pain and disability in older women</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1998</YR>
<VL>148</VL>
<NO>7</NO>
<PG>657-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maxwell-2006" NAME="Maxwell 2006" NOTES="&lt;p&gt;Maxwell L, Santiesso N, Tugwell PS, Wells GA, Judd M, Buchinder R and the Editorial Board of the Cochrane Musculoskeletal Group. The Journal of Rheumatology. Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews. 2006;33 (11):2305-2311.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Maxwell L, Santesso N, Tugwell PS, Wells GA, Judd M, Buchbinder R, Editorial Board of the Cochrane Musculoskeletal Group</AU>
<TI>Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews</TI>
<SO>The Journal of Rheumatology</SO>
<YR>2006</YR>
<VL>33</VL>
<NO>11</NO>
<PG>2305-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Menz-2001" NAME="Menz 2001" NOTES="&lt;p&gt;Menz HB and Lord SR. Foot pain impairs balance and functional ability in community-dwelling older people. Journal of the American Podiatric Medical Association. 2001;91 (5):222-9.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Menz HB, Lord SR</AU>
<TI>Foot pain impairs balance and functional ability in community-dwelling older people</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2001</YR>
<VL>91</VL>
<NO>5</NO>
<PG>222-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Menz-2006" NAME="Menz 2006" TYPE="JOURNAL_ARTICLE">
<AU>Menz HB, Tiedemann A, Kwan MMS, Plumb K, Lord SR</AU>
<TI>Foot pain in community-dwelling older people: an evaluation of the Manchester Foot Pain and Disability Index</TI>
<SO>Rheumatology</SO>
<YR>2006</YR>
<VL>45</VL>
<PG>863-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nawoczenski-1999" NAME="Nawoczenski 1999" NOTES="&lt;p&gt;Nawoczenski DA and Leduwig PM. Electromyographic effects of foot orthotics on selected lower extremity muscles during running. Archives of Physical Medicine. 1999;80 (5):540-544.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nawoczenski DA, Leduwig PM</AU>
<TI>Electromyographic effects of foot orthotics on selected lower extremity muscles during running</TI>
<SO>Archives of Physical Medicine</SO>
<YR>1999</YR>
<VL>80</VL>
<NO>5</NO>
<PG>540-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nawoczenski-2004" NAME="Nawoczenski 2004" NOTES="&lt;p&gt;Nawoczenski DA and Janisse DJ. Foot orthoses in rehabilitation- what's new. Clinical Sports Medicine. 2004;23 157-167.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nawoczenski DA, Janisse DJ</AU>
<TI>Foot orthoses in rehabilitation - what's new</TI>
<SO>Clinical Sports Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<PG>157-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nigg-1998" NAME="Nigg 1998" NOTES="&lt;p&gt;Nigg BM, Khan A, Fisher V and Stefanyshyn D. Effect of shoe insert construction on foot and leg movement. Medicine and Science in Sports and Exercise. 1998;30 (4):550-555.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nigg BM, Khan A, Fisher V, Stefanyshyn D</AU>
<TI>Effect of shoe insert construction on foot and leg movement</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1998</YR>
<VL>30</VL>
<NO>4</NO>
<PG>550-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norman-2001" NAME="Norman 2001" TYPE="JOURNAL_ARTICLE">
<AU>Norman G, Sridhar F, Guyatt G, Walter S</AU>
<TI>Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life</TI>
<SO>Medical Care</SO>
<YR>2001</YR>
<VL>39</VL>
<PG>1039-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novick-1990" NAME="Novick 1990" NOTES="&lt;p&gt;Novick A and Kelley DL. Position and movement changes of the foot with orthotic intervention during the loading response of gait. Journal of Orthopaedic and Sports Physical Therapy. 1990;11 (7):301-312.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Novick A, Kelley DL</AU>
<TI>Position and movement changes of the foot with orthotic intervention during the loading response of gait</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1990</YR>
<VL>11</VL>
<NO>7</NO>
<PG>301-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novick-1993" NAME="Novick 1993" NOTES="&lt;p&gt;Novick A, Stone J, Birke J, Brasseaux DM, B BJ, Hoard AS and Hawkins ES. Reduction of plantar pressure with the rigid relief orthosis. Journal of the American Podiatric Medical Association. 1993;83 (3):115-122.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Novick A, Stone J, Birke J, Brasseaux D, Broussard J, Hoard AS, Hawkins ES</AU>
<TI>Reduction of plantar pressure with the rigid relief orthosis</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>1993</YR>
<VL>83</VL>
<NO>3</NO>
<PG>115-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Razeghi-2000" NAME="Razeghi 2000" NOTES="&lt;p&gt;Razeghi M and Batt ME. Biomechanical analysis of the effect of orthotic shoe inserts: a review of the literature. Sports Medicine. 2000;29 (6):425-38.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Razeghi M, Batt ME</AU>
<TI>Biomechanical analysis of the effect of orthotic shoe inserts: a review of the literature</TI>
<SO>Sports Medicine</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>6</NO>
<PG>425-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Redmond-2000" NAME="Redmond 2000" NOTES="&lt;p&gt;Redmond A, B LPS, Landorf KB and Stickel WJ. Effect of cast and noncast foot orthoses on plantar pressures and force during normal gait. Journal of the American Podiatric Medical Association. 2000;9 441-449.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Redmond A, Lumb PS, Landorf KB, Stickel WJ</AU>
<TI>Effect of cast and noncast foot orthoses on plantar pressures and force during normal gait</TI>
<SO>Journal of the American Podiatric Medical Association</SO>
<YR>2000</YR>
<VL>9</VL>
<PG>441-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Review-Manager-2003" NAME="Review Manager 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan). Version 4.2 for Windows</TI>
<YR>2003</YR>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rome-2005" NAME="Rome 2005" TYPE="COCHRANE_REVIEW">
<AU>Rome K, Handoll HHG, Ashford R</AU>
<TI>Interventions for preventing and treating stress fractures and stress reactions of bone of the lower limbs in young adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD000450.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rome-2007" NAME="Rome 2007" TYPE="COCHRANE_REVIEW">
<AU>Rome K, Ashford RL, Evans A</AU>
<TI>Non-surgical interventions for paediatric pes planus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>1</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD006311"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sackley-2007" NAME="Sackley 2007" TYPE="COCHRANE_REVIEW">
<AU>Sackley C, Disler PB, Turner-Stokes L, Wade DT</AU>
<TI>Rehabilitation interventions for foot drop in neuromuscular disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD003908.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Scherer-2003" NAME="Scherer 2003" NOTES="&lt;p&gt;Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: MR000005. DOI: 10.1002/14651858.MR000005.pub3&lt;/p&gt;" TYPE="COCHRANE_REVIEW">
<AU>Scherer R, Langenberg P, von Elm E</AU>
<TI>Full publication of results initially presented in abstracts</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>Issue 4</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.MR000005.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Spahn-2004" NAME="Spahn 2004" NOTES="&lt;p&gt;Spahn G, Schiele R, Hell AK, Klinger HM, Jung R and Langlotz A. The prevalence of pain and deformities in the feet of adolescents. Results of a cross-sectional study. Z Orthop Ihre Grenzgeb. 2004;142 (4):389-396.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Spahn G, Schiele R, Hell AK, Klinger HM, Jung R, Langlotz A</AU>
<TI>The prevalence of pain and deformities in the feet of adolescents. Results of a cross-sectional study</TI>
<SO>Zeitschrift fur Orthopadie und ihre Grenzgebiete</SO>
<YR>2004</YR>
<VL>142</VL>
<NO>4</NO>
<PG>389-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spencer-2000" NAME="Spencer 2000" TYPE="COCHRANE_REVIEW">
<AU>Spencer S</AU>
<TI>Pressure relieving interventions for preventing and treating diabetic foot ulcers</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>3</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD002302"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stacoff-2000" NAME="Stacoff 2000" NOTES="&lt;p&gt;Stacoff A, Reinschmidt C, Nigg BM and et al. Effects of foot orthoses on skeletal motion during running. Clinical Biomechanics. 2000;15 (1):54-64.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Stacoff A, Reinschmidt C, Nigg BM et al</AU>
<TI>Effects of foot orthoses on skeletal motion during running</TI>
<SO>Clinical Biomechanics</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>1</NO>
<PG>54-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thomson-2004" NAME="Thomson 2004" TYPE="COCHRANE_REVIEW">
<AU>Thomson CE, Gibson JNA, Martin D</AU>
<TI>Interventions for the treatment of Morton's neuroma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>3</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD003118.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tomaro-1993" NAME="Tomaro 1993" NOTES="&lt;p&gt;Tomaro J and Burdett RG. The effect of foot orthotics on the EMG activity of selected leg muscles during gait. Journal of Orthopaedic Sports Physical Therapy. 1993;18 (4):532-536.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Tomaro J, Burdett RG</AU>
<TI>The effect of foot orthotics on the EMG activity of selected leg muscles during gait</TI>
<SO>Journal of Orthopaedic Sports Physical Therapy</SO>
<YR>1993</YR>
<VL>18</VL>
<NO>4</NO>
<PG>532-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tugwell-2004" NAME="Tugwell 2004" NOTES="&lt;p&gt;Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G (editors) Evidence-based Rheumatology. London: BMJ books; 2004&lt;/p&gt;" TYPE="BOOK">
<AU>Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G (editors)</AU>
<SO>Evidence-based Rheumatology</SO>
<YR>2004</YR>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wyrwich-2005" NAME="Wyrwich 2005" TYPE="JOURNAL_ARTICLE">
<AU>Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD</AU>
<TI>A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease</TI>
<SO>Health Services Research</SO>
<YR>2005</YR>
<VL>40</VL>
<PG>577-92</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-05-07 13:38:47 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-05-07 13:36:50 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-05-07 13:25:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burns-2006">
<CHAR_METHODS MODIFIED="2008-05-07 13:24:40 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Two-arm parallel-group design.<BR/>Type of foot pain: Plantar fasciitis.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:25:01 +1000" MODIFIED_BY="[Empty name]">
<P>Community sample of participants recruited in Sydney, Australia by referral from healthcare providers and advertisements in local media.<BR/>Inclusion criteria: Men and women 18 years or older who had musculoskeletal foot pain for more than 1 month and bilateral cavus feet of any aetiology. Cavus foot defined by a Foot Posture Index score of -2 or less.<BR/>Exclusion criteria: Pregnancy; recent foot trauma; current use of ankle-foot orthoses; lack of willingness to return for follow up.<BR/>Nr = 154. Na = 154.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom-made foot orthoses group<BR/>Age, mean (SD): 49.8 (14.3)<BR/>Sex, % females: 52 %<BR/>Pain duration, mean yrs (SD): 7.3 (9.4)<BR/>BMI, mean (SD): 28.1 (6.1)<BR/>Sham orthoses group<BR/>Age, mean (SD): 49.5 (14.4)<BR/>Sex, % females: 61 %<BR/>Pain duration, mean yrs (SD): 8.9 (11.4)<BR/>BMI, mean (SD): 27.4 (6.0)<BR/>Pes cavus aetiology was classified as congenital (130 patients had idiopathic and 1 had residual clubfoot), neuromuscular (16 had Charcot-Marie-Tooth disease, 4 had poliomyelitis, and 1 had polyneuropathy), or traumatic (2 had osseous malunion). Foot pain was bilateral in 68% of the cases, and common diagnoses included metatarsalgia, plantar heel pain, and mid-foot osteoarthritis.</P>
<P>
<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:25:43 +1000" MODIFIED_BY="[Empty name]">
<P>Treatment group: Custom-made foot orthoses moulded from neutral-suspension plaster casts. Casts scanned using a 3-dimensional laser scanner. Orthoses fabricated from 3 mm polypropylene using computer-aided design and computer-aided manufacturing milling machine to a standardised prescription that had been developed and pilot tested. Cast/scan modifications: Balance metatarsals 1-5; 20% medial arch expansion; 0° corrected calcaneal position; 0° intrinsic forefoot. Shell shape: Length proximal to metatarsal heads; standard (1-5) forefoot width; 6 mm lateral heel expansion; 12 mm heel cup height. Shell material: 3 mm polypropylene. Shell posting: Lateral half extrinsic heel post. Cast/scan modifications: 0° motion; 0 mm elevation; 0 mm heel lift. Top cover: Full-length 3 mm Poron Medical urethane (Rogers Corp, Woodstock, Connecticut) and Kashmeer.<BR/>Control group: Sham insoles made from flat, non-supportive, 3 mm latex foam covered with Kashmeer. Casts were made of both feet using the same technique as for the treatment group. However, the casts were not used to fabricate the intervention.<BR/>Written instructions for a progressive wearing schedule and footwear advice were provided. Participants with their own orthoses and insoles shoe inserts etc. were not allowed to use them at any time during the study. Routine treatment, such as medication, physical therapy, and massage, were continued as usual.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot Health Status Questionnaire (pain domain).<BR/>Function: Foot Health Status Questionnaire (function domain).<BR/>Health related quality of life: 36-Item Short-Form Health Survey; physical functioning, general health, vitality, and social functioning domains.<BR/>Compliance: Self-reported use of assigned intervention for most of shoe wearing time.<BR/>Adverse effects: Number and nature of adverse effects per group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:26:36 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chalmers-2000">
<CHAR_METHODS MODIFIED="2008-05-07 13:26:18 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover trial. Each participant was randomised to a sequence of 3 × 12 week phases, separated by 2 week washouts.<BR/>Type of foot pain: Metatarsal phalangeal joint painful synovitis in participants with rheumatoid arthritis.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:26:36 +1000" MODIFIED_BY="[Empty name]">
<P>Recruited from occupational therapy referrals.Screened by rheumatologist and occupational therapist.<BR/>Inclusion criteria: Diagnosis of rheumatoid arthritis using American College of Rheumatology criteria; over 18 years of age; minimum of 2 subluxed metatarsal phalangeal joints bilaterally; metatarsal phalangeal joint pain as most significant foot problem; participants using foot orthoses or shoe adaptations were required to stop their use and participate in a 2 week wash-out.<BR/>Exclusion criteria: Midtarsal pain with passive motion and on weight bearing; prior foot surgery (except hallux valgus correction); unstable medication regimen; impaired mental status; poor English comprehension; concurrent foot treatment (except scheduled regular podiatric skin and nail care).<BR/>Nr = 28. Na = 24.<BR/>Participant characteristics: Of those participants who completed the study: 21 women with a mean (SD) age of 60 (10) years; 3 men with a mean (SD) age of 63 (2) years; mean (SD) body weight 154 (46) lb.; average (SD) duration of rheumatoid arthritis 15 (9) years; mean of 7 metatarsal phalangeal joints with synovitis and 8 with subluxations.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Supportive shoes: Extra-depth shoes with high, firm heel counter, heel height of 1.5 to 2.0 cm, instep lacing, a wide and deep toe box, and a thick, composite sole, made by P.W. Minor or Drew Co. <BR/>Supportive shoes worn with soft orthoses: Soft orthoses formed by participant standing on preheated ¼ inch, low-density, full-foot length plastazote®. Medium density, ¼ inch plastazote lifts added to underside.<BR/>Supportive shoes worn with custom foot orthoses: Semi-rigid orthoses made from 3 mm subortholen®, from casts taken in a non-weightbearing position. Distal end of the subortholen followed the metatarsal heads line and ended just proximal to them. Underlying forefoot and hindfoot nickleplast posts were attached. A full-length leather liner, cushioned under the forefoot with 1/8 inch PPT® foam, was added. <BR/>Adjustments to orthoses were completed within 2 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: 100 mm visual analogue scale, anchored by 'no pain' and 'pain as bad as it can be'.<BR/>Function: Toronto Activities of Daily Living Measure (walking).<BR/>Compliance: Daily logs of intervention use and wear time.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:27:39 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Conrad-1996">
<CHAR_METHODS MODIFIED="2008-05-07 13:27:07 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Two-arm parallel-group design.<BR/>Type of foot pain: Foot pain and disability in rheumatoid arthritis<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:27:25 +1000" MODIFIED_BY="[Empty name]">
<P>Recruited from the arthritic clinics of Hines, Chicago and North Chicago.<BR/>Inclusion criteria: Between 18 and 75 years of age; foot pain; fulfilled American Rheumatism Association (ARA) criteria for classic or definite rheumatoid arthritis (RA) and were in an ARA functional class I or II; radiological changes of stage I or stage II in 1or both feet; active disease defined as having 6 or more painful joints or being tender on motion and/or 3 or more swollen joints with 45 minutes or longer of joint stiffness in the morning or a Westergreen sedimentation rate of 28 mm or more per hour; flexible functional discrepancies in their feet, measured as calcaneal valgus stance positions that could be controlled by a functional foot orthosis; and a minimum range of motion in feet and ankles making ambulation possible. In general, participants were chosen on the basis of their likelihood of benefiting from orthoses.<BR/>Exclusion criteria: Severe clinical foot deformity such as hallux valgus, rigid hammer digit syndrome, plantar displacement of metatarsal bones, hallux rigidus, surgical fusion of the hallux, rigidity or deformity of the midfoot or hindfoot, including ankle joints; comorbid conditions that could cause apropulsive gait; previous foot surgery; inability to write and provide responses on the questionnaire; inability to follow instructions; inability to comply with study protocols.<BR/>Nr = 102, Na = 88.<BR/>Participant characteristics: 63 had classic RA, 39 had definite RA, with 76 in stage I and 26 in stage II anatomical radiological stage.No sig. Differences were found at p&lt;0.05 between groups in age.15 were receiving NSAIDs only; 62 were receiving NSAIDs and prednisone; 35 were receiving NSAIDs and prednisone and disease modifying anti-rheumatic drugs.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:27:39 +1000" MODIFIED_BY="[Empty name]">
<P>All participants were measured for foot orthoses and had plaster moulds made of their feet.<BR/>Custom-made foot orthoses: fabricated from Rohadur and posted at rear and forefoot.<BR/>Placebo orthoses: Thin naugahyde shoe inserts designed to fit each participant's feet. No posting or inclined planes<BR/>All participants were instructed to wear comfortable dress shoes with boxed toes or gym shoes and were instructed on how to care for their foot orthoses.<BR/>Participants continued receiving customary treatment regimen for their arthritis at the clinics, which included medications, joint injections, physical therapy, hospitalisation or surgical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Pain scale of the Foot Function Index.<BR/>Function: Activity Limitation scale of Foot Function Index.<BR/>Compliance: Self-reported estimated time of wearing orthoses during the week prior to each visit.<BR/>Adverse effects: Total number of all adverse effects in each group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:28:14 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dimou-2004">
<CHAR_METHODS MODIFIED="2008-05-07 13:27:58 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Two-arm parallel-group design.<BR/>Type of foot pain: Plantar fasciitis</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: More than 18 and less than 60 years of age; compliance with researchers' instructions; diagnosis of plantar fasciitis, made if: plantar heel pain present for more than 7 weeks; 'first-step pain' when rising from bed or after prolonged sitting; heel pain relieved after a few steps; pain on palpation of the medial calcaneal tubercle; positive plantar fasciitis test (palpation of the anterior medial tubercle and along the arch distally as the big toe with foot and ankle dorsiflexed to tighten the fascia); pain that deteriorates toward the end of the day; heel pain relieved by rest.<BR/>Exclusion criteria: Pregnancy; calcaneal bursitis; tenosynovitis; fat pad syndrome; tarsal tunnel syndrome; calcaneal fracture; connective tissue / autoimmune disorders; 'etc.'<BR/>Nr = 20, Na = 20.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom foot orthoses group<BR/>Age, mean years (range): 40.6 (23-58)<BR/>Sex, % female: 30%<BR/>Pain duration, mean months (range): 21.2 (2-96)<BR/>Manipulation, mobilisation and stretching group<BR/>Age, mean years (range): 44.0 (27-59)<BR/>Sex, % female: 40%<BR/>Pain duration, mean months (range): 22.4 (2.5-60)</P>
<P>
<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:28:14 +1000" MODIFIED_BY="[Empty name]">
<P>Custom-made foot orthoses: From non-weight bearing subtalar and mid-tarsal neutral casts. An outer layer of high-density ethyl vinyl acetate (EVA), and an inner layer of low-density EVA. These were supplied to the participants 1 week after initial consultation and remained fitted in their shoes for the whole 8-week period. The participants were carefully advised as to how they should slowly 'break in', or accommodate to, the orthoses (i.e., 2 hours the first 2 days, 3 hours the next 2 days etc.).</P>
<P>Manipulation and mobilisation of foot with stretching: Chiropractic adjustments of all foot and ankle subluxations (joint hypomobility or fixation) twice a week for 4 weeks and at 1-month follow up. Various foot and ankle adjustments were delivered. The 'mortice separation', subtalar adjustment and forefoot figure-8 mobilisation were used most frequently. Participants were prescribed Achilles' tendon stretching exercises, both with the knee straight and flexed. These were to be held statically with a comfortable sense of stretch for 20 seconds and performed 10 times each, morning, afternoon, and evening, on a daily basis for the whole 8 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot &amp; Ankle Outcome Score (pain domain).<BR/>Compliance: Unclear measure.<BR/>Adverse effects: Total number of all adverse effects in each group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:29:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Landorf-2006">
<CHAR_METHODS MODIFIED="2008-05-07 13:28:39 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Three-arm parallel-group design.<BR/>Type of foot pain: Plantar fasciitis.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:28:50 +1000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Diagnosis of plantar fasciitis; symptoms for at least 4 weeks.<BR/>Exclusion criteria: History of major orthopaedic or medical condition (e.g. inflammatory arthritis or diabetes) that may have influenced the condition.<BR/>Nr = 136, Na at 3 months = 133, Na at 12 months = 131<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom-made foot orthoses group<BR/>Age, mean years (SD): 49.2 (12.0)<BR/>Women, No. (%): 34 (74)<BR/>BMI, mean (SD): 30.3 (6.1)<BR/>Symptom duration, median months (range): 12 (2-360)<BR/>Sham orthoses group<BR/>Age, mean years (SD): 48.5 (9.6)<BR/>Women, No. (%): 30 (67)<BR/>BMI, mean (SD): 29.6 (4.9)<BR/>Symptom duration, median months (range): 12 (1-240)<BR/>Non custom foot orthoses group<BR/>Age, mean years (SD): 47.3 (11.6)<BR/>Women, No. (%): 25 (57)<BR/>BMI, mean (SD): 32.9 (6.1)<BR/>Symptom duration, median months (range): 11 (2-360)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:29:04 +1000" MODIFIED_BY="[Empty name]">
<P>Neutral suspension plaster casts taken of each participant's feet. An appointment was made for 2 to 3 weeks later to issue the orthoses.<BR/>Customised orthoses: Fabricated using principles described by Hice. Plaster cast posted to neutral calcaneal stance position. Semirigid 4.5mm polypropylene heated and vacuum moulded over cast. Firm 400kg/m3 heel post applied inferior to heel. Inferior heel ground to 1-2mm thickness and parallel to forefoot (i.e. 0 degrees).<BR/>Sham orthoses: Fabricated by moulding 6 mm, soft (120 kg/m3) ethyl vinyl acetate foam over an unmodified cast of the foot. Inferior heel ground to 1-2mm thickness and parallel to forefoot (i.e. 0 degrees).<BR/>Non-custom made orthoses: A three-quarter-length (retail mould) Formthotic (Foot Science International, Christchurch, New Zealand) dispensed using the manufacturer's instructions. Made from a firm-density polyethylene foam sufficiently thick to fill the arch area and prevent orthosis flattening.<BR/>No other treatments (e.g. anti-inflammatory drugs or corticosteroid injections) were allowed during the 12 months that the participants were in the trial.</P>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot Health Status Questionnaire (pain domain).<BR/>Function: Foot Health Status Questionnaire (pain domain).<BR/>Compliance: Proportion of participants who self-reported breaking protocol (e.g. taken anti-inflammatory drugs, received a corticosteroid injection, used a night stretch splint or used alternative orthoses).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:29:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin-2001">
<CHAR_METHODS MODIFIED="2008-05-07 13:29:26 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Three-arm parallel-group design.<BR/>Type of foot pain: Plantar fasciitis</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:29:48 +1000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Plantar heel tenderness; history of pain in arising in the morning or after rest (first-step pain); no history of trauma to the heel within the previous 3 months.<BR/>Exclusion criteria: Other types of heel pain consistent with other diagnoses such as bursitis, tendinitis, or neurologic pain; self-treatment or professional treatment within 1 month of being evaluated in the podiatry clinic, including rigid over-the-counter (OTC) arch supports, injections, and non-steroidal anti-inflammatory drugs.<BR/>Nr = 255, Na = 220<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom-made foot orthoses group<BR/>Age, mean yrs (SD): 47 (13)<BR/>Sex, % female: 72<BR/>BMI, mean (SD): 32.0 (7.3)<BR/>Duration of symptoms, median (wks): 20<BR/>Non custom orthoses group<BR/>Age, mean yrs (SD): 48 (11)<BR/>Sex, % female: 76<BR/>BMI, mean (SD): 31.9 (6.6)<BR/>Duration of symptoms, median (wks): 16<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Custom made orthoses (plus taping): At the initial visit, each participant was placed in the supine position while the foot was held with the subtalar joint neutral and the midtarsal joint fully pronated. The plantar contour of the foot underwent scanning by a laser beam and the resultant image was transmitted to a computer. The information was processed in a prescription format and sent to Bergmann Orthotic Laboratory in Northfield, Illinois. All orthoses were made of rigid 5 mm Polydur (Atlas International, Sacramento, California) plastic material. The orthoses were intrinsically balanced in forefoot-to-rearfoot neutral bisection. They were posted using a non-compressible composition cork material. The orthoses were intrinsically balanced with 4° of rearfoot varus and with intrinsic forefoot posting. No top covers were used. The foot was taped using a low-Dye technique for approximately 2 weeks, after which the orthoses were dispensed.<BR/>Non custom made orthoses (plus taping): Made of a rigid plastic (Foot Soldiers, Professional Footcare Internationa, Valencia, California). The foot was taped using a low-Dye technique for 2 weeks, after which the arch supports were dispensed. <BR/>Posterior tension night splint group: Did not receive pre intervention taping, therefore excluded from analyses (unable to isolate effect of custom foot orthoses).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: 100 mm visual analogue scale.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>If the plantar fasciitis was bilateral, only the more symptomatic foot was entered into the study.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:30:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pfeffer-1999">
<CHAR_METHODS MODIFIED="2008-05-07 13:30:19 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Five-arm parallel-group design.<BR/>Type of foot pain: Proximal plantar fasciitis (heel pain syndrome)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>15 orthopaedic foot and ankle centres participated in the study. All participants were examined by an orthopaedic surgeon who specialised in foot and ankle disorders.<BR/>Inclusion criteria: Isolated pain over the medial calcaneal tuberosity, consistent with proximal plantar fasciitis; maximal tenderness over the medial calcaneal tuberosity at the insertion of the plantar fascia; 16 years of age and older [not clear if an inclusion criteria].<BR/>Exclusion criteria: Systemic disease; sciatica; local nerve entrapment (1st branch of lateral plantar nerve or posterior tibial nerve); previous treatment for the condition.<BR/>Nr = 236, Na = 190.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Stretching group<BR/>Median age, yrs (range): 47 (25-81)<BR/>Sex, % female: 71.8%<BR/>BMI, median (range): 28.0 (21.6-50.5)<BR/>Custom foot orthoses (plus stretching) group<BR/>Median age, yrs (range): 48.5 (23-69)<BR/>Sex, % female: 67.7%<BR/>BMI, median (range): 29.3(21.5-46.6)<BR/>Silicone heel pad (plus stretching) group<BR/>Median age, yrs (range): 49.5 (30-75)<BR/>Sex, % female: 59.5%<BR/>BMI, median (range): 28.0(20.0-43.6)<BR/>Felt insert (plus stretching) group<BR/>Median age, yrs (range): 48 (26-76)<BR/>Sex, % female: 69.1%<BR/>BMI, median (range): 28.1(18.3-48.9)<BR/>Rubber heel cup (plus stretching) group<BR/>Median age, yrs (range): 44 (27-69)<BR/>Sex, % female: 69.8%<BR/>BMI, median (range): 27.1(20.4-50.2)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:30:47 +1000" MODIFIED_BY="[Empty name]">
<P>Stretching: Achilles' and plantar fascia stretching for approximately 10 min, twice a day. Stretching exercises demonstrated with diagrams and a written explanation.<BR/>Custom foot orthoses (plus stretching): Made from a negative cast of each participant's foot, taken while the subtalar joint was in a neutral position. Orthoses were made in a uniform manner at Prolab (San Fransisco, CA). Either 1/4 inch or 3/16 inch polypropylene was used for each neutral orthosis, with the thickness determined by the weight of the participant. The time from casting to dispensing each orthotic was 10 to 12 days. The baseline questionnaire was not filled out until the participant received the orthotic device.<BR/>Non-custom foot orthoses (plus stretching): Silicone heel pad (Bauerfeind, Kennesaw, GA).<BR/>Non-custom foot orthoses (plus stretching): Felt insert (Hapad, Bethel Park, PA).<BR/>Non-custom foot orthoses (plus stretching): Rubber heel cup (Tuli International Comfort Products, San Marcos, CA).<BR/>All participants given identical written instructions specific to randomised treatment protocol.<BR/>No other treatment modalities were used in this study, including anti-inflammatory agents. Participants were encouraged not to change their regular shoe wear or activity level.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot Function Index (pain scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:31:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powell-2005">
<CHAR_METHODS MODIFIED="2008-05-07 13:31:07 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Three-arm parallel-group design.<BR/>Type of foot pain: Juvenile idiopathic arthritis (JIA)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:31:28 +1000" MODIFIED_BY="[Empty name]">
<P>Recruited from three paediatric rheumatology clinics at three Southern California children's hospitals.<BR/>Inclusion criteria: Assessed by paediatric rheumatologist to ensure diagnosis of juvenile idiopathic arthritis according to the International League of Associations for Rheumatology (ILAR) criteria; persistent pain in the joints of the lower extremity (ankle, subtalar, hindfoot, and/or metatarsal joints ); at least 5 years of age; presence of active disease of the ankle, subtalar, hindfoot, and/or metatarsal joints as determined by the tender and swollen foot joint count; history of persistent foot/ankle pain for more than 1 month but less than 2 years; no foot osseous anomaly noted during the physical evaluation; no history of foot/ankle surgery; stable medication(s) for 1 month prior to entry and during the course of the study; no joint injections for at least 6 month prior to entry and during the course of the study; no previous use of shoe inserts or foot orthoses; ability to walk 50 feet without assistive devices.<BR/>Exclusion criteria: Not reported.<BR/>Nr = 47, Na = 40<BR/>PARTICIPANT CHARACTERISTICS<BR/>Supportive shoe group<BR/>Age, mean yrs (SD): 13.77 (4.55)<BR/>Sex, % female: 69%<BR/>Custom-made foot orthoses (plus supportive shoes) group<BR/>Age, mean yrs (SD): 12.14 (3.32)<BR/>Sex, % female: 87%<BR/>Non-custom foot orthoses (plus supportive shoes) group<BR/>Age, mean yrs (SD): 12.17 (3.04)<BR/>Sex, % female: 67%<BR/>Types of JIA: enthesiitis related arthropathy = 11, polyarthritis = 21, oligoarthritis = 6, systemic arthritis = 2.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>New supportive athletic shoes with a medial longitudinal arch support and shock absorbing soles (cross-training type shoes). All children educated by a physical therapist about the recommended supportive athletic shoes to be worn during the study. <BR/>Custom foot orthoses (plus new supportive athletic shoes): Orthoses made of metal particle-reinforced polyolefin with shock absorbing functional posts, made from non-weight-bearing casting in a subtalar neutral position. <BR/>Non custom foot orthoses (plus new supportive athletic shoes): Inserts made of 1/8 inch flat neoprene (Spenco Medical Corporation).<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot Function Index (pain scale).<BR/>Function: Foot Function Index (activity Limitation scale).<BR/>Disability: Foot Function Index (disability scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:36:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roos-2006">
<CHAR_METHODS MODIFIED="2008-05-07 13:32:35 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Three-arm parallel-group design. After 12 weeks participants were allowed to crossover to another treatment group.<BR/>Type of foot pain: Plantar fasciitis</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:36:28 +1000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Between 20 and 60 years of age; seeking treatment for plantar fasciitis; activity level before current symptoms at least equivalent to heavy household work, heavy yard work, or walking on even ground; at least moderate pain when performing physical activities; duration of symptoms more than 4 weeks.<BR/>Exclusion criteria: Diagnosis other than plantar fasciitis.<BR/>Nr = 44, Na at 6, 12, and 26 weeks = 24, Na at 52 weeks = 38.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Gender: 79% female<BR/>Age, mean (range): 46 (22 to 63) years<BR/>Symptom duration before treatment, median (range): 4.2 (1-240) months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:33:31 +1000" MODIFIED_BY="[Empty name]">
<P>Custom-made foot orthoses: Non-weightbearing plaster cast was taken with the participant lying prone and the subtalar and midtarsal joints placed in neutral alignment. The alignment was achieved by manipulation manually. No wedges or posts were used during casting. The cast was total contact with the longitudinal arch. Bilateral foot orthoses were fabricated for all participants. Orthoses were made of ethyl-vinyl-acetate material of 55 shore A density and were fitted into each participant's shoes. Daily use of orthoses was recommended.<BR/>Night splint: An anterior night splint was used to hold the foot in 90° of dorsiflexion. Maintaining a foot position of neutral plantigrade, a 3.2 mm thickness of Omega Plus (North Coast Medical, USA) a low temperature thermoplastic material, was draped directly onto the anterior lower leg and foot of each participant. Each template of material was 70 mm wide and of length equal to the measure from the tibial tuberosity to the metatarsal heads. Reinforcement was applied at the anterior ankle crease before heating. Skin protection was provided by a stockinette. Once cooled, a liner of 3 mm low-density polyethylene was added, along with 4 Velcro straps for securing the night splint. These were placed immediately inferior to the tibial tuberosity at the proximal malleoli, at the level of the midtarsal joints and across the metatarsal heads. Each participant was directed on proper application of the splint and on its nighttime use only. Recommended 7 nights per week.<BR/>Foot orthosis and night splint:<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot &amp; Ankle Outcome Score (pain scale).<BR/>Function: Foot and Ankle Outcome Score (sport and recreation scale).<BR/>Disability: Foot and Ankle Outcome Score (Activities of Daily Living scale).<BR/>Health-related quality of life: Foot &amp; Ankle Outcome Score (quality of life scale).<BR/>Compliance: Participant daily logs of intervention use, returned by mail at 6 weeks and 3 months. Compliance considered 'good' if at least 75% of recommended wear time was reported (i.e. used at least five days per week).<BR/>Adverse effects: Number and nature of adverse effects per group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:35:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torkki-2001">
<CHAR_METHODS MODIFIED="2008-05-07 13:34:34 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Three-arm parallel-group design.<BR/>Type of foot pain: Painful hallux valgus</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients of 4 hospitals of the Uusimaa Health District Area, referred by general practitioners for orthopaedic evaluation because of hallux valgus.<BR/>Inclusion criteria: Adult less than 60 years of age; mild or moderate hallux valgus deformation; painful bunion with the hallux valgus angle (angle between the first metatarsal bone and the proximal phalanx) 35° or less and the intermetatarsal angle (angle between the 1st and 2nd metatarsal bones) 15° or less. All angles measured by the same investigator using the centre-of-head method. <BR/>Exclusion criteria: Any foot that had previously undergone bunion surgery, had hallux rigidus, or had hallux limitus; rheumatoid arthritis; use of foot orthoses; pregnancy; age older than 60 years.<BR/>Nr = 209, Na = 209.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom foot orthoses group<BR/>Age, mean (SD), years: 49 (10)<BR/>Women, %: 89<BR/>BMI, mean (SD): 23.9 (13.0)<BR/>Surgery group<BR/>Age, mean (SD), years: 48 (10)<BR/>Women, %: 93<BR/>BMI, mean (SD): 24.0 (14.0)<BR/>Watchful waiting group<BR/>Age, mean (SD), years: 47 (9)<BR/>Women, %: 96<BR/>BMI, mean (SD): 24.2 (15.0)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:35:13 +1000" MODIFIED_BY="[Empty name]">
<P>Custom-made foot orthoses: Negative casts with individual prescriptions written according to foot deformity were sent to ProLab (South San Fransisco, California). ProLab fabricated the polypropylene functional foot orthoses for both feet and sent the orthoses and usage instructions to the participant within 8 weeks.<BR/>Surgery: Chevron procedure. Most procedures performed by 1 of 3 experienced orthopaedic surgeons.<BR/>Watchful waiting: Participants were asked to avoid surgical and foot orthotic therapy during the follow-up period.<BR/>Foot orthosis group did not receive orthoses for up to 2 months after randomisation and surgery group did not receive surgery on the day of randomisation.<BR/>All participants were asked to contact the independent observer if their foot pain had so worsened that they required surgery before the end of follow up.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: 100 mm visual analogue scale.<BR/>Disability: 100 mm 'ability to work' visual analogue scale.<BR/>Health-related quality of life: Health-Related Quality of Life Index.<BR/>Satisfaction: 100 mm 'satisfaction' visual analogue scales (0= totally unsatisfied and 100=totally satisfied).<BR/>Compliance: Proportion of participants in the: (1) custom foot orthoses group who reported retrospective use of orthoses at least six days per week; (2) no intervention group who did not use foot orthoses or have surgery; (3) surgery group who received surgery.<BR/>Adverse effects number of adverse effects in just the surgery group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>If bilateral deformity, outcome measures were recorded separately for each foot. The foot with lower AOFAS (worse signs and symptoms) was included in data analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-05-07 13:36:50 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Woodburn-2002">
<CHAR_METHODS MODIFIED="2008-05-07 13:35:35 +1000" MODIFIED_BY="[Empty name]">
<P>RCT. Two-arm parallel-group design.<BR/>Type of foot pain: Painful correctable valgus deformity in the rearfoot in rheumatoid arthritis.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:35:48 +1000" MODIFIED_BY="[Empty name]">
<P>Enrolled from hospital outpatient clinics.<BR/>Inclusion criteria: Participants with rheumatoid arthritis, satisfying the 1987 American College of Rheumatology revised criteria for rheumatoid arthritis; history of bilateral, subtalar and/or ankle and/or talonavicular pain and valgus heel deformity; normal ranges of motion at the ankle, subtalar and midtarsal joints; passive range of motion testing revealing valgus heel deformity was correctable with =10° of subtalar inversion past neutral.<BR/>Exclusion criteria: Concomitant musculoskeletal disease; central or peripheral nervous system disease; endocrine disorders, especially diabetes mellitus; history of orthopaedic foot surgery; current use of foot orthoses; inappropriate footwear.<BR/>Nr = 101, Na = 98.<BR/>PARTICIPANT CHARACTERISTICS<BR/>Custom-made foot orthoses group<BR/>Age, mean (SD), years: 54.0 (11.8)<BR/>Sex, % female: 68%<BR/>Disease duration, median (IQR), yrs: 3 (1,7)<BR/>No intervention group<BR/>Age, mean (SD), years: 53.1 (11.1)<BR/>Sex, % female: 65%<BR/>Disease duration, median (IQR), yrs: 3 (2,6)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-07 13:36:50 +1000" MODIFIED_BY="[Empty name]">
<P>Custom-made foot orthoses: Designed and manufactured to a standardised protocol from impression casts taken of the feet using subtalar neutral suspension technique. Orthoses were constructed of Super-Lyte® carbon graphite composite with deep heel cup and contoured medial arch. The inbuilt correction was customised for each participant according to the degree of valgus heel deformity present using intrinsic posting in the rearfoot and maximum forefoot balancing techniques. All devices were covered with 1.6mm cushioning material (PPT) extended to the toe sulcus region.<BR/>No intervention group: Were not prescribed foot orthoses at baseline. Over 30 months these participants were permitted orthoses if prescribed at any subsequent outpatient medical consultation.<BR/>Normal daily walking aids were permitted.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: Foot Function Index (pain scale).<BR/>Function: Foot Function Index (activity limitation scale).<BR/>Disability: Foot Function Index (disability scale).<BR/>Compliance: Compared the proportion of participants allocated to the custom-made foot orthoses group who reported wearing the orthoses during the week prior to each follow-up (averaged across study) with the proportion of participants allocated to the no-intervention group who were not referred from outpatient clinics for foot orthoses. The mean reported wear time of orthoses was 6.3 (SD 3.5) hours per day, 6.1 (SD 1.9) days per week.<BR/>Adverse effects: Number and nature of adverse effects per group.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = Randomised Controlled Trial<BR/>Nr = Number randomised<BR/>Na = Number included in analysis<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-05-07 13:38:18 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-05-07 13:37:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Budiman_x002d_Mak-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-07 13:37:24 +1000" MODIFIED_BY="[Empty name]">
<P>Foot pain data not reported. Pain data presented in Conrad, K., Budiman-Mak, E., Roach, K., Hedeker, D. (1996). "Impacts of foot orthoses on pain and disability in rheumatoid arthritics". Journal of Clinical Epidemiology 49(1):1-7.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chao-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Doxey-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grau-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain not specific to foot: Achilles' tendon problems.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hodge-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: ethyl vinyl acetate formed directly to the foot and trimmed to fit.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kilmartin-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: cobra orthoses consisting of an heel menisci and arch filler made from 7 mm thick, hard, compressed felt, adhered to the under-surface of a fibreboard insole. Not made from an impression of the foot.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kusumoto-2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: Sorbothane® (polyurethane) pads of prepared shapes and sizes combined to make insole to conform to walking characteristics and shoes of individual participants. Not made from an impression of the foot.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Larsen-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>No initial foot pain: investigated the prevention of problems in the back and lower extremity. Not custom-made foot orthoses: Formthotic (Foot Science International, Christchurch, New Zealand)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lynch-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unable to isolate the effect of custom-made foot orthoses due to the unknown carry over effect of the low-dye taping provided to only the custom-made orthoses group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Magalhaes-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meijad-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: palliative orthoses, made of semiflexible, 10 mm thick Podofaam XE 1000. Performed on standing patients, printing the plantar projections.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Orteza-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: Aquaplast orthoses formed directly to the foot. Not made from an impression of the foot. Pain not specific to foot.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Poon-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Postema-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>No initial foot pain: pain or history of pain at the metatarsal region. No subgroup analysis for those presenting with pain at baseline. No use of validated pain measure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rome-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: prefabricated orthoses, manufactured by Talar Made Orthotics Ltd, Chesterfield, England.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Russell-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: Aquaplast orthoses formed directly to the foot. Not made from an impression of the foot.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Saggini-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain not specific to foot: diffuse pain and hyperalgesia in the peroneus longus muscle.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Saygi-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not custom-made foot orthoses: metatarsal pads.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sobel-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stell-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial or controlled clinical trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Torkki-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial. Patient preference: surgery offered to participants in the nonsurgical treatment arms.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Turlik-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial. Patient preference: participants offered adjunctive non-steroidal anti-inflammatory drugs (NSAIDS), local steroid injection or ultrasound therapy. Uneven use of NSAIDS between groups (18 in heel pad group vs 5 in custom-made foot orthoses group). Not considered in analyses</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wenger-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No initial foot pain and no foot specific pain outcome measure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-07 13:38:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Whitford-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-07 13:38:18 +1000" MODIFIED_BY="[Empty name]">
<P>No initial foot pain. Note: subgroup data for participants reporting foot pain at baseline may be made available for future review updates.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2008-05-07 13:38:47 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2008-05-07 13:38:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burns-_x0028_n.d._x0029_">
<CHAR_STUDY_NAME MODIFIED="2008-05-07 13:38:37 +1000" MODIFIED_BY="[Empty name]">
<P>The effect of custom-made foot orthoses for foot pain in people with diabetes and peripheral arterial disease: A randomised controlled trial.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS MODIFIED="2008-05-07 13:38:47 +1000" MODIFIED_BY="[Empty name]">
<P>People over the age of 18 year, with diabetes, foot pain and peripheral arterial disease. Target sample size: 60 people. Key exclusion criteria: wheelchair-bound; foot infection; current foot ulceration; amputation; pregnancy; recent foot trauma; current usage of prescribed foot orthoses; unwilling to wear supplied footwear, or lack of willingness to return for follow up.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Custom-made foot orthoses plus footwear versus sham foot orthoses plus footwear.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary: Foot pain. Secondary: plantar pressure, health related quality of life, functional ability, foot comfort, and activity levels.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>10th of July 2007</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION>
<P>Mr Caleb Wegener. Address: Podiatry Department Level 1, Block E Westmead Hospital Po Box 533 Wentworthville, NSW 2145. Australia. E-mail: caleb.wegener@swahs.health.nsw.gov.au</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES>
<P>Australian New Zealand Clinical Trials Registry number 12607000300471</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Burns-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chalmers-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Conrad-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dimou-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Landorf-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Martin-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pfeffer-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Powell-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Roos-2006">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Torkki-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Woodburn-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-04-23 14:21:06 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-04-23 14:20:07 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>MEDLINE search strategy</TITLE>
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Ovid MEDLINE</P>
</TH>
</TR>
<TR>
<TD>
<P>1. exp foot/<BR/>2. exp Foot Joints/<BR/>3. exp Foot Injuries/<BR/>4. exp Foot Bones/<BR/>5. exp Heel/<BR/>6. (foot or feet or heel$).tw.<BR/>7. or/1-6<BR/>8. exp Pain/<BR/>9. pain$.tw.<BR/>10. 8 or 9<BR/>11. 7 and 10<BR/>12. exp Fasciitis, Plantar/<BR/>13. plantar fasciitis.tw.<BR/>14. exp Sesamoid Bones/<BR/>15. sesamoiditis.tw.<BR/>16. exp Metatarsalgia/<BR/>17. exp Osteoarthritis/<BR/>18. osteoarthrit$.tw.<BR/>19. exp Tendinopathy/<BR/>20. (tendinitis or tendonitis).tw.<BR/>21. exp Fractures, Stress/<BR/>22. or/17-21<BR/>23. 7 and 22<BR/>24. or/11-16,23<BR/>25. exp Orthotic Devices/<BR/>26. (orthos$ or orthotic$).tw.<BR/>27. (shoe adj device$).tw.<BR/>28. in-shoe.tw.<BR/>29. (heel adj pad$).tw.<BR/>30. in-sole$.tw.<BR/>31. insole$.tw.<BR/>32. innersole$.tw.<BR/>33. ((orthopedic or orthopaedic) adj shoe$).tw.<BR/>34. or/25-33<BR/>35. 24 and 34<BR/>36. clinical trial.pt.<BR/>37. randomized.ab.<BR/>38. placebo.ab.<BR/>39. dt.fs.<BR/>40. clinical trials/<BR/>41. randomly.ab.<BR/>42. trial.ti.<BR/>43. groups.ab.<BR/>44. or/36-43<BR/>45. animals/<BR/>46. humans/<BR/>47. 45 and 46<BR/>48. 45 not 47<BR/>49. 44 not 48<BR/>50. 35 and 49<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" NO="2">
<TITLE>CINAHL search strategy</TITLE>
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>CINAHL</P>
</TH>
</TR>
<TR>
<TD>
<P>1. exp FOOT/<BR/>2. exp Foot Injuries/<BR/>3. exp Foot Bones/<BR/>4. exp Foot Diseases/<BR/>5. exp HEEL/<BR/>6. (foot or feet or heel$).tw.<BR/>7. or/1-6<BR/>8. exp PAIN/<BR/>9. pain$.tw.<BR/>10. 8 or 9<BR/>11. 7 and 10<BR/>12. exp PLANTAR FASCIITIS/<BR/>13. plantar fasciitis.tw.<BR/>14. exp Sesamoid Bones/<BR/>15. sesamoiditis.tw.<BR/>16. Metatarsalgia.tw.<BR/>17. exp OSTEOARTHRITIS/<BR/>18. osteoarthrit$.tw.<BR/>19. exp Tendinitis/<BR/>20. (tendinitis or tendonitis).tw.<BR/>21. exp Fractures, Stress/<BR/>22. or/17-21<BR/>23. 11 and 22<BR/>24. or/12-16,23<BR/>25. exp Orthoses/<BR/>26. (orthos$ or orthotic$).tw.<BR/>27. (shoe adj device$).tw.<BR/>28. in-shoe.tw.<BR/>29. (heel adj pad$).tw.<BR/>30. in-sole$.tw.<BR/>31. insole$.tw.<BR/>32. innersole$.tw.<BR/>33. ((orthopedic or orthopaedic) adj shoe$).tw.<BR/>34. or/25-33<BR/>35. 24 and 34<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" NO="3">
<TITLE>EMBASE search strategy</TITLE>
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>EMBASE</P>
</TH>
</TR>
<TR>
<TD>
<P>1. exp FOOT/<BR/>2. exp Foot Injury/<BR/>3. exp HEEL/<BR/>4. (foot or feet or heel$).tw.<BR/>5. or/1-4<BR/>6. exp PAIN/<BR/>7. pain$.tw.<BR/>8. 6 or 7<BR/>9. 5 and 8<BR/>10. exp PLANTAR FASCIITIS/<BR/>11. plantar fasciitis.tw.<BR/>12. exp Sesamoid Bone/<BR/>13. sesamoiditis.tw.<BR/>14. exp METATARSALGIA/<BR/>15. exp OSTEOARTHRITIS/<BR/>16. osteoarthrit$.tw.<BR/>17. exp Tendinitis/<BR/>18. (tendinitis or tendonitis).tw.<BR/>19. exp Stress Fracture/<BR/>20. or/15-19<BR/>21. 5 and 20<BR/>22. or/10-14,21<BR/>23. exp Orthotics/<BR/>24. (orthos$ or orthotic$).tw.<BR/>25. (shoe adj device$).tw.<BR/>26. in-shoe.tw.<BR/>27. (heel adj pad$).tw.<BR/>28. in-sole$.tw.<BR/>29. insole$.tw.<BR/>30. innersole$.tw.<BR/>31. ((orthopedic or orthopaedic) adj shoe$).tw.<BR/>32. or/23-31<BR/>33. 22 and 32<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" NO="4">
<TITLE>Cochrane Central Register of Controlled Trials search strategy</TITLE>
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Search strategy</P>
</TH>
</TR>
<TR>
<TD>
<P>#1MeSH descriptor Foot explode all trees<BR/>#2MeSH descriptor Foot Joints explode all trees<BR/>#3MeSH descriptor Foot Injuries explode all trees<BR/>#4MeSH descriptor Foot Bones explode all trees<BR/>#5MeSH descriptor Heel explode all trees<BR/>#6(foot or feet or heel*):ti,ab<BR/>#7(#1 OR #2 OR #3 OR #4 OR #5 OR #6)<BR/>#8MeSH descriptor Pain explode all trees<BR/>#9pain*:ti,ab<BR/>#10(#8 OR #9)<BR/>#11(#7 AND #10)<BR/>#12MeSH descriptor Fasciitis, Plantar explode all trees<BR/>#13"plantar fasciitis":ti,ab<BR/>#14MeSH descriptor Sesamoid Bones explode all trees<BR/>#15 sesamoiditis:ti,ab<BR/>#16MeSH descriptor Metatarsalgia explode all trees<BR/>#17MeSH descriptor Osteoarthritis explode all trees<BR/>#18osteoarthrit*:ti,ab<BR/>#19MeSH descriptor Tendinopathy explode all trees<BR/>#20(tendinitis or tendonitis):ti,ab<BR/>#21MeSH descriptor Fractures, Stress explode all trees<BR/>#22(#17 OR #18 OR #19 OR #20 OR #21)<BR/>#23(#7 AND #22)<BR/>#24(#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #23)<BR/>#25MeSH descriptor Orthotic Devices explode all trees<BR/>#26(orthos* or orthotic*):ti,ab<BR/>#27shoe next device*:ti,ab<BR/>#28in-shoe:ti,ab<BR/>#29heel next pad*:ti,ab<BR/>#30in-sole*:ti,ab<BR/>#31insole*:ti,ab<BR/>#32innersole*:ti,ab<BR/>#33((orthopedic or orthopaedic) next shoe*):ti,ab<BR/>#34(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33)<BR/>#35(#24 AND #34)<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" NO="5">
<TITLE>PEDro search strategy</TITLE>
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>PEDro</P>
</TH>
</TR>
<TR>
<TD>
<P>Using drop-down menus:<BR/>
<BR/>Therapy = Orthoses, tapering, splinting<BR/>
<BR/>Problem = Pain<BR/>
<BR/>Body Part = Foot or ankle<BR/>
<BR/>Method = Clinical trial<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" NO="6">
<TITLE>Allocation concealment criteria</TITLE>
<TABLE COLS="2" ROWS="6">
<TR>
<TH>
<P>Level</P>
</TH>
<TH>
<P>Criteria</P>
</TH>
</TR>
<TR>
<TD>
<P>(A) Adequate</P>
</TD>
<TD>
<P>·Centralised (e.g., allocation by a central office unaware of participant characteristics) or pharmacy-controlled randomisation.<BR/>·Pre-numbered or coded identical containers, which are administered serially to participants.<BR/>·On-site computer system combined with allocations kept in a locked unreadable computer file that can be accessed only after the characteristics of an enrolled participant have been entered.<BR/>·Sequentially numbered, sealed, opaque envelopes.</P>
</TD>
</TR>
<TR>
<TD>
<P>(B) Unclear</P>
</TD>
<TD>
<P>When no concealment approach is reported (e.g., merely stating that a list or table was used, only specifying that sealed envelopes were used, or reporting an apparently adequate concealment scheme in combination with other information that leads the reviewer to be suspicious).</P>
</TD>
</TR>
<TR>
<TD>
<P>(C) Inadequate</P>
</TD>
<TD>
<P>Includes alternation; the use of case record numbers, dates of birth or day of the week, and any procedure that is entirely transparent before allocation, such as an open list of random numbers.</P>
</TD>
</TR>
<TR>
<TD>
<P>(D) Not used</P>
</TD>
<TD>
<P>Clearly stated that allocation concealment was not used.</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" NO="7">
<TITLE>Grading the strength of evidence</TITLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TH>
<P>Level</P>
</TH>
<TH>
<P>Criteria</P>
</TH>
</TR>
<TR>
<TD>
<P>Platinum</P>
</TD>
<TD>
<P>Awarded if at least two individual controlled trials within the analysis had:<BR/>1. sample sizes of at least 50 per group. If they did not detect a statistically significant difference, they were adequately powered for a 20% relative difference in the relevant outcome;<BR/>2. blinding of participants and assessors of outcomes;<BR/>3. handling of withdrawals: &gt;80% follow up (imputations based on methods such as last observation carried forward (LOCF) acceptable); and<BR/>4. concealment of allocation.</P>
</TD>
</TR>
<TR>
<TD>
<P>Gold</P>
</TD>
<TD>
<P>Awarded if at least one randomised clinical trial met all the following criteria for the major outcome as reported: <BR/>1. sample sizes of at least 50 per group. Note: If they did not detect a statistically significant difference, they were adequately powered for a 20% relative difference in the relevant outcome;<BR/>2. blinding of participants and outcome assessors;<BR/>3. handling of withdrawals: &gt;80% follow up (imputations based on methods such as last observation carried forward (LOCF) acceptable); and<BR/>4. concealment of allocation.</P>
</TD>
</TR>
<TR>
<TD>
<P>Silver</P>
</TD>
<TD>
<P>Awarded if the above criteria were not met but the analysis included evidence from at least one study of non-randomised cohorts who did or did not receive therapy, or evidence from at least one high quality case-control study. A randomised trial with a 'head to head' comparison of interventions was considered silver ranking unless a reference was provided to a comparison of one of the interventions to placebo showing at least a 20% relative difference.</P>
</TD>
</TR>
<TR>
<TD>
<P>Bronze</P>
</TD>
<TD>
<P>Awarded if the above criteria were not met but included at least one high quality case series without controls (including simple before and after trials in which participants act as their own control) or if the conclusion is derived from expert opinion based on clinical experience without reference to any of the foregoing.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2008-04-23 14:20:24 +1000" MODIFIED_BY="[Empty name]" NO="8">
<TITLE>Methodological quality of included studies</TITLE>
<TABLE COLS="9" ROWS="12">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Random allocation</P>
</TH>
<TH>
<P>Concealed allocation</P>
</TH>
<TH>
<P>Blind therapist</P>
</TH>
<TH>
<P>Blind participants</P>
</TH>
<TH>
<P>Blind outcome assess</P>
</TH>
<TH>
<P>Withdrawals and loss</P>
</TH>
<TH>
<P>Follow-up</P>
</TH>
<TH>
<P>Risk of bias</P>
</TH>
</TR>
<TR>
<TD>
<P>Burns 2006</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Intention to treat</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Chalmers 2000</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Conrad 1996</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Dimou 2006</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Intention to treat</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Landorf 2006</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Martin 2001</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Per protocol</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Pfeffer 1999</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Powell 2005</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Roos 2006</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Torkki 2001</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>B</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Intention to treat</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Woodburn 2002</P>
</TD>
<TD>
<P>Y</P>
</TD>
<TD>
<P>A</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Available case</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>High</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" NO="9">
<TITLE>Clinical relevance table for comparison 01 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>3 months (Burns 2006)</P>
</TD>
<TD>
<P>Change scores from the Pain domain of FHSQ</P>
</TD>
<TD>
<P>154 (1)</P>
</TD>
<TD>
<P>46.7</P>
</TD>
<TD>
<P>11%(3.1, 18.4)</P>
</TD>
<TD>
<P>23.3%(6.7, 39.8)</P>
</TD>
<TD>
<P>5(3 to 16)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-10" NO="10">
<TITLE>Clinical relevance table for comparison 01 (dichotomous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control event rate</P>
</TH>
<TH>
<P>Wt absolute RD</P>
</TH>
<TH>
<P>Wt Rel % change</P>
</TH>
<TH>
<P>NNT(H)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>3 months (Burns 2006)</P>
</TD>
<TD>
<P>Total number of reported adverse effects</P>
</TD>
<TD>
<P>154 (1)</P>
</TD>
<TD>
<P>15.19%</P>
</TD>
<TD>
<P>-0.1%(-0.2, 0.0)</P>
</TD>
<TD>
<P>-39.0%(-74.0, 48.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-11" NO="11">
<TITLE>Clinical relevance table for comparison 02 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>3 months (Powell 2005)</P>
</TD>
<TD>
<P>Change scores from the Pain scale of FFI</P>
</TD>
<TD>
<P>28 (1)</P>
</TD>
<TD>
<P>47.4</P>
</TD>
<TD>
<P>19.0% (2.8 to 35.1)</P>
</TD>
<TD>
<P>40.5% (6.1 to 74.9)</P>
</TD>
<TD>
<P>3 (2 to 23)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-12" NO="12">
<TITLE>Clinical relevance table for comparison 03 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>3 months (Powell 2005)</P>
</TD>
<TD>
<P>Plain scores of the Pain subscale of the FFI</P>
</TD>
<TD>
<P>27 (1)</P>
</TD>
<TD>
<P>47.4</P>
</TD>
<TD>
<P>12.0%(-4.7 to 28.66)</P>
</TD>
<TD>
<P>25.5%(-10.0 to 61.1)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-13" NO="13">
<TITLE>Clinical relevance table for comparison 04 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="4">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 weeks (Chalmers 2000)</P>
</TD>
<TD>
<P>Plain scores from a 100 mm visual analogue scale</P>
</TD>
<TD>
<P>16 (1)</P>
</TD>
<TD>
<P>45.3</P>
</TD>
<TD>
<P>8.3% (-19.7, 36.4)</P>
</TD>
<TD>
<P>18.5% (-44.0, 81.1)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Pooled)</P>
</TD>
<TD>
<P>Change scores from the Pain scale of FFI</P>
</TD>
<TD>
<P>56 (2)</P>
</TD>
<TD>
<P>40.8</P>
</TD>
<TD>
<P>10.6% (-2.41 to 21.0)</P>
</TD>
<TD>
<P>26.2% (6.0 to 58.3)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Summary of change over 30 months (Woodburn 2002)</P>
</TD>
<TD>
<P>Pain scale of FFI; no interpretable scale range for summary statistic</P>
</TD>
<TD>
<P>98 (1)</P>
</TD>
<TD>
<P>40.8</P>
</TD>
<TD>
<P>No interpretable scale range</P>
</TD>
<TD>
<P>Summary data without scale range</P>
</TD>
<TD>
<P>Not calculable</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-14" NO="14">
<TITLE>Clinical relevance table for comparison 05 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>36 months (Conrad 1996)</P>
</TD>
<TD>
<P>Plain scores from the Pain scale of the FFI</P>
</TD>
<TD>
<P>88 (1)</P>
</TD>
<TD>
<P>Not reported</P>
</TD>
<TD>
<P>0.9%(-10.9, 12.6)</P>
</TD>
<TD>
<P>Not calculable</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-15" NO="15">
<TITLE>Clinical relevance table for comparison 05 (dichotomous data)</TITLE>
<TABLE COLS="9" ROWS="2">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control event rate</P>
</TH>
<TH>
<P>Wt absolute RD</P>
</TH>
<TH>
<P>Wt Rel % change</P>
</TH>
<TH>
<P>NNT(H)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>36 months (Conrad 1996)</P>
</TD>
<TD>
<P>Total number of reported adverse effects</P>
</TD>
<TD>
<P>88 (1)</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0.00 (-0.0, 0.0)</P>
</TD>
<TD>
<P>Not calculable</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-16" NO="16">
<TITLE>Clinical relevance table for comparison 06 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="6">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>2 to 3 months</P>
</TD>
<TD>
<P>Change scores the Pain domain of FHSQ</P>
</TD>
<TD>
<P>165 (2)</P>
</TD>
<TD>
<P>45.1(20.6)</P>
</TD>
<TD>
<P>-2.3%(-8.6, 4.0)</P>
</TD>
<TD>
<P>-5.0%(-19.2, 8.7)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Not eligible for pooling: Over-the-counter arch supports 3 months (Martin 2001)</P>
</TD>
<TD>
<P>Plain scores from a 100 mm VAS</P>
</TD>
<TD>
<P>133 (1)</P>
</TD>
<TD>
<P>58.0</P>
</TD>
<TD>
<P>3.0%(-4.6, 10.6)</P>
</TD>
<TD>
<P>5.2%(-8.0, 18.4)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Not eligible for pooling: Rubber heel cup after 2 months (Pfeffer 1999)</P>
</TD>
<TD>
<P>Change scores from the Pain scale of FFI</P>
</TD>
<TD>
<P>77 (1)</P>
</TD>
<TD>
<P>55.8</P>
</TD>
<TD>
<P>-8.6%(-22.1, 4.9)</P>
</TD>
<TD>
<P>-15.6%(-40.0, 8.8)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Not eligible for pooling: Silicone heel pad after 2 months (Pfeffer 1999)</P>
</TD>
<TD>
<P>Change scores from the Pain scale of FFI</P>
</TD>
<TD>
<P>76 (1)</P>
</TD>
<TD>
<P>55.8</P>
</TD>
<TD>
<P>3.9%(-15.8, 8.1)</P>
</TD>
<TD>
<P>-7.0%(-22.6, 14.6)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Prefabricated Formthotic after 12 months (Landorf 2006)</P>
</TD>
<TD>
<P>Change scores of the Pain domain of FHSQ</P>
</TD>
<TD>
<P>88 (1)</P>
</TD>
<TD>
<P>45.1</P>
</TD>
<TD>
<P>-6.9%(-17.0, 3.2)</P>
</TD>
<TD>
<P>-15.5%(-38.1, 7.1)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-17" NO="17">
<TITLE>Clinical relevance table for comparison 06 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 weeks (Chalmers 2000)</P>
</TD>
<TD>
<P>Change scores from the Pain subscale of the Foot &amp; Ankle Outcome Score</P>
</TD>
<TD>
<P>16 (1)</P>
</TD>
<TD>
<P>45.3</P>
</TD>
<TD>
<P>5.7%(-32.5, 58.2)</P>
</TD>
<TD>
<P>12.8%(-32.5, 58.2)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Chalmers 2000)</P>
</TD>
<TD>
<P>Change scores from the Pain subscale of the Foot &amp; Ankle Outcome Score</P>
</TD>
<TD>
<P>16 (1)</P>
</TD>
<TD>
<P>45.3</P>
</TD>
<TD>
<P>-13.2%(-31.8, 5.5)</P>
</TD>
<TD>
<P>-29.4%(-70.93, 12.2)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-18" NO="18">
<TITLE>Clinical relevance table for comparison 07 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 to 8 weeks (pooled)</P>
</TD>
<TD>
<P>FFI, Pain</P>
</TD>
<TD>
<P>96 (2)</P>
</TD>
<TD>
<P>55.8</P>
</TD>
<TD>
<P>1.1% (-7.4, 9.8)</P>
</TD>
<TD>
<P>1.9% (-13.4, 17.6)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Roos 2006)</P>
</TD>
<TD>
<P>Foot &amp; Ankle Outcome Score, Pain</P>
</TD>
<TD>
<P>25 (1)</P>
</TD>
<TD>
<P>53</P>
</TD>
<TD>
<P>5.9% (-6.7, 18.6)</P>
</TD>
<TD>
<P>11.3% (-12.7, 35.4)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-19" NO="19">
<TITLE>Clinical relevance table for comparison 07 (dichotomous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control event rate</P>
</TH>
<TH>
<P>Wt absolute RD</P>
</TH>
<TH>
<P>Wt Rel % change</P>
</TH>
<TH>
<P>NNT(H)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>1 week (Roos 2006)</P>
</TD>
<TD>
<P>Total numbers of reported adverse effects</P>
</TD>
<TD>
<P>30 (1)</P>
</TD>
<TD>
<P>60.0%</P>
</TD>
<TD>
<P>-0.2 (-0.6, 0.2)</P>
</TD>
<TD>
<P>-33.0% (-68.0, 40.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Roos 2006)</P>
</TD>
<TD>
<P>Total numbers of reported adverse effects</P>
</TD>
<TD>
<P>25 (1)</P>
</TD>
<TD>
<P>35.7%</P>
</TD>
<TD>
<P>0.01 (-0.4, 0.4)</P>
</TD>
<TD>
<P>2.0% (-64.0, 191.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-20" NO="20">
<TITLE>Clinical relevance table for comparison 08 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>3 months (Landorf 2006)</P>
</TD>
<TD>
<P>Change scores from the Pain domain of the FHSQ</P>
</TD>
<TD>
<P>89 (1)</P>
</TD>
<TD>
<P>45.1</P>
</TD>
<TD>
<P>5%(-5.1, 15.2)</P>
</TD>
<TD>
<P>11.3%(-11.5, 34.1)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months (Landorf 2006)</P>
</TD>
<TD>
<P>Change scores from the Pain domain of the FHSQ</P>
</TD>
<TD>
<P>88 (1)</P>
</TD>
<TD>
<P>45.1</P>
</TD>
<TD>
<P>-2.0%(-12.4, 7.5)</P>
</TD>
<TD>
<P>-5.5%(-27.8, 16.7)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-21" NO="21">
<TITLE>Clinical relevance table for comparison 10 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="4">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>2 weeks (Dimou 2006)</P>
</TD>
<TD>
<P>Plain scores from the Pain Scale Form: Worst of the Numeric Pain Rating Scale 101.</P>
</TD>
<TD>
<P>20 (1)</P>
</TD>
<TD>
<P>53.7</P>
</TD>
<TD>
<P>-23.1% (-42.3, -3.9)</P>
</TD>
<TD>
<P>-43.4% (-79.5, -7.3)</P>
</TD>
<TD>
<P>2 (2 to 30)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>1 month (Dimou 2006)</P>
</TD>
<TD>
<P>Plain scores from the Pain Scale Form: Worst of the Numeric Pain Rating Scale 101.</P>
</TD>
<TD>
<P>20 (1)</P>
</TD>
<TD>
<P>53.7</P>
</TD>
<TD>
<P>-11.0% (-28.5, 6.5)</P>
</TD>
<TD>
<P>-20.7% (-53.7, 12.3)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>2 months (Dimou 2006)</P>
</TD>
<TD>
<P>Plain scores from the Pain Scale Form: Worst of the Numeric Pain Rating Scale 101.</P>
</TD>
<TD>
<P>20 (1)</P>
</TD>
<TD>
<P>53.7</P>
</TD>
<TD>
<P>-6.0% (-21.1, 9.1)</P>
</TD>
<TD>
<P>-11.4% (-39.8, 17.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-22" NO="22">
<TITLE>Clinical relevance table for comparison 11 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 weeks (Roos 2006)</P>
</TD>
<TD>
<P>Change scores from the Pain subscale of the Foot and Ankle Outcome score.</P>
</TD>
<TD>
<P>25 (1)</P>
</TD>
<TD>
<P>53</P>
</TD>
<TD>
<P>0.9% (-14.4, 12.6)</P>
</TD>
<TD>
<P>1.7% (-27.4, 24.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Roos 2006)</P>
</TD>
<TD>
<P>Plain scores from the Pain subscale of the Foot and Ankle Outcome score.</P>
</TD>
<TD>
<P>23 (1)</P>
</TD>
<TD>
<P>53</P>
</TD>
<TD>
<P>5.9% (-12.6, 24.5)</P>
</TD>
<TD>
<P>11.3% (-24.0, 46.6)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-23" NO="23">
<TITLE>Clinical relevance table for comparison 11 (dichotomous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control event rate</P>
</TH>
<TH>
<P>Wt absolute RD</P>
</TH>
<TH>
<P>Wt Rel % change</P>
</TH>
<TH>
<P>NNT(H)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>1 week (Roos 2006)</P>
</TD>
<TD>
<P>Adverse effects</P>
</TD>
<TD>
<P>28 (1)</P>
</TD>
<TD>
<P>60%</P>
</TD>
<TD>
<P>-0.4 (-0.7, -0.0)</P>
</TD>
<TD>
<P>-62.0% (-87.0, 13.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>3 months (Roos 2006)</P>
</TD>
<TD>
<P>Adverse effects</P>
</TD>
<TD>
<P>23 (1)</P>
</TD>
<TD>
<P>35.7%</P>
</TD>
<TD>
<P>-0.3 (-0.6, 0.1)</P>
</TD>
<TD>
<P>-69.0% (-96.0, 125.0)</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-24" NO="24">
<TITLE>Clinical relevance table for comparison 12 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 months (Torkki 2001)</P>
</TD>
<TD>
<P>Plain scores from 100 mm VAS</P>
</TD>
<TD>
<P>138 (1)</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>8.9%(1.2, 16.7)</P>
</TD>
<TD>
<P>20.0%(2.6, 37.4)</P>
</TD>
<TD>
<P>6(3 to 52)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months (Torkki 2001)</P>
</TD>
<TD>
<P>Plain scores from 100 mm VAS</P>
</TD>
<TD>
<P>138 (1)</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>0.0%(-8.1, 8.1)</P>
</TD>
<TD>
<P>0%</P>
</TD>
<TD>
<P>n/a</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-25" MODIFIED="2008-04-23 14:20:52 +1000" MODIFIED_BY="[Empty name]" NO="25">
<TITLE>Clinical relevance table for comparison 13 (continuous data)</TITLE>
<TABLE COLS="9" ROWS="3">
<TR>
<TH>
<P>Type of foot pain</P>
</TH>
<TH>
<P>Outcome (scale)</P>
</TH>
<TH>
<P># pts (# trials)</P>
</TH>
<TH>
<P>Control baseline m*</P>
</TH>
<TH>
<P>Wt absolute change</P>
</TH>
<TH>
<P>Relative % change*</P>
</TH>
<TH>
<P>NNT(B)</P>
</TH>
<TH>
<P>Stat sig</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>6 months (Torkki 2001)</P>
</TD>
<TD>
<P>Plain scores from a 100 mm VAS</P>
</TD>
<TD>
<P>140 (1)</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>-9.9% (-17.6, -2.2)</P>
</TD>
<TD>
<P>-22.2% (-39.5, -4.9)</P>
</TD>
<TD>
<P>5(3 to 33)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months (Torkki 2001)</P>
</TD>
<TD>
<P>Plain scores from a 100 mm VAS</P>
</TD>
<TD>
<P>140 (1)</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>-16.8% (-24.4, -9.3)</P>
</TD>
<TD>
<P>-37.8% (-54.7, -20.8)</P>
</TD>
<TD>
<P>3(2 to 5)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-26" MODIFIED="2008-04-23 14:21:06 +1000" MODIFIED_BY="[Empty name]" NO="26">
<TITLE>Summary table of level of evidence and number needed to treat the benefit (NNTB)</TITLE>
<TABLE COLS="6" ROWS="6">
<TR>
<TH>
<P>Foot pain type</P>
</TH>
<TH>
<P>Platinum</P>
</TH>
<TH>
<P>Gold</P>
</TH>
<TH>
<P>Silver</P>
</TH>
<TH>
<P>Bronze</P>
</TH>
<TH>
<P>NNTB</P>
</TH>
</TR>
<TR>
<TD>
<P>Painful pes cavus</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Foot pain in juveinlile idiopathic arthritis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Foot pain in rheumatoid arthritis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Plantar fasciitis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Painful bunion with hallux valgus</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>*</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>6</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-05-07 13:47:51 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-05-07 13:41:54 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Custom-made foot orthoses versus sham orthoses for painful cavus feet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="75" TOTAL_2="79" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="18.59091921093732" CI_START="3.2090807890626794" EFFECT_SIZE="10.899999999999999" ESTIMABLE="YES" MEAN_1="31.2" MEAN_2="20.3" ORDER="10031" SD_1="25.8" SD_2="22.7" SE="3.924010477540561" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="75" TOTAL_2="79" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="18.65043487917026" CI_START="3.3495651208297454" EFFECT_SIZE="11.000000000000002" ESTIMABLE="YES" MEAN_1="25.6" MEAN_2="14.6" ORDER="10032" SD_1="27.2" SD_2="20.6" SE="3.9033548266784033" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="300" TOTAL_2="316" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>SF-36 Physical functioning domain at 3 months</NAME>
<CONT_DATA CI_END="14.926220088508746" CI_START="4.073779911491253" EFFECT_SIZE="9.5" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="2.6" ORDER="10033" SD_1="19.3" SD_2="14.6" SE="2.768530509392049" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>SF-36 General health domain at 3 months</NAME>
<CONT_DATA CI_END="6.695033200188722" CI_START="-5.695033200188722" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.0" ORDER="10034" SD_1="18.4" SD_2="20.8" SE="3.1607893048312894" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>SF-36 Vitality domain at 3 months</NAME>
<CONT_DATA CI_END="10.740509133189661" CI_START="0.25949086681033773" EFFECT_SIZE="5.5" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="3.0" ORDER="10035" SD_1="17.8" SD_2="15.2" SE="2.673778280889919" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>SF-36 Social functioning domain at 3 months</NAME>
<CONT_DATA CI_END="8.283994625670312" CI_START="-3.2839946256703136" EFFECT_SIZE="2.499999999999999" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.2" ORDER="10036" SD_1="20.1" SD_2="16.2" SE="2.9510718927968695" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="300" TOTAL_2="316" WEIGHT="0.0" Z="0.0">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Sham worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="12" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Total adverse effects at 3 months</NAME>
<DICH_DATA CI_END="1.4768649354448193" CI_START="0.2556374426988" EFFECT_SIZE="0.6144444444444445" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.16934077935178307" LOG_CI_START="-0.5923755356210363" LOG_EFFECT_SIZE="-0.2115173781346266" ORDER="10037" O_E="0.0" SE="0.44743593397160397" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" VAR="0.20019891500904155" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="12" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Additional foot pain at 3 months</NAME>
<DICH_DATA CI_END="1.0407279224866748" CI_START="0.11845460247777435" EFFECT_SIZE="0.3511111111111111" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="0.017337206737378784" LOG_CI_START="-0.9264480603792209" LOG_EFFECT_SIZE="-0.4545554268209211" ORDER="10038" O_E="0.0" SE="0.5543841377167088" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" VAR="0.30734177215189873" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Ankle instability at 3 months</NAME>
<DICH_DATA CI_END="107.85850000362085" CI_START="0.2568256653300465" EFFECT_SIZE="5.2631578947368425" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0328543762276845" LOG_CI_START="-0.5903615781333427" LOG_EFFECT_SIZE="0.721246399047171" ORDER="10039" O_E="0.0" SE="1.540890036720063" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" VAR="2.3743421052631577" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Skin irritation at 3 months</NAME>
<DICH_DATA CI_END="76.33094981492451" CI_START="0.1306455532540124" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8827006665059793" LOG_CI_START="-0.88390536764435" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="10040" O_E="0.0" SE="1.6251180793806412" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="79" VAR="2.6410087719298243" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="75" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Sham worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="16" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="1.8289546898470352" CI_START="0.5197641063921082" EFFECT_SIZE="0.975" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.26220294648617437" LOG_CI_START="-0.2841937150891008" LOG_EFFECT_SIZE="-0.010995384301463193" ORDER="10041" O_E="0.0" SE="0.3209561037164124" STUDY_ID="STD-Burns-2006" TOTAL_1="75" TOTAL_2="78" VAR="0.1030128205128205" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-05-07 13:42:19 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Custom-made foot orthoses versus standardised intervention for foot pain in juvenile idiopathic arthritis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="35.5038923382687" CI_START="2.8761076617312966" EFFECT_SIZE="19.189999999999998" ESTIMABLE="YES" MEAN_1="-18.35" MEAN_2="-37.54" ORDER="10042" SD_1="17.05" SD_2="25.47" SE="8.323567405804699" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="35.54105100982059" CI_START="3.2189489901794097" EFFECT_SIZE="19.380000000000003" ESTIMABLE="YES" MEAN_1="-8.54" MEAN_2="-27.92" ORDER="10043" SD_1="11.06" SD_2="27.89" SE="8.245585703256234" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="34.421767259097585" CI_START="2.678232740902411" EFFECT_SIZE="18.549999999999997" ESTIMABLE="YES" MEAN_1="-15.6" MEAN_2="-34.15" ORDER="10044" SD_1="13.51" SD_2="26.35" SE="8.097989240767719" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-05-07 13:42:43 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Custom-made foot orthoses versus non custom foot orthoses for foot pain in juvenile idiopathic arthritis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated off-the-shelf shoe insert at 3 months</NAME>
<CONT_DATA CI_END="28.95006788797109" CI_START="-4.730067887971092" EFFECT_SIZE="12.11" ESTIMABLE="YES" MEAN_1="-18.35" MEAN_2="-30.46" ORDER="10045" SD_1="17.05" SD_2="25.56" SE="8.592029251967586" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated off-the-shelf shoe insert at 3 months</NAME>
<CONT_DATA CI_END="23.907649475653372" CI_START="-1.0676494756533685" EFFECT_SIZE="11.420000000000002" ESTIMABLE="YES" MEAN_1="-8.54" MEAN_2="-19.96" ORDER="10046" SD_1="11.06" SD_2="19.73" SE="6.371366807836448" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated off-the-shelf shoe insert at 3 months</NAME>
<CONT_DATA CI_END="30.223045710706195" CI_START="-1.4630457107061954" EFFECT_SIZE="14.38" ESTIMABLE="YES" MEAN_1="-15.6" MEAN_2="-29.98" ORDER="10047" SD_1="13.51" SD_2="25.26" SE="8.083335120274718" STUDY_ID="STD-Powell-2005" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-05-07 13:43:16 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Custom-made foot orthoses versus no intervention or standard intervention for foot pain in rheumatoid arthritis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="58" TOTAL_2="56" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="36.723429300652846" CI_START="-19.92342930065285" EFFECT_SIZE="8.399999999999999" ESTIMABLE="YES" MEAN_1="-36.6" MEAN_2="-45.0" ORDER="10048" SD_1="21.6" SD_2="34.7" SE="14.450994775447121" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Summary of change over 30 months</NAME>
<CONT_DATA CI_END="548.2333603686171" CI_START="67.36663963138275" EFFECT_SIZE="307.79999999999995" ESTIMABLE="YES" MEAN_1="333.4" MEAN_2="25.6" ORDER="10049" SD_1="632.8" SD_2="581.3" SE="122.67233595368326" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.4549464082308403" CI_END="0.8181225424393188" CI_START="0.266973762270497" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.5425481523549079" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" NO="2" P_CHI2="0.4831282973487393" P_Q="0.7518939325828353" P_Z="1.1396479071956752E-4" Q="0.0999464488201709" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="108" TOTAL_2="103" UNITS="" WEIGHT="200.00000000000003" Z="3.8587578409178316">
<NAME>Foot pain 3 months</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.3549999594106694" CI_END="0.976736434317024" CI_START="-0.09749009146362253" DF="1.0" EFFECT_SIZE="0.4396231714267007" ESTIMABLE="YES" I2="26.19925978190211" ID="CMP-004.02.01" NO="1" P_CHI2="0.2444060828983139" P_Z="0.10866649317036013" STUDIES="2" TAU2="0.055148855459781855" TOTAL_1="58" TOTAL_2="55" WEIGHT="100.00000000000001" Z="1.6042158000882523">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.9562358082586391" CI_START="-1.0731041540844952" EFFECT_SIZE="-0.058434172912928115" ESTIMABLE="YES" MEAN_1="-40.4" MEAN_2="-38.9" ORDER="10050" SD_1="15.8" SD_2="31.2" SE="0.5176982787312188" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="7" WEIGHT="13.738849521158908"/>
<CONT_DATA CI_END="0.9953490849130149" CI_START="0.18546592614255347" EFFECT_SIZE="0.5904075055277842" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="-0.1" ORDER="10051" SD_1="26.8" SD_2="18.7" SE="0.20660664307066773" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="86.2611504788411"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9953490849130149" CI_START="0.18546592614255347" DF="0.0" EFFECT_SIZE="0.5904075055277842" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.02" NO="2" P_CHI2="1.0" P_Z="0.004268036713620563" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="100.00000000000001" Z="2.8576404744441892">
<NAME>Sensitivity analysis</NAME>
<CONT_DATA CI_END="0.9953490849130149" CI_START="0.18546592614255347" EFFECT_SIZE="0.5904075055277842" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="-0.1" ORDER="10052" SD_1="26.8" SD_2="18.7" SE="0.20660664307066773" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="58" TOTAL_2="56" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks (1 to 9 scale)</NAME>
<CONT_DATA CI_END="1.0248987236470004" CI_START="-0.5248987236470005" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="7.38" MEAN_2="7.13" ORDER="10053" SD_1="0.52" SD_2="0.99" SE="0.3953637565584382" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>30 months</NAME>
<CONT_DATA CI_END="249.1325117093657" CI_START="-86.33251170936569" EFFECT_SIZE="81.4" ESTIMABLE="YES" MEAN_1="63.9" MEAN_2="-17.5" ORDER="10054" SD_1="416.1" SD_2="430.5" SE="85.57938463789046" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.07275046065486293" CI_END="0.35931000533984947" CI_START="-0.1809272519488587" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0891913766954954" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.04" NO="4" P_CHI2="0.9642783996059269" P_Q="0.9446755301488752" P_Z="0.517523814086993" Q="0.004815609993904915" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="108" TOTAL_2="103" UNITS="" WEIGHT="200.0" Z="0.6471670870389262">
<NAME>Function 3 months</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.06793485066095802" CI_END="0.4494289061003453" CI_START="-0.2888627639340085" DF="1.0" EFFECT_SIZE="0.08028307108316841" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.01" NO="1" P_CHI2="0.7943677165998612" P_Z="0.6699187494006541" STUDIES="2" TAU2="0.0" TOTAL_1="58" TOTAL_2="55" WEIGHT="100.00000000000001" Z="0.42625952391947575">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.969165743802437" CI_START="-1.0599423856994228" EFFECT_SIZE="-0.0453883209484929" ESTIMABLE="YES" MEAN_1="7.25" MEAN_2="7.29" ORDER="10055" SD_1="0.71" SD_2="0.95" SE="0.5176391366135311" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="7" WEIGHT="13.238706533421794"/>
<CONT_DATA CI_END="0.4957689189013098" CI_START="-0.2968509584925523" EFFECT_SIZE="0.09945898020437878" ESTIMABLE="YES" MEAN_1="-18.6" MEAN_2="-20.5" ORDER="10056" SD_1="19.1" SD_2="18.8" SE="0.20220266383615884" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="86.76129346657822"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4957689189013098" CI_START="-0.2968509584925523" DF="0.0" EFFECT_SIZE="0.09945898020437878" ESTIMABLE="YES" I2="0.0" ID="CMP-004.04.02" NO="2" P_CHI2="1.0" P_Z="0.6228058090396474" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="100.0" Z="0.49187769496928385">
<NAME>Sensitivity analysis</NAME>
<CONT_DATA CI_END="0.4957689189013098" CI_START="-0.2968509584925523" EFFECT_SIZE="0.09945898020437878" ESTIMABLE="YES" MEAN_1="-18.6" MEAN_2="-20.5" ORDER="10057" SD_1="19.1" SD_2="18.8" SE="0.20220266383615884" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="100" TOTAL_2="96" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="10.543806016475491" CI_START="-9.343806016475488" EFFECT_SIZE="0.6000000000000014" ESTIMABLE="YES" MEAN_1="-38.6" MEAN_2="-39.2" ORDER="10058" SD_1="26.4" SD_2="23.8" SE="5.073463642654132" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>30 months</NAME>
<CONT_DATA CI_END="557.0458779215774" CI_START="61.154122078422745" EFFECT_SIZE="309.1" ESTIMABLE="YES" MEAN_1="334.1" MEAN_2="25.0" ORDER="10059" SD_1="634.0" SD_2="618.3" SE="126.50532350458616" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="48" EVENTS_2="45" I2="0.0" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CFO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparison</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="48" EVENTS_2="45" I2="0.0" ID="CMP-004.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Over 30 months</NAME>
<DICH_DATA CI_END="1.1231195375281837" CI_START="0.9336281357082945" EFFECT_SIZE="1.024" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="45" LOG_CI_END="0.05042598219739055" LOG_CI_START="-0.029826068917766617" LOG_EFFECT_SIZE="0.010299956639811961" ORDER="10060" O_E="0.0" SE="0.047140452079103175" STUDY_ID="STD-Woodburn-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.0022222222222222227" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-05-07 13:43:45 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Custom-made foot orthoses versus sham orthoses for foot pain in rheumatoid arthritis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="44" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>36 months</NAME>
<CONT_DATA CI_END="12.770990885426226" CI_START="-10.970990885426222" EFFECT_SIZE="0.9000000000000021" ESTIMABLE="YES" MEAN_1="-28.2" MEAN_2="-29.1" ORDER="10061" SD_1="29.1" SD_2="27.7" SE="6.056739296774372" STUDY_ID="STD-Conrad-1996" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="44" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>36 months</NAME>
<CONT_DATA CI_END="7.203886424647191" CI_START="-10.40388642464719" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-16.5" MEAN_2="-14.9" ORDER="10062" SD_1="19.3" SD_2="22.7" SE="4.491861327091274" STUDY_ID="STD-Conrad-1996" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="44" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>36 months</NAME>
<CONT_DATA CI_END="16.026264464778805" CI_START="-7.626264464778815" EFFECT_SIZE="4.199999999999996" ESTIMABLE="YES" MEAN_1="-34.1" MEAN_2="-38.3" ORDER="10063" SD_1="28.6" SD_2="28.0" SE="6.033919275079989" STUDY_ID="STD-Conrad-1996" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Sham worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>36 months</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="10064" O_E="0.0" SE="0.0" STUDY_ID="STD-Conrad-1996" TOTAL_1="44" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Sham worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="14" I2="0.0" ID="CMP-005.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>36 months</NAME>
<DICH_DATA CI_END="1.8435494974533477" CI_START="0.5424318692725014" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.2656548024695426" LOG_CI_START="-0.2656548024695426" LOG_EFFECT_SIZE="0.0" ORDER="10065" O_E="0.0" SE="0.3120938919661796" STUDY_ID="STD-Conrad-1996" TOTAL_1="44" TOTAL_2="44" VAR="0.09740259740259738" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-05-07 13:44:12 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Custom-made foot orthoses versus non custom foot orthoses for foot pain in rheumatoid arthritis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="16" TOTAL_2="16" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Soft plastazote orthoses 6 weeks</NAME>
<CONT_DATA CI_END="26.340502041098254" CI_START="-14.74050204109826" EFFECT_SIZE="5.799999999999997" ESTIMABLE="YES" MEAN_1="-36.6" MEAN_2="-42.4" ORDER="10066" SD_1="21.6" SD_2="20.3" SE="10.480040553356652" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Soft plastazote orthoses at 3 months</NAME>
<CONT_DATA CI_END="5.525477027864728" CI_START="-32.12547702786472" EFFECT_SIZE="-13.299999999999997" ESTIMABLE="YES" MEAN_1="-40.4" MEAN_2="-27.1" ORDER="10067" SD_1="15.8" SD_2="22.1" SE="9.60501171264252" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="16" TOTAL_2="16" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Soft plastazote at 6 weeks</NAME>
<CONT_DATA CI_END="1.5108942511903534" CI_START="-0.2508942511903536" EFFECT_SIZE="0.6299999999999999" ESTIMABLE="YES" MEAN_1="7.38" MEAN_2="6.75" ORDER="10068" SD_1="0.52" SD_2="1.16" SE="0.44944410108488464" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Soft plastazote at 3 months</NAME>
<CONT_DATA CI_END="1.776254170185809" CI_START="-0.5362541701858088" EFFECT_SIZE="0.6200000000000001" ESTIMABLE="YES" MEAN_1="7.25" MEAN_2="6.63" ORDER="10069" SD_1="0.71" SD_2="1.51" SE="0.5899364372540487" STUDY_ID="STD-Chalmers-2000" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2008-05-07 13:45:27 +1000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Custom-made foot orthoses versus standardised intervention for plantar fasciitis</NAME>
<CONT_OUTCOME CHI2="0.17941161419684878" CI_END="0.45670478119221375" CI_START="-0.35003766849814494" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.05333355634703439" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" NO="1" P_CHI2="0.6718793839043136" P_Q="1.0" P_Z="0.795522957198764" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="43" TOTAL_2="53" UNITS="" WEIGHT="100.0" Z="0.25914552940097824">
<NAME>Foot pain 6-8 weeks</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.17941161419684878" CI_END="0.45670478119221375" CI_START="-0.35003766849814494" DF="1.0" EFFECT_SIZE="0.05333355634703439" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.01" NO="1" P_CHI2="0.6718793839043136" P_Z="0.795522957198764" STUDIES="2" TAU2="0.0" TOTAL_1="43" TOTAL_2="53" WEIGHT="100.0" Z="0.25914552940097824">
<NAME>6-8 weeks</NAME>
<CONT_DATA CI_END="0.5613832817381547" CI_START="-0.3589815842512904" EFFECT_SIZE="0.10120084874343212" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="15.8" ORDER="10070" SD_1="29.38" SD_2="32.85" SE="0.23479126995423527" STUDY_ID="STD-Pfeffer-1999" TOTAL_1="34" TOTAL_2="39" WEIGHT="76.83334765343898"/>
<CONT_DATA CI_END="0.7326357654445519" CI_START="-0.9434771354525333" EFFECT_SIZE="-0.10542068500399077" ESTIMABLE="YES" MEAN_1="13.87" MEAN_2="15.82" ORDER="10071" SD_1="17.48" SD_2="18.04" SE="0.42758767868135583" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="23.166652346561023"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain 3 months</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="18.753953542818763" CI_START="-6.753953542818762" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="76.0" MEAN_2="70.0" ORDER="10072" SD_1="17.0" SD_2="15.0" SE="6.507238726537997" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="20.123527432465835" CI_START="-24.60352743246583" EFFECT_SIZE="-2.2399999999999984" ESTIMABLE="YES" MEAN_1="18.98" MEAN_2="21.22" ORDER="10073" SD_1="23.21" SD_2="31.38" SE="11.410172640347723" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="16.086138362663693" CI_START="-24.086138362663693" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="59.0" MEAN_2="63.0" ORDER="10074" SD_1="29.0" SD_2="20.0" SE="10.24821809028155" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="13.17580328156496" CI_START="-17.27580328156496" EFFECT_SIZE="-2.0500000000000007" ESTIMABLE="YES" MEAN_1="10.11" MEAN_2="12.16" ORDER="10075" SD_1="16.75" SD_2="20.21" SE="7.768409726741998" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="20.753953542818763" CI_START="-4.753953542818762" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="83.0" MEAN_2="75.0" ORDER="10076" SD_1="17.0" SD_2="15.0" SE="6.507238726537997" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="21.362143963070103" CI_START="-13.982143963070106" EFFECT_SIZE="3.6899999999999995" ESTIMABLE="YES" MEAN_1="13.66" MEAN_2="9.97" ORDER="10077" SD_1="19.57" SD_2="23.29" SE="9.016565662668151" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="25.75876660592928" CI_START="-9.758766605929281" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="54.0" MEAN_2="46.0" ORDER="10078" SD_1="26.0" SD_2="17.0" SE="9.060761700729282" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-007.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="26" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Comparison worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="9" I2="0.0" ID="CMP-007.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>1 week</NAME>
<DICH_DATA CI_END="1.4041551637319367" CI_START="0.3165208916536036" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1474151014043323" LOG_CI_START="-0.4995976195156949" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="10079" O_E="0.0" SE="0.3800584750330461" STUDY_ID="STD-Roos-2006" TOTAL_1="15" TOTAL_2="15" VAR="0.1444444444444445" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="5" I2="0.0" ID="CMP-007.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="2.913131944483337" CI_START="0.3558692962188836" EFFECT_SIZE="1.018181818181818" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.46436015557284555" LOG_CI_START="-0.44870948054893245" LOG_EFFECT_SIZE="0.007825337511956526" ORDER="10080" O_E="0.0" SE="0.5363416240255251" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" VAR="0.28766233766233773" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2008-05-07 13:45:56 +1000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Custom-made foot orthoses versus sham orthoses for painful plantar fasciitis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="15.394178665771825" CI_START="-5.19417866577183" EFFECT_SIZE="5.099999999999998" ESTIMABLE="YES" MEAN_1="23.4" MEAN_2="18.3" ORDER="10081" SD_1="26.9" SD_2="22.5" SE="5.252228483263465" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="7.5496708001367345" CI_START="-12.549670800136735" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="37.2" ORDER="10082" SD_1="24.6" SD_2="23.5" SE="5.127477279892516" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sham</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="18.37325691665337" CI_START="2.4267430833466266" EFFECT_SIZE="10.399999999999999" ESTIMABLE="YES" MEAN_1="21.9" MEAN_2="11.5" ORDER="10083" SD_1="21.9" SD_2="16.1" SE="4.068062974394124" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="20.578787641177428" CI_START="0.22121235882257118" EFFECT_SIZE="10.399999999999999" ESTIMABLE="YES" MEAN_1="30.0" MEAN_2="19.6" ORDER="10084" SD_1="22.5" SD_2="26.0" SE="5.193354429707079" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="180" TOTAL_2="174" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Sham orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Sham worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-008.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="2.5347842376871204" CI_START="0.0942929745756588" EFFECT_SIZE="0.4888888888888889" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.40394099784298043" LOG_CI_START="-1.0255206637492553" LOG_EFFECT_SIZE="-0.31078983295313745" ORDER="10085" O_E="0.0" SE="0.8396728559686236" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" VAR="0.705050505050505" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-008.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>3 months (using alternative foot orthoses)</NAME>
<DICH_DATA CI_END="3.963030152230738" CI_START="0.00965921824625852" EFFECT_SIZE="0.1956521739130435" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5980273766232662" LOG_CI_START="-2.0150580211077647" LOG_EFFECT_SIZE="-0.7085153222422492" ORDER="10086" O_E="0.0" SE="1.534939297608539" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" VAR="2.356038647342995" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="12" I2="0.0" ID="CMP-008.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<DICH_DATA CI_END="1.4049792408257245" CI_START="0.2888414111502629" EFFECT_SIZE="0.6370370370370371" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.14766990740021538" LOG_CI_START="-0.5393405419030921" LOG_EFFECT_SIZE="-0.19583531725143838" ORDER="10087" O_E="0.0" SE="0.40355333867733356" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" VAR="0.1628552971576227" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="7" I2="0.0" ID="CMP-008.03.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>12 months (using alternative foot orthoses)</NAME>
<DICH_DATA CI_END="1.0637545574779748" CI_START="0.01751759049929208" EFFECT_SIZE="0.1365079365079365" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.026841433758492343" LOG_CI_START="-1.7565256301785204" LOG_EFFECT_SIZE="-0.864842098210014" ORDER="10088" O_E="0.0" SE="1.0475586411659408" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" VAR="1.0973791066814322" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2008-05-07 13:46:21 +1000" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Custom-made foot orthoses versus non custom foot orthoses for plantar fasciitis</NAME>
<CONT_OUTCOME CHI2="0.6482351659055812" CI_END="0.09874005387951179" CI_START="-0.3950531727184612" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.1481565594194747" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.01" NO="1" P_CHI2="0.7231652616629292" P_Q="0.6996033765706864" P_Z="0.23954455948146636" Q="0.1488849494173271" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="124" TOTAL_2="130" UNITS="" WEIGHT="200.0" Z="1.1761259770051733">
<NAME>Foot pain 2-3 months</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.49935021648825406" CI_END="0.19403777550066825" CI_START="-0.4188718669595578" DF="1.0" EFFECT_SIZE="-0.11241704572944478" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.01" NO="1" P_CHI2="0.47978582274850756" P_Z="0.47215631715878126" STUDIES="2" TAU2="0.0" TOTAL_1="79" TOTAL_2="86" WEIGHT="100.0" Z="0.7189750188745067">
<NAME>2-3 months</NAME>
<CONT_DATA CI_END="0.20252139937075977" CI_START="-0.6310451066076327" EFFECT_SIZE="-0.21426185361843644" ESTIMABLE="YES" MEAN_1="23.4" MEAN_2="29.3" ORDER="10089" SD_1="26.9" SD_2="27.7" SE="0.2126484242959204" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" WEIGHT="54.06452557712275"/>
<CONT_DATA CI_END="0.45961112957077155" CI_START="-0.444709317996545" EFFECT_SIZE="0.007450905787113263" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="18.8" ORDER="10090" SD_1="29.38" SD_2="24.07" SE="0.2306982308604854" STUDY_ID="STD-Pfeffer-1999" TOTAL_1="34" TOTAL_2="42" WEIGHT="45.93547442287725"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.20252139937075977" CI_START="-0.6310451066076327" DF="0.0" EFFECT_SIZE="-0.21426185361843644" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.02" NO="2" P_CHI2="1.0" P_Z="0.3136526376426828" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0" Z="1.0075873090894425">
<NAME>Sensitivity analysis 2-3 months</NAME>
<CONT_DATA CI_END="0.20252139937075977" CI_START="-0.6310451066076327" EFFECT_SIZE="-0.21426185361843644" ESTIMABLE="YES" MEAN_1="23.4" MEAN_2="29.3" ORDER="10091" SD_1="26.9" SD_2="27.7" SE="0.2126484242959204" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="184" TOTAL_2="190" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>Rubber heel cup at 2 months</NAME>
<CONT_DATA CI_END="4.9155719235583994" CI_START="-22.315571923558398" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="27.7" ORDER="10092" SD_1="29.38" SD_2="31.36" SE="6.94684801912499" STUDY_ID="STD-Pfeffer-1999" TOTAL_1="34" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="42" WEIGHT="0.0" Z="0.0">
<NAME>Silicone heel pad at 2 months</NAME>
<CONT_DATA CI_END="8.141138007482708" CI_START="-15.941138007482705" EFFECT_SIZE="-3.8999999999999986" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="22.9" ORDER="10093" SD_1="29.38" SD_2="22.78" SE="6.143550648104591" STUDY_ID="STD-Pfeffer-1999" TOTAL_1="34" TOTAL_2="42" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="62" WEIGHT="0.0" Z="0.0">
<NAME>Over-the-counter arch support at 3 months</NAME>
<CONT_DATA CI_END="10.655699567875615" CI_START="-4.655699567875614" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-23.0" MEAN_2="-26.0" ORDER="10094" SD_1="23.0" SD_2="22.0" SE="3.906040941702396" STUDY_ID="STD-Martin-2001" TOTAL_1="71" TOTAL_2="62" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.02.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 12 months</NAME>
<CONT_DATA CI_END="3.1970005704381386" CI_START="-17.19700057043814" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="41.7" ORDER="10095" SD_1="24.6" SD_2="24.2" SE="5.20264691130591" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours other FO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 3 months</NAME>
<CONT_DATA CI_END="5.817459048183986" CI_START="-13.417459048183987" EFFECT_SIZE="-3.8000000000000007" ESTIMABLE="YES" MEAN_1="21.9" MEAN_2="25.7" ORDER="10096" SD_1="21.9" SD_2="24.3" SE="4.906957027805244" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 12 months</NAME>
<CONT_DATA CI_END="6.6425389142130715" CI_START="-13.442538914213069" EFFECT_SIZE="-3.3999999999999986" ESTIMABLE="YES" MEAN_1="30.0" MEAN_2="33.4" ORDER="10097" SD_1="22.5" SD_2="25.4" SE="5.123838495721011" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-009.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="180" TOTAL_2="174" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Other foot orthoses</GROUP_LABEL_2>
<GRAPH_LABEL_1>Other orthoses worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-009.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 3 months</NAME>
<DICH_DATA CI_END="3.714831400322382" CI_START="0.11438226691144417" EFFECT_SIZE="0.6518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.56993910784862" LOG_CI_START="-0.9416413005382951" LOG_EFFECT_SIZE="-0.18585109634483743" ORDER="10098" O_E="0.0" SE="0.8879098143301708" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" VAR="0.7883838383838383" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 3 months (using alternative foot orthoses)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="10099" O_E="0.0" SE="0.0" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="11" I2="0.0" ID="CMP-009.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 12 months</NAME>
<DICH_DATA CI_END="1.5608360894696207" CI_START="0.30942057515768256" EFFECT_SIZE="0.694949494949495" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.1933572982088026" LOG_CI_START="-0.5094508109328798" LOG_EFFECT_SIZE="-0.15804675636203858" ORDER="10100" O_E="0.0" SE="0.41283296226607236" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" VAR="0.17043105473338033" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-009.04.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="43" WEIGHT="0.0" Z="0.0">
<NAME>Prefabricated Formthotic at 12 months (using alternative foot orthoses)</NAME>
<DICH_DATA CI_END="5.079317300633042" CI_START="0.044941394960661706" EFFECT_SIZE="0.4777777777777778" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7058053436830495" LOG_CI_START="-1.347353451402526" LOG_EFFECT_SIZE="-0.32077405385973834" ORDER="10101" O_E="0.0" SE="1.2060356395332144" STUDY_ID="STD-Landorf-2006" TOTAL_1="45" TOTAL_2="43" VAR="1.4545219638242894" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2008-05-07 13:46:47 +1000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Custom-made foot orthoses versus manipulation, mobilisation and stretching for plantar fasciitis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Manip/mob/stretch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours manip/mob/st</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>2 weeks</NAME>
<CONT_DATA CI_END="-3.9288518532575445" CI_START="-42.67114814674245" EFFECT_SIZE="-23.3" ESTIMABLE="YES" MEAN_1="-44.6" MEAN_2="-21.3" ORDER="10102" SD_1="22.1" SD_2="22.1" SE="9.883420460549072" STUDY_ID="STD-Dimou-2004" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>1 month</NAME>
<CONT_DATA CI_END="6.605755319646949" CI_START="-28.805755319646945" EFFECT_SIZE="-11.099999999999998" ESTIMABLE="YES" MEAN_1="-34.4" MEAN_2="-23.3" ORDER="10103" SD_1="20.2" SD_2="20.2" SE="9.03371462909915" STUDY_ID="STD-Dimou-2004" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>2 months</NAME>
<CONT_DATA CI_END="9.151492206032522" CI_START="-21.351492206032518" EFFECT_SIZE="-6.099999999999998" ESTIMABLE="YES" MEAN_1="-30.4" MEAN_2="-24.3" ORDER="10104" SD_1="17.4" SD_2="17.4" SE="7.781516561699267" STUDY_ID="STD-Dimou-2004" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-010.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Manip/mob/stretch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Manip/mob/stre worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>2 months</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="10105" O_E="0.0" SE="0.0" STUDY_ID="STD-Dimou-2004" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2008-05-07 13:47:03 +1000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Custom-made foot orthoses versus night splint for plantar fasciitis</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours night splint</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="12.730937152183664" CI_START="-14.510937152183665" EFFECT_SIZE="-0.8900000000000006" ESTIMABLE="YES" MEAN_1="14.93" MEAN_2="15.82" ORDER="10106" SD_1="16.6" SD_2="18.04" SE="6.949585430969078" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="24.715607694028645" CI_START="-12.715607694028645" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="76.0" MEAN_2="70.0" ORDER="10107" SD_1="26.0" SD_2="15.0" SE="9.548954900016005" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours night splint</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="4.763981124559368" CI_START="-34.78398112455936" EFFECT_SIZE="-15.009999999999998" ESTIMABLE="YES" MEAN_1="6.21" MEAN_2="21.22" ORDER="10108" SD_1="18.6" SD_2="31.38" SE="10.08895126672429" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="22.384366879369797" CI_START="-24.384366879369797" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="62.0" MEAN_2="63.0" ORDER="10109" SD_1="32.0" SD_2="20.0" SE="11.931018663517644" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours night splint</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="16.741738372565777" CI_START="-14.641738372565774" EFFECT_SIZE="1.0500000000000007" ESTIMABLE="YES" MEAN_1="13.21" MEAN_2="12.16" ORDER="10110" SD_1="19.6" SD_2="20.21" SE="8.006136080224026" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="18.538275159527345" CI_START="-16.538275159527345" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="76.0" MEAN_2="75.0" ORDER="10111" SD_1="24.0" SD_2="15.0" SE="8.948263997638232" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours night splint</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>6 weeks</NAME>
<CONT_DATA CI_END="11.709761884009156" CI_START="-23.689761884009158" EFFECT_SIZE="-5.99" ESTIMABLE="YES" MEAN_1="3.98" MEAN_2="9.97" ORDER="10112" SD_1="21.7" SD_2="23.29" SE="9.030656697583536" STUDY_ID="STD-Roos-2006" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="29.34532948403641" CI_START="-11.345329484036409" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="55.0" MEAN_2="46.0" ORDER="10113" SD_1="28.0" SD_2="17.0" SE="10.3804608883213" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-011.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="22" TOTAL_2="29" WEIGHT="0.0" Z="0.0">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Night splint worse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CFO worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-011.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>1 week</NAME>
<DICH_DATA CI_END="1.126970635570045" CI_START="0.13126250978847795" EFFECT_SIZE="0.38461538461538464" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.05191260018449492" LOG_CI_START="-0.8818592961261308" LOG_EFFECT_SIZE="-0.414973347970818" ORDER="10114" O_E="0.0" SE="0.5485022341382949" STUDY_ID="STD-Roos-2006" TOTAL_1="13" TOTAL_2="15" VAR="0.30085470085470084" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="5" I2="0.0" ID="CMP-011.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="2.2465497079284855" CI_START="0.0430839002205026" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.35151603238384765" LOG_CI_START="-1.3656849885780589" LOG_EFFECT_SIZE="-0.5070844780971057" ORDER="10115" O_E="0.0" SE="1.0086923799951686" STUDY_ID="STD-Roos-2006" TOTAL_1="9" TOTAL_2="14" VAR="1.0174603174603174" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-011.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Night splint</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours night splint</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="15" I2="0.0" ID="CMP-011.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="1.7931665186261427" CI_START="0.7590544977127632" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.2536206212758076" LOG_CI_START="-0.11972704201458118" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="10116" O_E="0.0" SE="0.21930626551751342" STUDY_ID="STD-Roos-2006" TOTAL_1="20" TOTAL_2="25" VAR="0.0480952380952381" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2008-05-07 13:47:29 +1000" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Custom-made foot orthoses versus no intervention for painful bunion with halgus valgus</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="16.843405793872197" CI_START="1.156594206127803" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="-36.0" MEAN_2="-45.0" ORDER="10117" SD_1="24.0" SD_2="23.0" SE="4.001811184154393" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="8.190625499407377" CI_START="-8.190625499407377" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-40.0" MEAN_2="-40.0" ORDER="10118" SD_1="23.0" SD_2="26.0" SE="4.1789673504278575" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="12.856844956580131" CI_START="-4.856844956580131" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="84.0" MEAN_2="80.0" ORDER="10119" SD_1="25.0" SD_2="28.0" SE="4.518881482742435" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="6.5106394842437645" CI_START="-10.510639484243764" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="81.0" MEAN_2="83.0" ORDER="10120" SD_1="26.0" SD_2="25.0" SE="4.3422427918954645" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="3.968941351132188" CI_START="-0.9689413511321878" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="92.0" MEAN_2="90.5" ORDER="10121" SD_1="6.5" SD_2="8.2" SE="1.2596871017053792" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="2.9034690123369793" CI_START="-1.9034690123369793" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="92.7" MEAN_2="92.2" ORDER="10122" SD_1="7.0" SD_2="7.4" SE="1.226282233395734" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="138" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Participant satisfaction with treatment</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comparison</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="35.47796638805037" CI_START="14.522033611949631" EFFECT_SIZE="25.0" ESTIMABLE="YES" MEAN_1="66.0" MEAN_2="41.0" ORDER="10123" SD_1="26.0" SD_2="36.0" SE="5.345999452387509" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-012.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="19.6701420662883" CI_START="-1.6701420662883013" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="61.0" ORDER="10124" SD_1="26.0" SD_2="37.0" SE="5.4440500695181235" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="67" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-012.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparison group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CFO</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparison</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="67" EVENTS_2="65" I2="0.0" ID="CMP-012.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<DICH_DATA CI_END="1.106979515224274" CI_START="0.9598056626055379" EFFECT_SIZE="1.0307692307692307" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="65" LOG_CI_END="0.04413958428669485" LOG_CI_START="-0.01781669217075322" LOG_EFFECT_SIZE="0.013161446057970814" ORDER="10125" O_E="0.0" SE="0.03639342347961966" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="69" VAR="0.0013244812725669314" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2008-05-07 13:47:51 +1000" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Custom-made foot orthoses versus surgery for painful bunion with hallux valgus</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="142" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Foot pain</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgery</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="-2.2096595952281044" CI_START="-17.790340404771896" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-36.0" MEAN_2="-26.0" ORDER="10126" SD_1="24.0" SD_2="23.0" SE="3.9747365085384763" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="-9.379451610359647" CI_START="-24.620548389640355" EFFECT_SIZE="-17.0" ESTIMABLE="YES" MEAN_1="-40.0" MEAN_2="-23.0" ORDER="10127" SD_1="23.0" SD_2="23.0" SE="3.888106337540009" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="142" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disability</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgery</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="7.121596742468114" CI_START="-9.121596742468114" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="84.0" MEAN_2="85.0" ORDER="10128" SD_1="25.0" SD_2="24.0" SE="4.143747949722664" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="-0.43910810777589226" CI_START="-15.560891892224108" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="81.0" MEAN_2="89.0" ORDER="10129" SD_1="26.0" SD_2="19.0" SE="3.8576687897652495" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="142" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgery</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="2.288111869838367" CI_START="-2.288111869838367" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="92.0" MEAN_2="92.0" ORDER="10130" SD_1="6.5" SD_2="7.3" SE="1.1674254669405668" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="1.9926674997389195" CI_START="-2.3926674997389252" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="92.7" MEAN_2="92.9" ORDER="10131" SD_1="7.0" SD_2="6.2" SE="1.1187284649281333" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="142" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Participant satisfaction with treatment</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgery</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.04.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.645658965754988" CI_START="-17.64565896575499" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="66.0" MEAN_2="74.0" ORDER="10132" SD_1="26.0" SD_2="32.0" SE="4.9213450052341345" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-013.04.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="-1.0527365094892147" CI_START="-18.947263490510785" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="80.0" ORDER="10133" SD_1="26.0" SD_2="28.0" SE="4.565014235509253" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="132" EVENTS_2="132" I2="0.0" I2_Q="0.0" ID="CMP-013.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="142" WEIGHT="0.0" Z="0.0">
<NAME>Compliance</NAME>
<GROUP_LABEL_1>Custom foot orthoses</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgery</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CFO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="65" EVENTS_2="66" I2="0.0" ID="CMP-013.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<DICH_DATA CI_END="1.1052285931567416" CI_START="0.92919153828117" EFFECT_SIZE="1.0133948177426437" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="66" LOG_CI_END="0.04345211193897409" LOG_CI_START="-0.03189475377336044" LOG_EFFECT_SIZE="0.005778679082806827" ORDER="10134" O_E="0.0" SE="0.04425912189242584" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" VAR="0.0019588698706886083" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="67" EVENTS_2="66" I2="0.0" ID="CMP-013.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="69" TOTAL_2="71" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<DICH_DATA CI_END="1.1269455340240488" CI_START="0.9682272992561849" EFFECT_SIZE="1.0445761967501097" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="66" LOG_CI_END="0.05190292683190008" LOG_CI_START="-0.014022676550344716" LOG_EFFECT_SIZE="0.018940125140777694" ORDER="10135" O_E="0.0" SE="0.038725025763730415" STUDY_ID="STD-Torkki-2001" TOTAL_1="69" TOTAL_2="71" VAR="0.0014996276204015842" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>